false--12-31Q220190001590714P7YP3YP1Y770000083000001487000004000000004000000002893000002583000000.02250.02250.02500.02750.0250.033500000008000000001100000000.000.03250.0350.0350.04466000000070000009000003100000240000000001400000000000002000000200000020000003000001700000 0001590714 2019-01-01 2019-06-30 0001590714 2019-07-26 0001590714 2019-04-01 2019-06-30 0001590714 2018-01-01 2018-06-30 0001590714 2018-04-01 2018-06-30 0001590714 2018-12-31 0001590714 2019-06-30 0001590714 2017-12-31 0001590714 2018-06-30 0001590714 us-gaap:CommonStockMember 2017-12-31 0001590714 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-06-30 0001590714 us-gaap:RetainedEarningsMember 2018-01-01 2018-06-30 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001590714 us-gaap:NoncontrollingInterestMember 2017-12-31 0001590714 us-gaap:TreasuryStockMember 2018-06-30 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-06-30 0001590714 us-gaap:AccountingStandardsUpdate201601Member us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 0001590714 us-gaap:ParentMember 2018-01-01 2018-06-30 0001590714 us-gaap:TreasuryStockMember 2017-12-31 0001590714 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-06-30 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 0001590714 us-gaap:CommonStockMember 2018-06-30 0001590714 us-gaap:PreferredStockMember 2018-06-30 0001590714 us-gaap:ParentMember 2018-01-01 0001590714 us-gaap:ParentMember 2017-12-31 0001590714 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 0001590714 us-gaap:PreferredStockMember 2017-12-31 0001590714 us-gaap:ParentMember 2018-06-30 0001590714 us-gaap:NoncontrollingInterestMember 2018-06-30 0001590714 us-gaap:RetainedEarningsMember 2018-06-30 0001590714 us-gaap:TreasuryStockMember 2018-01-01 0001590714 us-gaap:CommonStockMember 2018-01-01 0001590714 2018-01-01 0001590714 us-gaap:CommonStockMember 2018-01-01 2018-06-30 0001590714 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001590714 us-gaap:PreferredStockMember 2018-01-01 0001590714 us-gaap:RetainedEarningsMember 2017-12-31 0001590714 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001590714 us-gaap:RetainedEarningsMember 2018-01-01 0001590714 us-gaap:NoncontrollingInterestMember 2018-01-01 0001590714 us-gaap:AccountingStandardsUpdate201601Member us-gaap:RetainedEarningsMember 2018-01-01 0001590714 us-gaap:NoncontrollingInterestMember 2019-04-01 2019-06-30 0001590714 us-gaap:TreasuryStockMember 2019-03-31 0001590714 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001590714 us-gaap:ParentMember 2019-04-01 2019-06-30 0001590714 2019-03-31 0001590714 us-gaap:CommonStockMember 2019-03-31 0001590714 us-gaap:RetainedEarningsMember 2019-06-30 0001590714 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001590714 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001590714 us-gaap:PreferredStockMember 2019-06-30 0001590714 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001590714 us-gaap:TreasuryStockMember 2019-06-30 0001590714 us-gaap:NoncontrollingInterestMember 2019-03-31 0001590714 us-gaap:CommonStockMember 2019-06-30 0001590714 us-gaap:ParentMember 2019-06-30 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001590714 us-gaap:TreasuryStockMember 2019-04-01 2019-06-30 0001590714 us-gaap:NoncontrollingInterestMember 2019-06-30 0001590714 us-gaap:ParentMember 2019-03-31 0001590714 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001590714 us-gaap:PreferredStockMember 2019-03-31 0001590714 us-gaap:RetainedEarningsMember 2019-03-31 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001590714 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001590714 us-gaap:CommonStockMember 2018-12-31 0001590714 us-gaap:ParentMember 2019-01-01 2019-06-30 0001590714 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-06-30 0001590714 us-gaap:TreasuryStockMember 2019-01-01 2019-06-30 0001590714 us-gaap:ParentMember 2018-12-31 0001590714 us-gaap:CommonStockMember 2019-01-01 2019-06-30 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-06-30 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001590714 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-06-30 0001590714 us-gaap:PreferredStockMember 2018-12-31 0001590714 us-gaap:RetainedEarningsMember 2018-12-31 0001590714 us-gaap:TreasuryStockMember 2018-12-31 0001590714 us-gaap:NoncontrollingInterestMember 2018-12-31 0001590714 us-gaap:RetainedEarningsMember 2019-01-01 2019-06-30 0001590714 us-gaap:CommonStockMember 2018-04-01 2018-06-30 0001590714 us-gaap:RetainedEarningsMember 2018-03-31 0001590714 us-gaap:ParentMember 2018-04-01 2018-06-30 0001590714 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0001590714 us-gaap:NoncontrollingInterestMember 2018-04-01 2018-06-30 0001590714 us-gaap:PreferredStockMember 2018-03-31 0001590714 2018-03-31 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0001590714 us-gaap:NoncontrollingInterestMember 2018-03-31 0001590714 us-gaap:ParentMember 2018-03-31 0001590714 us-gaap:TreasuryStockMember 2018-03-31 0001590714 us-gaap:CommonStockMember 2018-03-31 0001590714 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-04-01 2018-06-30 0001590714 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0001590714 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001590714 esi:USDSeniorNotesDueTwoThousandAndTwentyFiveMember us-gaap:SeniorNotesMember 2018-12-31 0001590714 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember esi:AgriculturalSolutionsBusinessMember 2019-01-31 2019-01-31 0001590714 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember esi:AgriculturalSolutionsBusinessMember 2018-01-01 2018-12-31 0001590714 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember esi:AgriculturalSolutionsBusinessMember 2018-07-01 2019-06-30 0001590714 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember esi:AgriculturalSolutionsBusinessMember 2019-04-01 2019-06-30 0001590714 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember esi:AgriculturalSolutionsBusinessMember 2019-01-01 2019-06-30 0001590714 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember esi:AgriculturalSolutionsBusinessMember 2018-07-20 0001590714 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember esi:AgriculturalSolutionsBusinessMember 2018-01-01 2018-06-30 0001590714 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember esi:AgriculturalSolutionsBusinessMember 2018-04-01 2018-06-30 0001590714 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember esi:AgriculturalSolutionsBusinessMember 2019-06-30 0001590714 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember esi:AgriculturalSolutionsBusinessMember 2018-12-31 0001590714 us-gaap:BuildingImprovementsMember 2018-12-31 0001590714 esi:MachineryEquipmentFixturesandSoftwareMember 2019-06-30 0001590714 esi:LandAndLeaseholdImprovementsMember 2018-12-31 0001590714 us-gaap:ConstructionInProgressMember 2018-12-31 0001590714 esi:MachineryEquipmentFixturesandSoftwareMember 2018-12-31 0001590714 us-gaap:BuildingImprovementsMember 2019-06-30 0001590714 us-gaap:ConstructionInProgressMember 2019-06-30 0001590714 esi:LandAndLeaseholdImprovementsMember 2019-06-30 0001590714 esi:ElectronicsSegmentMember 2019-06-30 0001590714 esi:IndustrialAndSpecialtySegmentMember 2019-06-30 0001590714 esi:IndustrialAndSpecialtySegmentMember 2019-01-01 2019-06-30 0001590714 esi:ElectronicsSegmentMember 2019-01-01 2019-06-30 0001590714 esi:ElectronicsSegmentMember 2018-12-31 0001590714 esi:IndustrialAndSpecialtySegmentMember 2018-12-31 0001590714 us-gaap:DevelopedTechnologyRightsMember 2018-12-31 0001590714 us-gaap:CustomerListsMember 2018-12-31 0001590714 us-gaap:TradeNamesMember 2018-12-31 0001590714 us-gaap:NoncompeteAgreementsMember 2019-06-30 0001590714 us-gaap:CustomerListsMember 2019-06-30 0001590714 us-gaap:NoncompeteAgreementsMember 2018-12-31 0001590714 us-gaap:DevelopedTechnologyRightsMember 2019-06-30 0001590714 us-gaap:TradeNamesMember 2019-06-30 0001590714 us-gaap:TradeNamesMember 2018-12-31 0001590714 us-gaap:TradeNamesMember 2019-06-30 0001590714 us-gaap:TradeNamesMember 2019-01-01 2019-03-31 0001590714 us-gaap:LineOfCreditMember 2019-06-30 0001590714 esi:FirstLienCreditFacilityTermLoansMember us-gaap:LineOfCreditMember 2019-06-30 0001590714 us-gaap:RevolvingCreditFacilityMember esi:EurocurrencyRateMember 2019-01-31 2019-01-31 0001590714 us-gaap:RevolvingCreditFacilityMember 2018-01-01 2018-12-31 0001590714 esi:LinesofCreditandRevolvingLinesofCreditMember us-gaap:LineOfCreditMember 2018-12-31 0001590714 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2019-01-31 0001590714 esi:USDSeniorNotesDueTwoThousandAndTwentyFiveMember us-gaap:SeniorNotesMember 2019-02-01 2019-02-01 0001590714 us-gaap:SeniorNotesMember 2019-06-30 0001590714 us-gaap:LetterOfCreditMember 2019-01-31 0001590714 us-gaap:RevolvingCreditFacilityMember 2019-01-31 0001590714 esi:LinesofCreditandRevolvingLinesofCreditMember us-gaap:LineOfCreditMember 2019-06-30 0001590714 esi:FirstLienCreditFacilityTermLoansMember us-gaap:LineOfCreditMember 2018-12-31 0001590714 2019-01-31 2019-01-31 0001590714 us-gaap:RevolvingCreditFacilityMember 2019-01-31 2019-01-31 0001590714 esi:USDSeniorNotesDueTwoThousandAndTwentyFiveMember us-gaap:SeniorNotesMember 2019-06-30 0001590714 esi:FirstLienCreditFacilityUSDollarTermLoanDueTwoThousandAndTwentySixMember us-gaap:DomesticLineOfCreditMember 2019-01-31 0001590714 us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2019-01-31 2019-01-31 0001590714 us-gaap:SeniorNotesMember 2018-12-31 0001590714 us-gaap:LineOfCreditMember 2018-12-31 0001590714 us-gaap:RevolvingCreditFacilityMember 2019-06-30 0001590714 us-gaap:RevolvingCreditFacilityMember 2019-01-01 2019-06-30 0001590714 esi:EURSeniorNotesDueTwoThousandTwentyThreeMember us-gaap:SeniorNotesMember 2019-06-30 0001590714 esi:FirstLienCreditFacilityUSDollarTermLoanDueTwoThousandTwentyInterestAtGreaterOfThreePointFivePercentorLIBORPlusTwoPointFiveZeroPercentMember us-gaap:DomesticLineOfCreditMember 2019-06-30 0001590714 esi:FirstLienCreditFacilityUSDollarTermLoanDueTwoThousandTwentyOneInterestAtGreaterOfFourPointZeroPercentOrLIBORPlusThreePointZeroPercentMember us-gaap:DomesticLineOfCreditMember 2018-12-31 0001590714 us-gaap:NotesPayableOtherPayablesMember 2018-12-31 0001590714 esi:FirstLienCreditFacilityUSDollarTermLoanDueTwoThousandAndTwentySixMember us-gaap:DomesticLineOfCreditMember 2019-06-30 0001590714 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2018-12-31 0001590714 esi:FirstLienCreditFacilityEuroTermLoanDueTwoThousandTwentyOneInterestAtGreaterOfThreePointFivePercentorEURIBORPlusTwoPointSevenFivePercentMember us-gaap:ForeignLineOfCreditMember 2019-06-30 0001590714 esi:FirstLienCreditFacilityEuroTermLoanDueTwoThousandTwentyOneInterestAtGreaterOfThreePointFivePercentorEURIBORPlusTwoPointSevenFivePercentMember us-gaap:ForeignLineOfCreditMember 2018-12-31 0001590714 esi:USDSeniorNotesDueTwoThousandAndTwentyTwoMember us-gaap:SeniorNotesMember 2019-06-30 0001590714 esi:FirstLienCreditFacilityEuroTermLoanDueTwoThousandTwentyInterestAtGreaterOfThreePointTwoFivePercentorEURIBORPlusTwoPointFivePercentMember us-gaap:ForeignLineOfCreditMember 2018-12-31 0001590714 esi:FirstLienCreditFacilityUSDollarTermLoanDueTwoThousandTwentyOneInterestAtGreaterOfFourPointZeroPercentOrLIBORPlusThreePointZeroPercentMember us-gaap:DomesticLineOfCreditMember 2019-06-30 0001590714 esi:FirstLienCreditFacilityUSDollarTermLoanDueTwoThousandAndTwentySixMember us-gaap:DomesticLineOfCreditMember 2018-12-31 0001590714 esi:FirstLienCreditFacilityEuroTermLoanDueTwoThousandTwentyInterestAtGreaterOfThreePointTwoFivePercentorEURIBORPlusTwoPointFivePercentMember us-gaap:ForeignLineOfCreditMember 2019-06-30 0001590714 esi:EURSeniorNotesDueTwoThousandTwentyThreeMember us-gaap:SeniorNotesMember 2018-12-31 0001590714 us-gaap:NotesPayableOtherPayablesMember 2019-06-30 0001590714 esi:USDSeniorNotesDueTwoThousandAndTwentyTwoMember us-gaap:SeniorNotesMember 2018-12-31 0001590714 esi:FirstLienCreditFacilityUSDollarTermLoanDueTwoThousandTwentyInterestAtGreaterOfThreePointFivePercentorLIBORPlusTwoPointFiveZeroPercentMember us-gaap:DomesticLineOfCreditMember 2018-12-31 0001590714 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2019-06-30 0001590714 esi:FirstLienCreditFacilityEuroTermLoanDueTwoThousandTwentyOneInterestAtGreaterOfThreePointFivePercentorEURIBORPlusTwoPointSevenFivePercentMember us-gaap:ForeignLineOfCreditMember esi:EURIBORMember 2019-01-01 2019-06-30 0001590714 esi:FirstLienCreditFacilityUSDollarTermLoanDueTwoThousandTwentyInterestAtGreaterOfThreePointFivePercentorLIBORPlusTwoPointFiveZeroPercentMember us-gaap:DomesticLineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-06-30 0001590714 esi:FirstLienCreditFacilityEuroTermLoanDueTwoThousandTwentyInterestAtGreaterOfThreePointTwoFivePercentorEURIBORPlusTwoPointFivePercentMember us-gaap:ForeignLineOfCreditMember esi:EURIBORMember 2019-01-01 2019-06-30 0001590714 esi:FirstLienCreditFacilityUSDollarTermLoanDueTwoThousandTwentyOneInterestAtGreaterOfFourPointZeroPercentOrLIBORPlusThreePointZeroPercentMember us-gaap:DomesticLineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-06-30 0001590714 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-06-30 0001590714 us-gaap:InterestRateSwapMember 2019-01-01 2019-06-30 0001590714 us-gaap:ForeignExchangeForwardMember 2019-01-01 2019-06-30 0001590714 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-12-31 0001590714 esi:MacDermidMember 2019-06-30 0001590714 esi:EuroNotesMember us-gaap:InterestRateSwapMember us-gaap:NotesPayableToBanksMember 2019-06-30 0001590714 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2019-06-30 0001590714 esi:MacDermidMember esi:ContingentConsiderationCommonStockPerformanceTargetMember 2019-01-01 2019-06-30 0001590714 esi:MacDermidMember esi:ContingentConsiderationAdjustedEBITDAPerformanceMetricMember 2019-01-01 2019-06-30 0001590714 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2018-12-31 0001590714 esi:ContingentConsiderationAdjustedEBITDAPerformanceMetricMember 2019-01-01 2019-06-30 0001590714 esi:EuroNotesMember us-gaap:InterestRateSwapMember us-gaap:MediumTermNotesMember 2019-01-31 0001590714 us-gaap:ForeignExchangeForwardMember 2018-12-31 0001590714 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-06-30 0001590714 esi:USDNotesMember us-gaap:InterestRateSwapMember us-gaap:NotesPayableToBanksMember 2019-06-30 0001590714 esi:MacDermidMember esi:ContingentConsiderationAdjustedEBITDAPerformanceMetricMember us-gaap:MeasurementInputDiscountRateMember 2019-06-30 0001590714 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-06-30 0001590714 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2019-01-01 2019-06-30 0001590714 us-gaap:ForeignExchangeForwardMember 2019-06-30 0001590714 us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001590714 us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001590714 us-gaap:AccruedLiabilitiesMember esi:ForeignExchangeAndMetalsContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001590714 us-gaap:AccruedLiabilitiesMember esi:ForeignExchangeAndMetalsContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001590714 us-gaap:OtherCurrentAssetsMember esi:ForeignExchangeAndMetalsContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001590714 us-gaap:OtherCurrentAssetsMember esi:ForeignExchangeAndMetalsContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001590714 us-gaap:OtherLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001590714 us-gaap:AccruedLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001590714 esi:ContingentConsiderationMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001590714 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001590714 us-gaap:AccruedLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001590714 us-gaap:OtherLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001590714 us-gaap:OtherAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001590714 us-gaap:OtherAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001590714 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001590714 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001590714 us-gaap:OtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001590714 us-gaap:OtherAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001590714 us-gaap:OtherAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001590714 us-gaap:OtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001590714 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001590714 esi:ContingentConsiderationMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001590714 esi:MacDermidMember 2018-01-01 2018-12-31 0001590714 2019-02-08 2019-02-08 0001590714 esi:MacDermidMember 2018-04-01 2018-06-30 0001590714 us-gaap:SeriesAPreferredStockMember 2019-06-30 0001590714 us-gaap:SeriesAPreferredStockMember 2019-01-01 2019-06-30 0001590714 esi:PDHMember esi:MacDermidMember 2013-10-31 2013-10-31 0001590714 esi:MacDermidMember 2018-01-01 2018-06-30 0001590714 us-gaap:CommonStockMember 2019-02-08 2019-02-08 0001590714 esi:MacDermidMember 2019-01-01 2019-06-30 0001590714 esi:FounderEntitiesMember us-gaap:SeriesAPreferredStockMember 2019-06-30 0001590714 esi:MacDermidMember 2013-10-31 0001590714 esi:PDHMember 2019-03-29 0001590714 esi:FounderEntitiesMember us-gaap:SeriesAPreferredStockMember 2019-01-01 2019-06-30 0001590714 us-gaap:SeriesAPreferredStockMember 2018-12-31 0001590714 esi:SharesIssuableUponConversionOfPDHNonControllingInterestMember 2018-04-01 2018-06-30 0001590714 esi:SharesIssuableUponConversionOfFounderPreferredSharesMember 2019-04-01 2019-06-30 0001590714 esi:ContingentlyIssuableForTheContingentConsiderationMember 2019-04-01 2019-06-30 0001590714 esi:SharesIssuableUponConversionOfFounderPreferredSharesMember 2018-01-01 2018-06-30 0001590714 esi:SharesIssuableUponConversionOfPDHNonControllingInterestMember 2018-01-01 2018-06-30 0001590714 esi:ContingentlyIssuableForTheContingentConsiderationMember 2018-04-01 2018-06-30 0001590714 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-06-30 0001590714 us-gaap:RestrictedStockUnitsRSUMember 2019-04-01 2019-06-30 0001590714 esi:SharesIssuableUponConversionOfPDHNonControllingInterestMember 2019-01-01 2019-06-30 0001590714 esi:SharesIssuableUponConversionOfFounderPreferredSharesMember 2018-04-01 2018-06-30 0001590714 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-06-30 0001590714 esi:SharesIssuableUponConversionOfPDHNonControllingInterestMember 2019-04-01 2019-06-30 0001590714 esi:SharesIssuableUponConversionOfFounderPreferredSharesMember 2019-01-01 2019-06-30 0001590714 esi:ContingentlyIssuableForTheContingentConsiderationMember 2019-01-01 2019-06-30 0001590714 esi:ContingentlyIssuableForTheContingentConsiderationMember 2018-01-01 2018-06-30 0001590714 us-gaap:RestrictedStockUnitsRSUMember 2018-04-01 2018-06-30 0001590714 esi:AnnualFeesMember esi:MariposaCapitalMember 2019-01-31 2019-01-31 0001590714 esi:MariposaCapitalMember 2019-01-01 2019-06-30 0001590714 esi:AnnualFeesMember esi:MariposaCapitalMember 2019-02-01 2019-02-01 0001590714 esi:IndustrialAndSpecialtySegmentMember 2018-01-01 2018-06-30 0001590714 esi:IndustrialSolutionsMember esi:IndustrialAndSpecialtySegmentMember 2019-01-01 2019-06-30 0001590714 esi:ElectronicsSegmentMember 2018-01-01 2018-06-30 0001590714 esi:IndustrialAndSpecialtySegmentMember 2019-04-01 2019-06-30 0001590714 esi:ElectronicsSegmentMember 2019-04-01 2019-06-30 0001590714 esi:EnergySolutionsMember esi:IndustrialAndSpecialtySegmentMember 2019-04-01 2019-06-30 0001590714 esi:ElectronicsSolutionsMember esi:ElectronicsSegmentMember 2019-04-01 2019-06-30 0001590714 esi:ElectronicsSolutionsMember esi:ElectronicsSegmentMember 2018-04-01 2018-06-30 0001590714 esi:ElectronicsSegmentMember 2018-04-01 2018-06-30 0001590714 esi:AssemblySolutionsMember esi:ElectronicsSegmentMember 2018-01-01 2018-06-30 0001590714 esi:IndustrialAndSpecialtySegmentMember 2018-04-01 2018-06-30 0001590714 esi:EnergySolutionsMember esi:IndustrialAndSpecialtySegmentMember 2018-04-01 2018-06-30 0001590714 esi:IndustrialSolutionsMember esi:IndustrialAndSpecialtySegmentMember 2018-04-01 2018-06-30 0001590714 esi:SemiConductorsMember esi:ElectronicsSegmentMember 2019-04-01 2019-06-30 0001590714 esi:AssemblySolutionsMember esi:ElectronicsSegmentMember 2019-01-01 2019-06-30 0001590714 esi:EnergySolutionsMember esi:IndustrialAndSpecialtySegmentMember 2018-01-01 2018-06-30 0001590714 esi:IndustrialSolutionsMember esi:IndustrialAndSpecialtySegmentMember 2019-04-01 2019-06-30 0001590714 esi:IndustrialSolutionsMember esi:IndustrialAndSpecialtySegmentMember 2018-01-01 2018-06-30 0001590714 esi:ElectronicsSolutionsMember esi:ElectronicsSegmentMember 2018-01-01 2018-06-30 0001590714 esi:SemiConductorsMember esi:ElectronicsSegmentMember 2019-01-01 2019-06-30 0001590714 esi:EnergySolutionsMember esi:IndustrialAndSpecialtySegmentMember 2019-01-01 2019-06-30 0001590714 esi:ElectronicsSolutionsMember esi:ElectronicsSegmentMember 2019-01-01 2019-06-30 0001590714 esi:GraphicsSolutionsMember esi:IndustrialAndSpecialtySegmentMember 2018-01-01 2018-06-30 0001590714 esi:SemiConductorsMember esi:ElectronicsSegmentMember 2018-01-01 2018-06-30 0001590714 esi:GraphicsSolutionsMember esi:IndustrialAndSpecialtySegmentMember 2018-04-01 2018-06-30 0001590714 esi:AssemblySolutionsMember esi:ElectronicsSegmentMember 2018-04-01 2018-06-30 0001590714 esi:AssemblySolutionsMember esi:ElectronicsSegmentMember 2019-04-01 2019-06-30 0001590714 esi:SemiConductorsMember esi:ElectronicsSegmentMember 2018-04-01 2018-06-30 0001590714 esi:GraphicsSolutionsMember esi:IndustrialAndSpecialtySegmentMember 2019-04-01 2019-06-30 0001590714 esi:GraphicsSolutionsMember esi:IndustrialAndSpecialtySegmentMember 2019-01-01 2019-06-30 iso4217:USD xbrli:pure iso4217:USD xbrli:shares xbrli:shares iso4217:EUR esi:segment
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________

FORM 10-Q
_______________


QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2019
OR
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
 
Commission file number: 001-36272
ELEMENTLOGOUPDATEDREGRGBA05.JPG
Element Solutions Inc
(Exact name of Registrant as specified in its charter)
Delaware
 
 
37-1744899
(State or other jurisdiction of incorporation or organization)
 
 
(I.R.S. Employer Identification No.)
 
 
 
 
 
500 East Broward Boulevard,
Suite 1860
 
33394
Fort Lauderdale,
Florida
 
 
(Zip Code)
(Address of principal executive offices)
 
 
 
Registrant’s telephone number, including area code: (561) 207-9600
_______________
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
ESI
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes        No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes        No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.    



Large accelerated filer
Accelerated filer
Non-accelerated filer  
Smaller reporting company
 
 
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes   No
Number of shares of common stock outstanding at July 26, 2019: 256,664,544



TABLE OF CONTENTS



 
Page
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Condensed Consolidated Statements of Operations
 
 
Three and Six Months Ended June 30, 2019 and 2018
1
 
Condensed Consolidated Statements of Comprehensive (Loss) Income
 
 
Three and Six Months Ended June 30, 2019 and 2018
2
 
Condensed Consolidated Balance Sheets
 
 
June 30, 2019 and December 31, 2018
3
 
Condensed Consolidated Statements of Cash Flows
 
 
Six Months Ended June 30, 2019 and 2018
4
 
Condensed Consolidated Statements of Changes in Stockholders' Equity
 
 
Three and Six Months Ended June 30, 2019 and 2018
5
 
7
22
34
34
 
 
 
 
 
 
 
35
35
35
35
35
35
36
 
 
 
37



GLOSSARY OF DEFINED TERMS


Terms    
 
Definitions
Element Solutions;
We; Us; Our; the Company
 
Element Solutions Inc, a Delaware corporation, and, where the context requires, its subsidiaries or operating businesses.
Arysta
 
Arysta LifeScience Inc., parent company of the former Agricultural Solutions segment.
Arysta Sale
 
Sale of 100% of the issued and outstanding shares of common stock of Arysta and its subsidiaries to UPL for net cash proceeds of approximately $4.28 billion, completed on January 31, 2019.
Arysta Sale Agreement
 
Stock Purchase Agreement, dated July 20, 2018, as amended by Amendment Number One to Stock Purchase Agreement, dated as of January 25, 2019, related to the Arysta Sale.
ASU
 
Accounting Standards Update.
Board
 
Element Solutions' board of directors.
EBITDA
 
Earnings before interest, taxes, depreciation and amortization.
ESPP
 
Element Solutions Inc 2014 Employee Stock Purchase Plan.
Exchange Act
 
Securities Exchange Act of 1934, as amended.
FASB
 
Financial Accounting Standard Board.
Founder Entities
 
Mariposa Acquisition, LLC and Berggruen Holdings Ltd. and affiliates, collectively.
GAAP
 
Generally accepted accounting principles in the United States.
MacDermid
 
MacDermid, Incorporated, a Connecticut corporation.
MacDermid Acquisition
 
Element Solutions' acquisition of 100% of the equity of MacDermid Holdings, LLC, completed on October 31, 2013 and March 4, 2014.
New Credit Agreement
 
Element Solutions' new Credit Agreement, dated as of January 31, 2019, among, inter alia, Element Solutions and MacDermid, as borrowers, certain subsidiaries of Element Solutions and MacDermid from time to time parties thereto, the lenders from time to time parties thereto, and Barclays Bank PLC, as administrative agent and collateral agent.
NYSE
 
New York Stock Exchange.
OEM
 
Original Equipment Manufacturer.
PDH
 
Platform Delaware Holdings, Inc., a former subsidiary of Element Solutions.
Prior Senior Notes
 
Element Solutions' 6.00% EUR Notes due 2023 and 6.50% USD Notes due 2022, collectively.
Prior Senior Notes Indenture
 
The indenture, dated as of February 2, 2015, governing the Prior Senior Notes prior to their redemption.
Quarterly Report
 
This quarterly report on Form 10-Q for the three and six months ended June 30, 2019.
Retaining Holder
 
Each Holder whose equity interest of MacDermid Holdings, LLC, held immediately prior to the closing of the MacDermid Acquisition, was converted into shares of common stock of PDH pursuant to a Retaining Holder Securityholders’ Agreement dated October 31, 2013.
SEC
 
Securities and Exchange Commission.
Series A Preferred Stock
 
2,000,000 shares of Element Solutions' Series A convertible preferred stock held by the Founder Entities and convertible into shares of Element Solutions' common stock, on a one-for-one basis, at any time at the option of the Founder Entities.
UPL
 
UPL Corporation Ltd., a Mauritius public limited company and a wholly-owned subsidiary of UPL Limited.
2018 Annual Report
 
Element Solutions' annual report on Form 10-K for the fiscal year ended December 31, 2018, filed with the SEC on February 28, 2019.
5.875% USD Notes Indenture
 
The indenture, dated November 24, 2017, governing the 5.875% USD Notes due 2025.
5.875% USD Notes due 2025
 
Element Solutions' $800 million aggregate principal amount of 5.875% senior notes due 2025, denominated in U.S. dollars, issued on November 24, 2017.
6.00% EUR Senior Notes due 2023
 
Element Solutions’ €350,000,000 aggregate principal amount of 6.00% senior notes due 2023, denominated in euros, issued on February 2, 2015 and redeemed on February 1, 2019.
6.50% USD Senior Notes due 2022
 
Element Solutions’ $1,100,000,000 aggregate principal amount of 6.50% senior notes due 2022, denominated in U.S. dollars, issued on February 2, 2015 and redeemed on February 1, 2019.


i


Discontinued Operations
Unless otherwise specified, the results and disclosures presented in this Quarterly Report exclude discontinued operations. Discontinued operations relate to the former Agricultural Solutions business of Element Solutions which consisted of Arysta and its subsidiaries. Accordingly, Agricultural Solutions' assets, liabilities, operating results and cash flows for all periods presented have been classified as discontinued operations within the unaudited Condensed Consolidated Financial Statements. The Arysta Sale was completed on January 31, 2019. See Note 3, Discontinued Operations, to the unaudited Condensed Consolidated Financial Statements included in this Quarterly Report for additional information.
Forward-Looking Statements
This Quarterly Report contains forward-looking statements that can be identified by words such as "expect," "anticipate," "project," "will," "should," "believe," "intend," "plan," "assume," "estimate," "predict," "seek," "continue," "outlook," "may," "might," "can have," "likely," "potential," "target," "hope," "goal" or "priority" and variations of such words and similar expressions. Examples of forward looking statements include, but are not limited to, statements, beliefs, projections and expectations regarding our corporate reorganization; business strategy and potential repurchases of our common stock; cost savings and efficiencies relating to the Arysta Sale or otherwise; the impact of new accounting standards and accounting changes; our dividend policy; the effects of global economic conditions on our business and financial condition; our hedging activities; timing and outcome of environmental and legal matters; our goodwill and other intangible assets; price volatility and cost environment; our liquidity and capital resources; our funding sources; our capital expenditures; our debt; off-balance sheet arrangements and contractual obligations; general views about future operating results; our risk management programs; our business and management strategies; future prospects; and other events or developments that we expect or anticipate will occur in the future.
Forward-looking statements are not guarantees of future performance, actions or events and are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management’s underlying estimates, assumptions or expectations prove to be inaccurate or are unrealized, actual results may differ materially from those contemplated by these statements. A discussion of such risks and uncertainties include, without limitation, the risks set forth in Part I, Item 1A, Risk Factors, of our 2018 Annual Report. Any forward-looking statement made by us in this Quarterly Report is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Please consult any further disclosures on related subjects in our Form 10-K, 10-Q and 8-K reports filed with the SEC.
Non-GAAP Financial Measures
This Quarterly Report contains non-GAAP financial measures, such as operating results on a constant currency and organic basis. Non-GAAP financial measures should not be considered in isolation from, as a substitute for, or superior to, performance measures calculated in accordance with GAAP. For definitions of these non-GAAP financial measures and additional information on why they are presented, their respective limitations and reconciliations to the most comparable applicable GAAP measures, see "Non-GAAP Financial Measures" in the Management's Discussion and Analysis of Financial Condition and Results of Operations section in Part I, Item 2, and Note 15, Segment Information, to the unaudited Condensed Consolidated Financial Statements, both included in this Quarterly Report.


ii



PART I. FINANCIAL INFORMATION



Item 1. Condensed Consolidated Financial Statements
 
ELEMENT SOLUTIONS INC AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(dollars in millions, except per share amounts)
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Net sales
$
456.7

 
$
501.6

 
$
916.5

 
$
994.1

Cost of sales
263.7

 
286.9

 
525.2

 
568.3

Gross profit
193.0

 
214.7

 
391.3

 
425.8

Operating expenses:
 

 
 
 
 

 
 

Selling, technical, general and administrative
126.4

 
144.3

 
268.8

 
285.1

Research and development
11.1

 
11.2

 
21.9

 
22.6

Total operating expenses
137.5

 
155.5

 
290.7

 
307.7

Operating profit
55.5

 
59.2

 
100.6

 
118.1

Other expense:
 

 
 

 
 

 
 

Interest expense, net
(18.2
)
 
(78.3
)
 
(56.3
)
 
(155.5
)
Foreign exchange (loss) gain
(28.3
)
 
(2.4
)
 
(1.2
)
 
5.1

Other (expense) income, net
(1.1
)
 
1.9

 
(49.1
)
 
13.7

Total other expense
(47.6
)
 
(78.8
)
 
(106.6
)
 
(136.7
)
Income (loss) before income taxes and non-controlling interests
7.9

 
(19.6
)
 
(6.0
)
 
(18.6
)
Income tax benefit (expense)
6.8

 
(30.0
)
 
17.2

 
(39.9
)
Net income (loss) from continuing operations
14.7

 
(49.6
)
 
11.2

 
(58.5
)
(Loss) income from discontinued operations, net of tax
(13.3
)
 
61.4

 
14.1

 
108.3

Net income
1.4

 
11.8

 
25.3

 
49.8

Net loss (income) attributable to the non-controlling interests
0.1

 
0.2

 
(0.6
)
 
(0.5
)
Net income attributable to common stockholders
$
1.5

 
$
12.0

 
$
24.7

 
$
49.3

 
 
 
 
 
 
 
 
Earnings (loss) per share
 

 
 

 
 

 
 

Basic from continuing operations
$
0.06

 
$
(0.17
)
 
$
0.04

 
$
(0.21
)
Basic from discontinued operations
(0.05
)
 
0.21

 
0.05

 
0.38

Basic attributable to common stockholders
$
0.01

 
$
0.04

 
$
0.09

 
$
0.17

 
 
 
 
 
 
 
 
Diluted from continuing operations
$
0.06

 
$
(0.17
)
 
$
0.04

 
$
(0.21
)
Diluted from discontinued operations
(0.05
)
 
0.21

 
0.05

 
0.38

Diluted attributable to common stockholders
$
0.01

 
$
0.04

 
$
0.09

 
$
0.17

 
 
 
 
 
 
 
 
Weighted average common shares outstanding
 

 
 
 
 

 
 

Basic
257.3

 
288.2

 
262.7

 
288.0

Diluted
259.6

 
288.2

 
265.3

 
288.0


See accompanying notes to the Condensed Consolidated Financial Statements


1


ELEMENT SOLUTIONS INC AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME
(Unaudited)
(dollars in millions)
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Net income
$
1.4

 
$
11.8

 
$
25.3

 
$
49.8

 
 

 
 

 
 

 
 

Other comprehensive (loss) income
 
 
 
 
 
 
 
Foreign currency translation:
 
 
 
 
 
 
 
Other comprehensive (loss) income before reclassifications, net of tax (benefit) of $(0.7) and $0.0 for the three months ended June 30, 2019 and 2018, and $0.0 for the six months ended June 30, 2019 and 2018, respectively
(0.1
)
 
(377.8
)
 
94.1

 
(318.6
)
Reclassifications, net of tax of $0.0 for the three and six months ended June 30, 2019 and 2018, respectively

 

 
479.8

 

Total foreign currency translation adjustments
(0.1
)
 
(377.8
)
 
573.9

 
(318.6
)
Pension and post-retirement plans:
 
 
 
 
 
 
 
Reclassifications, net of tax of $0.0 for the three and six months ended June 30, 2019 and 2018, respectively

 

 
(2.1
)
 

Total pension and post-retirement plans

 

 
(2.1
)
 

Derivative financial instruments:
 
 
 
 
 
 
 
Other comprehensive (loss) income before reclassifications, net of tax expense (benefit) of $2.4 and $0.9 for the three months ended June 30, 2019 and 2018, and $0.0 and $3.1 for the six months ended June 30, 2019 and 2018, respectively
(18.5
)
 
10.4

 
(27.7
)
 
7.8

Reclassifications, net of tax of $0.00 and $0.0 for the three months ended June 30, 2019 and 2018, and $1.4 and $0.0 for the six months ended June 30, 2019 and 2018, respectively
0.3

 
(7.8
)
 
(5.4
)
 
0.9

Total unrealized (loss) gain arising on qualified hedging derivatives
(18.2
)
 
2.6

 
(33.1
)
 
8.7

Other comprehensive (loss) income
(18.3
)
 
(375.2
)
 
538.7

 
(309.9
)
Comprehensive (loss) income
(16.9
)
 
(363.4
)
 
564.0

 
(260.1
)
Comprehensive loss (income) attributable to the non-controlling interests

 
35.1

 
(40.2
)
 
32.8

Comprehensive (loss) income attributable to common stockholders
$
(16.9
)
 
$
(328.3
)
 
$
523.8

 
$
(227.3
)
 
See accompanying notes to the Condensed Consolidated Financial Statements


2


ELEMENT SOLUTIONS INC AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(dollars in millions)
 
June 30,
 
December 31,
 
2019
 
2018
Assets
 
 
 
Cash and cash equivalents
$
247.6

 
$
233.6

Accounts receivable, net of allowance for doubtful accounts of $8.3 and $7.7 at June 30, 2019 and December 31, 2018, respectively
374.7

 
382.4

Inventories
201.6

 
188.1

Prepaid expenses
23.7

 
14.3

Other current assets
69.1

 
42.5

Current assets of discontinued operations
9.6

 
1,621.3

Total current assets
926.3

 
2,482.2

Property, plant and equipment, net
256.7

 
266.9

Goodwill
2,177.9

 
2,182.6

Intangible assets, net
967.0

 
1,024.5

Other assets
105.6

 
32.9

Non-current assets of discontinued operations
6.8

 
3,412.4

Total assets
$
4,440.3

 
$
9,401.5

Liabilities and stockholders' equity
 

 
 

Accounts payable
$
106.1

 
$
100.9

Current installments of long-term debt and revolving credit facilities
57.8

 
25.3

Accrued expenses and other current liabilities
116.2

 
189.5

Current liabilities of discontinued operations
57.9

 
826.8

Total current liabilities
338.0

 
1,142.5

Debt
1,515.3

 
5,350.7

Pension and post-retirement benefits
48.6

 
49.5

Deferred income taxes
120.3

 
133.0

Other liabilities
186.9

 
128.5

Non-current liabilities of discontinued operations

 
416.2

Total liabilities
2,209.1

 
7,220.4

Commitments and contingencies (Note 12)


 


Stockholders' Equity
 

 
 

Preferred stock - Series A

 

Common stock: 400.0 shares authorized (2019: 258.3 shares issued; 2018: 289.3 shares issued)
2.6

 
2.9

Additional paid-in capital
4,109.4

 
4,062.1

Treasury stock (2019: 1.7 shares; 2018: 0.3 shares)
(16.8
)
 
(3.5
)
Accumulated deficit
(1,604.0
)
 
(1,195.4
)
Accumulated other comprehensive loss
(258.4
)
 
(756.9
)
Total stockholders' equity
2,232.8

 
2,109.2

Non-controlling interests
(1.6
)
 
71.9

Total equity
2,231.2

 
2,181.1

Total liabilities and stockholders' equity
$
4,440.3

 
$
9,401.5


See accompanying notes to the Condensed Consolidated Financial Statements


3


ELEMENT SOLUTIONS INC AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(dollars in millions)
 
Six Months Ended June 30,
 
2019
 
2018
Cash flows from operating activities:
 

 
Net income
$
25.3

 
$
49.8

Net income from discontinued operations, net of tax
14.1

 
108.3

Net income (loss) from continuing operations
11.2

 
(58.5
)
Reconciliation of net loss from continuing operations to net cash flows used in operating activities:
 

 
 

Depreciation and amortization
77.5

 
79.8

Deferred income taxes
(10.8
)
 
(18.0
)
Foreign exchange gain
(8.6
)
 
(7.7
)
Other, net
79.8

 
5.6

Changes in assets and liabilities, net of acquisitions:
 
 
 
Accounts receivable
5.4

 
(11.3
)
Inventories
(13.9
)
 
(27.1
)
Accounts payable
5.4

 
12.2

Accrued expenses
(93.5
)
 
1.0

Prepaid expenses and other current assets
(24.9
)
 
17.5

Other assets and liabilities
(22.3
)
 
(6.2
)
Net cash flows provided by (used in) operating activities of continuing operations
5.3

 
(12.7
)
Cash flows from investing activities:
 

 
 

Capital expenditures
(11.4
)
 
(11.0
)
Proceeds from disposal of property, plant and equipment

 
1.6

Acquisition of business, net of cash acquired

 
(28.2
)
Proceeds from Arysta Sale (net of cash $148.7 million)
4,281.8

 

Proceeds from the sale of equity investment

 
25.0

Other, net
7.9

 
0.8

Net cash flows provided by (used in) investing activities of continuing operations
4,278.3

 
(11.8
)
Cash flows from financing activities:
 

 
 

Debt proceeds, net of discount
749.1

 

Repayments of borrowings
(4,603.0
)
 
(0.2
)
Change in lines of credit, net
25.1

 
60.0

Repurchases of common stock
(445.1
)
 

Payment of financing fees
(39.5
)
 
(1.0
)
Other, net
(8.8
)
 
0.3

Net cash flows (used in) provided by financing activities of continuing operations
(4,322.2
)
 
59.1

Cash flows from discontinued operations:
 
 
 
Net cash flows used in operating activities of discontinued operations
(135.3
)
 
(79.0
)
Net cash flows used in investing activities of discontinued operations
(5.0
)
 
(20.9
)
Net cash flows provided by financing activities of discontinued operations
4.8

 
44.1

Net cash flows used in discontinued operations
(135.5
)
 
(55.8
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
6.2

 
(15.8
)
Net decrease in cash, cash equivalents and restricted cash
(167.9
)
 
(37.0
)
Cash, cash equivalents and restricted cash at beginning of period (1)
415.5

 
483.9

Cash, cash equivalents and restricted cash at end of period (2)
$
247.6

 
$
446.9

(1) Includes cash, cash equivalents and restricted cash of discontinued operations of $181.9 million and $225.4 million at December 31, 2018 and 2017, respectively.
(2) Includes cash, cash equivalents and restricted cash of discontinued operations of $166.6 million at June 30, 2018.

 See accompanying notes to the Condensed Consolidated Financial Statements


4


ELEMENT SOLUTIONS INC AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
(Unaudited)
(dollars in millions, except share amounts)
Three Months Ended June 30, 2019
Preferred Stock
 
Common Stock
 
Additional
Paid-in
Capital
 
Treasury Stock
 
Accumulated
Deficit
 
Accumulated Other Comprehensive (Loss) Income
 
Total
Stockholders'
Equity
 
Non-
controlling Interests
 
Total Equity
Shares
 
Amount
 
Shares
 
Amount
 
 
Shares
 
Amount
 
 
 
 
 
Balance at March 31, 2019
2,000,000

 
$

 
257,955,093

 
$
2.6

 
$
4,105.1

 
512,956

 
$
(5.4
)
 
$
(1,605.5
)
 
$
(240.1
)
 
$
2,256.7

 
$
(1.5
)
 
$
2,255.2

Net income

 

 

 

 

 

 

 
1.5

 

 
1.5

 
(0.1
)
 
1.4

Other comprehensive loss, net of taxes

 

 

 

 

 

 

 

 
(18.3
)
 
(18.3
)
 

 
(18.3
)
Exercise/ vesting of share based compensation

 

 
336,703

 

 
1.9

 

 

 

 

 
1.9

 

 
1.9

Issuance of common stock under ESPP

 

 
32,027

 

 
0.3

 

 

 

 

 
0.3

 

 
0.3

Repurchases of common stock

 

 

 

 

 
1,154,585

 
(11.4
)
 

 

 
(11.4
)
 
 
 
(11.4
)
Equity compensation expense

 

 

 

 
2.1

 

 

 

 

 
2.1

 

 
2.1

Changes in non-controlling interests

 

 

 

 

 

 

 

 

 

 

 

Balance at June 30, 2019
2,000,000

 
$

 
258,323,823

 
$
2.6

 
$
4,109.4

 
1,667,541

 
$
(16.8
)
 
$
(1,604.0
)
 
$
(258.4
)
 
$
2,232.8

 
$
(1.6
)
 
$
2,231.2


Three Months Ended June 30, 2018
Preferred Stock
 
Common Stock
 
Additional
Paid-in
Capital
 
Treasury Stock
 
Accumulated
Deficit
 
Accumulated Other Comprehensive (Loss) Income
 
Total
Stockholders'
Equity
 
Non-
controlling Interests
 
Total Equity
Shares
 
Amount
 
Shares
 
Amount
 
 
Shares
 
Amount
 
 
 
 
 
Balance at March 31, 2018
2,000,000

 
$

 
288,115,844

 
$
2.9

 
$
4,043.6

 
6,618.0

 
$
(0.1
)
 
$
(833.7
)
 
$
(356.9
)
 
$
2,855.8

 
$
111.2

 
$
2,967.0

Net income (loss)

 

 

 

 

 

 

 
12.0

 

 
12.0

 
(0.2
)
 
11.8

Other comprehensive loss, net of taxes

 

 

 

 
 
 

 

 

 
(340.4
)
 
(340.4
)
 
(34.8
)
 
(375.2
)
Exercise/ vesting of share based compensation

 

 
29,549

 

 

 

 

 

 

 

 

 

Conversion of shares of common stock of PDH into common stock

 

 
29,069

 

 
0.4

 

 

 

 

 
0.4

 
(0.4
)
 

Issuance of common stock under ESPP

 

 
33,443

 

 
0.3

 

 

 

 

 
0.3

 

 
0.3

Equity compensation expense

 

 

 

 
4.3

 

 

 

 

 
4.3

 

 
4.3

Changes in non-controlling interests

 

 

 

 

 

 

 

 

 

 
(3.8
)
 
(3.8
)
Balance at June 30, 2018
2,000,000

 
$

 
288,207,905

 
$
2.9

 
$
4,048.6

 
6,618.0

 
$
(0.1
)
 
$
(821.7
)
 
$
(697.3
)
 
$
2,532.4

 
$
72.0

 
$
2,604.4


See accompanying notes to the Condensed Consolidated Financial Statements







5



ELEMENT SOLUTIONS INC AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (continued)
(Unaudited)
(dollars in millions, except share amounts)
Six Months Ended June 30, 2019
Preferred Stock
 
Common Stock
 
Additional
Paid-in
Capital
 
Treasury Stock
 
Accumulated
Deficit
 
Accumulated Other Comprehensive (Loss) Income
 
Total
Stockholders'
Equity
 
Non-
controlling Interests
 
Total Equity
Shares
 
Amount
 
Shares
 
Amount
 
 
Shares
 
Amount
 
 
 
 
 
Balance at December 31, 2018
2,000,000

 
$

 
289,316,170

 
$
2.9

 
$
4,062.1

 
341,967

 
$
(3.5
)
 
$
(1,195.4
)
 
$
(756.9
)
 
$
2,109.2

 
$
71.9

 
$
2,181.1

Net income

 

 

 

 

 

 

 
24.7

 

 
24.7

 
0.6

 
25.3

Other comprehensive income, net of taxes

 

 

 

 

 

 

 

 
49.1

 
49.1

 

 
49.1

Arysta Sale

 

 

 

 
(5.7
)
 

 

 

 
463.3

 
457.6

 
(46.6
)
 
411.0

Exercise/ vesting of share based compensation

 

 
1,929,518

 

 
1.9

 
170,989

 
(1.9
)
 

 

 

 

 

Conversion of shares of common stock of PDH into common stock

 

 
4,019,710

 
0.1

 
41.1

 

 

 

 
(13.9
)
 
27.3

 
(27.3
)
 

Issuance of common stock under ESPP

 

 
58,425

 

 
0.6

 

 

 

 

 
0.6

 

 
0.6

Repurchases of common stock

 

 
(37,000,000
)
 
(0.4
)
 

 
1,154,585

 
(11.4
)
 
(433.3
)
 

 
(445.1
)
 

 
(445.1
)
Equity compensation expense

 

 

 

 
9.4

 

 

 

 

 
9.4

 

 
9.4

Changes in non-controlling interests

 

 

 

 

 

 

 

 

 

 
(0.2
)
 
(0.2
)
Balance at June 30, 2019
2,000,000

 
$

 
258,323,823

 
$
2.6

 
$
4,109.4

 
1,667,541

 
$
(16.8
)
 
$
(1,604.0
)
 
$
(258.4
)
 
$
2,232.8

 
$
(1.6
)
 
$
2,231.2


Six Months Ended June 30, 2018
Preferred Stock
 
Common Stock
 
Additional
Paid-in
Capital
 
Treasury Stock
 
Accumulated
Deficit
 
Accumulated Other Comprehensive (Loss) Income
 
Total
Stockholders'
Equity
 
Non-
controlling Interests
 
Total Equity
Shares
 
Amount
 
Shares
 
Amount
 
 
Shares
 
Amount
 
 
 
 
 
Balance at December 31, 2017
2,000,000

 
$

 
287,405,939

 
$
2.9

 
$
4,032.0

 
6,618

 
$
(0.1
)
 
$
(869.7
)
 
$
(422.0
)
 
$
2,743.1

 
$
116.9

 
$
2,860.0

Impact of ASU 2016-01 adoption

 

 

 

 

 

 

 
(1.3
)
 
1.3

 

 

 

Adjusted balance at January 1, 2018
2,000,000

 

 
287,405,939

 
2.9

 
4,032.0

 

 
(0.1
)
 
(871.0
)
 
(420.7
)
 
2,743.1

 
116.9

 
2,860.0

Net income

 

 

 

 

 

 

 
49.3

 

 
49.3

 
0.5

 
49.8

Other comprehensive loss, net of taxes

 

 

 

 

 

 

 

 
(276.6
)
 
(276.6
)
 
(33.3
)
 
(309.9
)
Exercise/ vesting of share based compensation

 

 
44,549

 

 

 

 

 

 

 

 

 

Conversion of shares of common stock of PDH into common stock

 

 
686,610

 

 
8.6

 

 

 

 

 
8.6

 
(8.6
)
 

Issuance of common stock under ESPP

 

 
70,807

 

 
0.6

 

 

 

 

 
0.6

 

 
0.6

Equity compensation expense

 

 

 

 
7.4

 

 

 

 

 
7.4

 

 
7.4

Changes in non-controlling interests

 

 

 

 

 

 

 

 

 

 
(3.5
)
 
(3.5
)
Balance at June 30, 2018
2,000,000

 
$

 
288,207,905

 
$
2.9

 
$
4,048.6

 
6,618

 
$
(0.1
)
 
$
(821.7
)
 
$
(697.3
)
 
$
2,532.4

 
$
72.0

 
$
2,604.4


See accompanying notes to the Condensed Consolidated Financial Statements


6


ELEMENT SOLUTIONS INC AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements
(Unaudited)

1. BACKGROUND AND BASIS OF PRESENTATION
Background
Element Solutions was incorporated in Delaware in January 2014 and its shares of common stock, par value $0.01 per share, trade on the NYSE under the ticker symbol “ESI.”
Element Solutions is a leading global specialty chemicals company whose operating businesses formulate a broad range of solutions that enhance the performance of products people use every day. Developed in multi-step technological processes, the innovative solutions of the Company's businesses enable customers' manufacturing processes in several key industries, including electronic circuitry, semiconductor, communications infrastructure, automotive systems, industrial surface finishing, consumer packaging and offshore energy. Element Solutions delivers its products to customers through its sales and service workforce, regional distributors and manufacturing representatives.
Basis of Presentation
The accompanying unaudited Condensed Consolidated Financial Statements include the accounts and transactions of the Company and have been prepared on a basis that is consistent with the accounting principles applied in the Company’s 2018 Annual Report. In the opinion of management, these unaudited Condensed Consolidated Financial Statements reflect all adjustments that are normal, recurring and necessary for a fair statement of the Company's financial position, results of operations and cash flows for interim periods, but are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2019. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and the related notes thereto included in the Company’s 2018 Annual Report.
On January 31, 2019, the Company completed the Arysta Sale for net cash proceeds of approximately $4.28 billion, after certain post-closing adjustments. Agricultural Solutions' assets, liabilities, operating results and cash flows for all periods presented have been classified as discontinued operations within the unaudited Condensed Consolidated Financial Statements. See Note 3, Discontinued Operations, for additional information. The Company's Prior Senior Notes, 5.875% USD Notes due 2025 and term loans then outstanding under the Company's second amended and restated credit agreement, dated August 6, 2014, as further amended and restated, were not required to be immediately redeemed or repaid in connection with the Arysta Sale. As such, the related liabilities and interest expense are not included in discontinued operations and therefore fully burdened continuing operations.
The process of preparing the Company’s unaudited Condensed Consolidated Financial Statements requires the use of estimates and judgments that affect the reported amount of assets, liabilities, net sales and expenses. These estimates and judgments are based on historical experience, future expectations and other factors as well as assumptions the Company believes to be reasonable under the circumstances. These estimates and judgments are reviewed on an ongoing basis and revised as necessary. Actual amounts may differ materially from these estimates.
Certain other prior year amounts have been reclassified to conform to the current year’s presentation.
2. RECENT ACCOUNTING PRONOUNCEMENTS
Recently Adopted Accounting Pronouncements
Leases (Topic 842) - In February 2016, the FASB issued ASU No. 2016-02, “Leases.” This ASU requires lessees to recognize most leases in their balance sheets, but to continue to record expenses on their income statements in a manner similar to current accounting. The ASU is required to be applied to leases in existence as of the date of initial application using a modified retrospective transition approach. The Company adopted the new standard on January 1, 2019. No cumulative-effect adjustment was required to the opening balance of retained earnings on the adoption date.


7

ELEMENT SOLUTIONS INC AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements
(Unaudited)



The Company made updates to its systems, policies and internal controls over financial reporting in preparation of adopting the new guidance. Upon the prospective adoption of ASC 842 during the first quarter of 2019, the Company elected the following package of transition practical expedients:
Not to separate non-lease components from lease components and account for them as a single lease component;
Not to reassess arrangements entered into prior to January 1, 2019 for whether an arrangement is or contains a lease, the lease classification applied or to separate initial direct costs; and
To use hindsight in determining the lease term for lease contracts that have historically been renewed or amended.
At December 31, 2018, the Company was not a lessor to any significant lease agreements and substantially all of the leases under which the Company was a lessee were classified as operating leases under the existing ASC 840 guidance. As such, consistent with the Company's practical expedient election to not reassess lease classification, substantially all the Company's existing leases will continue to be classified as operating leases under ASC 842. As a lessee, the Company categorizes its operating leases into two general categories: real estate and other.
This new standard had no impact on the Company’s Condensed Consolidated Statements of Operations or Cash Flows but its Condensed Consolidated Balance Sheet at June 30, 2019 was impacted by the recognition of right of use (ROU) assets of $64.0 million in "Other Assets" which reflected the present value of remaining operating lease payments under existing lease arrangements, as well as current and non-current lease liabilities of $14.9 million and $49.3 million, reported in "Accrued expenses and other current liabilities" and "Other liabilities," respectively.
See Note 11, Leases, for more information.
Derivatives and Hedging (Topic 815) - In August 2017, the FASB issued ASU No. 2017-12, “Targeted Improvements to Accounting for Hedging Activities.” This ASU improves the financial reporting of hedge relationships by updating hedging designation and measurement guidance. The update also simplifies the application of existing hedge accounting guidance related to assessing hedge effectiveness. The guidance is effective prospectively as of January 1, 2019 and is applied to contracts in existence at the date of adoption. This new guidance did not have a material impact on the Company's unaudited Condensed Consolidated Financial Statements.
3. DISCONTINUED OPERATIONS
On July 20, 2018, the Company agreed to sell to UPL 100% of the then issued and outstanding shares of common stock of Arysta and its subsidiaries pursuant to the terms and conditions of the Arysta Sale Agreement. The Arysta Sale was completed on January 31, 2019 for net cash proceeds of approximately $4.28 billion, after certain post-closing adjustments relating to, among other things, cash, indebtedness and working capital, as finalized with UPL on May 17, 2019.
The Company's former Agricultural Solutions business was previously its own reportable segment and has been presented for all periods as discontinued operations in this Quarterly Report as the Arysta Sale represented a significant strategic shift and was determined to have a major effect on the Company's operations and financial results. Corporate costs previously allocated to the Agricultural Solutions segment were reallocated to the remaining segments for all periods presented as these costs were not clearly identifiable as costs of the former Agricultural Solutions segment.
In the second quarter of 2019, the Company recorded a loss of $18.8 million on the Arysta Sale, for a 2019 year-to-date gain of $2.5 million. The sale resulted in an overall loss of $448 million as an estimated impairment loss of $450 million was recorded in 2018, primarily due to the reclassification of foreign currency translation adjustments from "Accumulated other comprehensive loss" within Stockholders’ Equity into earnings within the Condensed Consolidated Statement of Operations. The Company may record an additional gain or loss in the future as it settles certain tax assets and liabilities associated with the Arysta Sale.
In connection with the Arysta Sale, the Company agreed to retain certain liabilities associated with legal and tax proceedings, primarily related to an Arysta subsidiary in Brazil. The Company does not expect to incur any material losses as a result of these proceedings. However, the resolutions of these matters may take several years and, to the extent not covered by insurance, may adversely impact the Company's financial position or results of operations.


8

ELEMENT SOLUTIONS INC AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements
(Unaudited)



The following table details the components comprising net (loss) income from the Company's discontinued operations attributable to common stockholders:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 (dollars in millions)
2019
 
2018
 
2019 (1)
 
2018
Net sales
$

 
$
520.9

 
$
65.3

 
$
992.5

Cost of sales

 
(312.7
)
 
(45.5
)
 
(590.7
)
Selling, technical, general and administrative
(0.8
)
 
(135.7
)
 
(37.4
)
 
(271.9
)
Research and development

 
(14.8
)
 
(4.6
)
 
(26.9
)
(Loss) gain on Arysta Sale
(18.8
)
 

 
2.5

 

Operating (loss) profit
(19.6
)
 
57.7

 
(19.7
)
 
103.0

Other, net
(0.6
)
 
(40.9
)
 
8.7

 
15.8

(Loss) income from discontinued operations, before income taxes
(20.2
)
 
16.8

 
(11.0
)
 
118.8

Income tax benefit (expense)
6.9

 
44.6

 
25.1

 
(10.5
)
(Loss) income from discontinued operations, net of tax
(13.3
)
 
61.4

 
14.1

 
108.3

Net loss (income) from discontinued operations attributable to the non-controlling interests
0.1

 
(0.4
)
 

 
0.2

Net (loss) income from discontinued operations attributable to common stockholders
$
(13.2
)
 
$
61.0

 
$
14.1

 
$
108.5

(1) 
Includes activity through January 31, 2019, when the Arysta Sale was completed, and certain post-closing adjustments relating to, among other things, cash, indebtedness and working capital as of the closing date.
The carrying value of major classes of assets and liabilities related to the Company's discontinued operations were as follows:
 
June 30,
 
December 31,
 
 (dollars in millions)
2019
 
2018
 
Assets
 
 
 
 
Cash and cash equivalents
$

 
$
177.8

 
Accounts receivable, net

 
919.4

 
Inventories

 
369.1

 
Other current assets
9.6

(1) 
155.0

 
Current assets of discontinued operations
$
9.6

 
$
1,621.3

 
Property, plant and equipment, net
$

 
$
172.0

 
Goodwill

 
1,816.9

 
Intangible assets, net

 
1,797.7

 
Other assets
6.8

 
(374.2
)
(2) 
Non-current assets of discontinued operations
$
6.8

 
$
3,412.4

 
Liabilities
 
 
 
 
Accounts payable
$

 
$
365.7

 
Current installments of revolving credit facilities

 
52.5

 
Accrued expenses and other current liabilities
57.9

 
408.6

 
Current liabilities of discontinued operations
$
57.9

 
$
826.8

 
Deferred income taxes
$

 
$
369.9

 
Other liabilities

 
46.3

 
Non-current liabilities of discontinued operations
$

 
$
416.2

 
(1) 
Primarily comprised of a receivable from UPL associated with certain post-closing adjustments.
(2) 
Includes the impairment loss of $450 million on discontinued operations at December 31, 2018.


9

ELEMENT SOLUTIONS INC AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements
(Unaudited)



4. INVENTORIES
The major components of inventory, on a net basis, were as follows: 
 (dollars in millions)
June 30,
2019
 
December 31,
2018
Finished goods
$
118.0

 
$
109.4

Work in process
17.9

 
15.3

Raw materials and supplies
65.7

 
63.4

Total inventories
$
201.6

 
$
188.1


5. PROPERTY, PLANT AND EQUIPMENT
The major components of property, plant and equipment were as follows:
 (dollars in millions)
June 30,
2019
 
December 31,
2018
Land and leasehold improvements
$
67.5

 
$
67.8

Buildings and improvements
104.7

 
101.0

Machinery, equipment, fixtures and software
212.1

 
207.3

Construction in process
11.7

 
14.9

Total property, plant and equipment
396.0

 
391.0

Accumulated depreciation
(139.3
)
 
(124.1
)
Property, plant and equipment, net
$
256.7

 
$
266.9


For the three months ended June 30, 2019 and 2018, the Company recorded depreciation expense of $10.4 million and $11.2 million, respectively. For the six months ended June 30, 2019 and 2018, the Company recorded depreciation expense of $20.7 million and $22.9 million, respectively.
6. GOODWILL AND INTANGIBLE ASSETS
Goodwill
The changes in the carrying amount of goodwill were as follows:
 (dollars in millions)
 
Electronics
 
Industrial & Specialty
 
Total
Balance at December 31, 2018
(*)
$
1,226.7

 
$
955.9

 
$
2,182.6

Foreign currency translation
 
(2.4
)
 
(2.3
)
 
(4.7
)
Balance at June 30, 2019
(*)
$
1,224.3

 
$
953.6

 
$
2,177.9

(*) Includes accumulated impairment losses of $46.6 million associated with the Company's Industrial & Specialty segment.
Indefinite-Lived Intangible Assets
The carrying value of indefinite-lived intangible assets other than goodwill, which consisted solely of tradenames, was $105 million and $150 million at June 30, 2019 and December 31, 2018, respectively.
During the first quarter of 2019, the Company determined that the useful life of one of its tradenames no longer met the criteria to be considered an indefinite-lived asset and concluded no indication of impairment. Subsequently, the Company started amortizing


10

ELEMENT SOLUTIONS INC AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements
(Unaudited)



this tradename over 15 years, consistent with other similar finite-lived assets.
Finite-Lived Intangible Assets
Intangible assets subject to amortization were as follows:
 
June 30, 2019
 
December 31, 2018
 (dollars in millions)
Gross Carrying
Amount
 
Accumulated
Amortization
 
Net Book
Value
 
Gross Carrying
Amount
 
Accumulated
Amortization
 
Net Book
Value
Customer lists
$
925.7

 
$
(317.3
)
 
$
608.4

 
$
927.8

 
$
(283.2
)
 
$
644.6

Developed technology
381.5

 
(175.1
)
 
206.4

 
381.3

 
(155.6
)
 
225.7

Tradenames
50.8

 
(3.2
)
 
47.6

 
5.9

 
(1.6
)
 
4.3

Non-compete agreements
1.5

 
(1.4
)
 
0.1

 
1.5

 
(1.3
)
 
0.2

Total
$
1,359.5

 
$
(497.0
)
 
$
862.5

 
$
1,316.5

 
$
(441.7
)
 
$
874.8


For the three months ended June 30, 2019 and 2018, the Company recorded amortization expense on intangible assets of $28.4 million, respectively. For the six months ended June 30, 2019 and 2018, the Company recorded amortization expense on intangible assets of $56.8 million and $56.9 million, respectively.
7.  DEBT
The Company’s debt and finance lease obligations consisted of the following:
 (dollars in millions)
Maturity Date
 
Interest Rate
 
June 30,
2019
 
December 31,
2018
USD Term Loans (1)
2026
 
LIBOR plus 2.25%
 
$
736.4

 
$

Senior Notes - USD 800 million (2)
2025
 
5.875%
 
785.8

 
784.9

Senior Notes - USD 1.10 billion (2)
2022
 
6.50%
 

 
1,067.1

Senior Notes - EUR 350 million (2)
2023
 
6.00%
 

 
397.4

First Lien Credit Facility - USD Term Loans (1)
2020
 
> of 3.50% or LIBOR plus 2.50%
 

 
624.3

First Lien Credit Facility - USD Term Loans (1)
2021
 
> of 4.00% or LIBOR plus 3.00%
 

 
1,124.7

First Lien Credit Facility - Euro Term Loans (1)
2020
 
> of 3.25% or EURIBOR plus 2.50%
 

 
666.2

First Lien Credit Facility - Euro Term Loans (1)
2021
 
> of 3.50% or EURIBOR plus 2.75%
 

 
685.3

Borrowings under the Revolving Credit Facility
2024
 
LIBOR plus 2.25%
 
50.0

 
25.0

Other
 
 
 
 
0.9

 
1.1

Total debt and finance lease obligations
 
1,573.1

 
5,376.0

Less: current installments of long-term debt and revolving credit facilities
 
57.8

 
25.3

Total long-term debt and finance lease obligations
 
$
1,515.3

 
$
5,350.7


 
(1)
Term loans, net of unamortized discounts and debt issuance costs of $9.8 million and $22.4 million at June 30, 2019 and December 31, 2018, respectively. Weighted average effective interest rate of 2.4% and 4.6% at June 30, 2019 and December 31, 2018, respectively, including the effects of interest rate swaps and net investment hedges. See Note 8, Financial Instruments, for further information regarding the Company's interest rate swaps and net investment hedges.
(2) 
Senior notes, net of unamortized premium, discounts and debt issuance costs of $14.2 million and $29.9 million at June 30, 2019 and December 31, 2018, respectively. Weighted average effective interest rate of 6.2% and 6.5% at June 30, 2019 and December 31, 2018, respectively.



11

ELEMENT SOLUTIONS INC AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements
(Unaudited)



New Credit Agreement
The Company is a party to the New Credit Agreement, which provides for senior secured credit facilities in an aggregate principal amount of $1.08 billion, consisting of a revolving facility in an aggregate principal amount of $330 million maturing in 2024 and a term loan in an aggregate principal amount of $750 million maturing in 2026. On the closing date of the Arysta Sale, the $750 million term loan was borrowed under the New Credit Agreement.
The New Credit Agreement replaced the Company's second amended and restated credit agreement, dated August 6, 2014, as further amended and restated, which was terminated on January 31, 2019, the closing date of the Arysta Sale, as the Company paid down its then existing credit facilities, including the first lien credit facility and the revolving credit facility, under this agreement and expensed $22.9 million of unamortized premiums, discounts and debt issuance costs, which was recorded in the Condensed Consolidated Statement of Operations as "Other (expense) income, net."
Borrowings under the New Credit Agreement bear interest at a rate per annum equal to a base rate, as defined in the New Credit Agreement, plus, in each case, an applicable rate equal to a spread of 1.25% with respect to Base Rate Loans and a spread of 2.25% with respect to Eurocurrency Rate Loans. The Company is required to pay a commitment fee in respect of any undrawn portion of the Revolver of 0.50% per annum, subject to a stepdown to 0.375% based on the Company’s first lien net leverage ratio.
The revolving facility under the New Credit Agreement includes borrowing capacity in the form of letters of credit of up to $100 million. In connection with the termination of the Company's second amended and restated credit agreement and entry into the New Credit Agreement, all letters of credit outstanding on January 31, 2019 under the second amended and restated credit agreement were rolled into the New Credit Agreement.
The credit facilities under the New Credit Agreement are guaranteed, jointly and severally, by certain of the Company’s domestic subsidiaries and secured by a first-priority security interest in substantially all of the assets of the borrowers and the guarantors, including mortgages on material real property, subject to certain exceptions.
Covenants, Events of Default and Provisions
The New Credit Agreement contains customary representations and warranties, and affirmative and negative covenants, including limitations on additional indebtedness, dividends, and other distributions, entry into new lines of business, use of loan proceeds, capital expenditures, restricted payments, restrictions on liens on the assets of the borrowers or any guarantor, transactions with affiliates, amendments to organizational documents, accounting changes, sale and leaseback transactions, and dispositions. If the borrowers have total outstanding borrowings under the revolver (subject to certain exceptions) in excess of 30% of the commitment amount under the revolver, the revolver requires that the Company maintain a first lien net leverage ratio of at least 5.0 to 1.0, subject to a right to cure.
The New Credit Agreement requires the borrowers to make mandatory prepayments of borrowings, subject to certain exceptions, as described in the New Credit Agreement. In addition, the New Credit Agreement contains customary events of default that include, among others, non-payment of principal, interest or fees, violation of covenants, inaccuracy of representations and warranties, failure to make payment on, or defaults with respect to, certain other material indebtedness, bankruptcy and insolvency events, material judgments and change of control provisions. Upon the occurrence of an event of default, and after the expiration of any applicable grace period, payment of any outstanding loans under the New Credit Agreement may be accelerated and the lenders could foreclose on their security interests in the assets of the borrowers and the guarantors.
At June 30, 2019, the Company was in compliance with the debt covenants contained in the credit facilities of the New Credit Agreement and, in accordance with applicable debt covenants, had full availability of its unused borrowing capacity of $275 million, net of letters of credit, under the revolving facility.


12

ELEMENT SOLUTIONS INC AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements
(Unaudited)



Senior Notes
Prior Senior Notes
On February 1, 2019, the Company completed the redemption of all outstanding Prior Senior Notes and, as a result, the Prior Senior Notes Indenture was terminated, releasing the Company and the guarantors named therein from their obligation under the Prior Senior Notes and the Prior Senior Notes Indenture. In connection with this redemption, the Company expensed $44.0 million, consisting of $29.5 million of call premiums and $14.5 million of unamortized premiums, discounts and debt issuance costs, which was recorded in the Condensed Consolidated Statement of Operations as "Other (expense) income, net." The Company funded the redemption with a portion of the net proceeds from the Arysta Sale and a portion of the borrowings under the New Credit Agreement. The 5.875% USD Notes due 2025 were not redeemed and remain outstanding.
5.875% USD Notes due 2025
The 5.875% USD Notes due 2025 are governed by the 5.875% USD Notes Indenture which provides, among other things, for customary affirmative and negative covenants, events of default and other customary provisions. The Company has the option to redeem the 5.875% USD Notes due 2025 prior to their maturity, subject to, in certain cases, the payment of an applicable make-whole premium. The 5.875% USD Notes due 2025 are fully and unconditionally guaranteed on a senior unsecured basis by certain of the Company’s domestic subsidiaries that guarantee the obligations of the borrowers under the New Credit Agreement.
Lines of Credit and Other Debt Facilities
The Company has access to various revolving lines of credit, short-term debt facilities and overdraft facilities worldwide which are used to fund short-term cash needs. At June 30, 2019 and December 31, 2018, the aggregate principal amount outstanding under such facilities totaled $50.0 million and $25.0 million, respectively. The Company also had letters of credit outstanding of $5.1 million and $10.2 million at June 30, 2019 and December 31, 2018, respectively, of which $4.8 million and $9.7 million at June 30, 2019 and December 31, 2018, respectively, reduced the borrowings available under the various facilities. At June 30, 2019, the availability under these facilities totaled approximately $303 million, net of outstanding letters of credit.
8. FINANCIAL INSTRUMENTS
Derivatives and Hedging
In the normal course of business, the Company is exposed to risks relating to changes in foreign currency exchange rates, commodity prices and interest rates. Derivative financial instruments, such as foreign currency exchange forward contracts, commodities futures contracts, interest rate swaps and net investment hedges are used to manage the risks associated with changes in the conditions of those markets. All derivatives are recognized in the Condensed Consolidated Balance Sheets at fair value. The counterparties to the Company’s derivative agreements are major international financial institutions. The Company continually monitors its derivative positions and the credit ratings of its counterparties and does not anticipate nonperformance on their part.
Foreign Currency
The Company conducts a significant portion of its business in currencies other than the U.S. dollar and a portion of its business in currencies other than the functional currencies of its subsidiaries. As a result, the Company’s operating results are impacted by foreign currency exchange rate volatility.
At June 30, 2019, the Company held foreign currency forward contracts to purchase and sell various currencies in order to mitigate such foreign currency exposure, primarily with the U.S. dollar and euro. The Company has not designated any foreign currency exchange forward contracts as eligible for hedge accounting and, as a result, changes in the fair value of foreign currency forward contracts are recorded in the Condensed Consolidated Statements of Operations as "Other (expense) income, net." The total notional value of foreign currency exchange forward contracts held at June 30, 2019 and December 31, 2018 was approximately $148.8 million and $102 million, respectively, with settlement dates generally within one year.


13

ELEMENT SOLUTIONS INC AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements
(Unaudited)



Commodities
As part of its risk management policy, the Company enters into commodities futures contracts for the purpose of mitigating its exposure to fluctuations in prices of certain metals used in the production of its finished goods.  The Company held futures contracts to purchase and sell various metals, primarily tin and silver, with a notional value of $39.5 million and $28.9 million at June 30, 2019 and December 31, 2018, respectively. Substantially all contracts outstanding at June 30, 2019 had delivery dates within one year. The Company has not designated these derivatives as hedging instruments and, accordingly, records changes in their fair values in the Condensed Consolidated Statements of Operations as "Other (expense) income, net."
Unrealized gains and losses on derivative contracts are accounted for as "Operating activities" in the Condensed Consolidated Statements of Cash Flows.
Interest Rates
During the six months ended June 30, 2019, the Company:
Terminated and settled interest rate swaps previously entered into to effectively fix the floating base rate portion of its interest payments on approximately $1.12 billion of prior U.S. dollar denominated debt and €276 million of prior euro denominated debt at 1.96% and 1.20%, respectively, through June 2020. Upon termination and settlement, the Company received a cash payment of $8.2 million and reclassified $7.1 million of income from "Accumulated other comprehensive loss" to "Other (expense) income, net" in the Condensed Consolidated Statement of Operations. The proceeds are reflected as cash flows from Investing Activities on the Condensed Consolidated Statement of Cash Flows.
Entered into interest rate swaps to effectively fix the floating rate of the interest payments associated with its new $750 million term loan under New Credit Agreement through January 2024. These contracts were designated as a cash flow hedge. All interest payments to be paid during the last two years preceding the maturity date of this new term loan (February 2024 to January 2026) will revert back to a floating rate of interest. The proceeds are reflected as cash flows from Operating Activities on the Condensed Consolidated Statement of Cash Flows.
Entered into cross-currency swaps to effectively convert the new $750 million term loan under the New Credit Agreement, a U.S. dollar denominated debt obligation, into fixed-rate euro-denominated debt. Under these contracts, which expire in January 2024, the Company is obligated to make periodic euro-denominated coupon payments to the hedge counterparties on an aggregate initial notional amount of €662 million, in exchange for periodic U.S. dollar-denominated coupon payments from these hedge counterparties on an aggregate initial notional amount of $750 million. The Company has also designated these contracts as a net investment hedge of the foreign currency exposure of a portion of its net investment in its European operations. The proceeds are reflected as cash flows from Operating Activities on the Condensed Consolidated Statement of Cash Flows.
The net result of the above hedges is a fixed interest rate of approximately 2.4% through January 2024.
Changes in the fair value of a derivative instrument that is designated as, and meets all the required criteria of, a cash flow hedge are recorded in "Other comprehensive (loss) income" and reclassified from "Accumulated other comprehensive loss" into earnings as the underlying hedged item affects earnings. Amounts reclassified into earnings related to interest rate swaps are included in the Condensed Consolidated Statements of Operations as "Interest expense, net." Changes in the fair value of a derivative instrument that is designated as, and meets all the required criteria of, a net investment hedge are recorded in "Foreign currency translation" in "Accumulated other comprehensive loss" offsetting the translation adjustment attributable to the hedged portion of the Company’s net investment in its European operations.
For the three and six months ended June 30, 2019, the Company's interest rate swaps and cross-currency swaps were deemed highly effective. The Company expects to reclassify $5.1 million of expense from "Accumulated other comprehensive loss" to "Interest expense, net" in the Condensed Consolidated Statements of Operations within the next twelve months.


14

ELEMENT SOLUTIONS INC AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements
(Unaudited)



Fair Value Measurements
The following table presents the Company’s financial assets and liabilities that are measured at fair value on a recurring basis:
 (dollars in millions)
Balance sheet location
 
Classification
 
June 30,
2019
 
December 31,
2018
Asset Category
 
 
 
 
 
 
 
Foreign exchange and metals contracts not designated as hedging instruments
Other current assets
 
Level 2
 
$
0.6

 
$
0.9

Interest rate swaps designated as cash flow hedging instruments
Other current assets
 
Level 2
 

 
6.5

Cross currency swaps designated as net investment hedge
Other current assets
 
Level 2
 
18.2

 

Interest rate swaps designated as cash flow hedging instruments
Other assets
 
Level 2
 

 
2.6

Available for sale equity securities
Other assets
 
Level 1
 
0.3

 
0.3

Total
 
 
 
 
$
19.1

 
$
10.3

 
 
 
 
 
 
 
 
Liability Category
 
 
 
 
 
 
 
Foreign exchange and metals contracts not designated as hedging instruments
Accrued expenses and other liabilities
 
Level 2
 
$
2.0

 
$
1.2

Interest rate swaps designated as cash flow hedging instruments
Accrued expenses and other liabilities
 
Level 2
 
5.1

 
0.6

Interest rate swaps designated as cash flow hedging instruments
Other liabilities
 
Level 2
 
22.4

 
0.3

Cross currency swaps designated as net investment hedge
Other liabilities
 
Level 2
 
18.8

 

Long-term contingent consideration
Other liabilities
 
Level 3
 
20.6

 
57.4

Total
 
 
 
 
$
68.9

 
$
59.5


The following methods and assumptions were used to estimate the fair value of each class of the Company’s financial assets and liabilities:
Derivatives - Derivative assets and liabilities include foreign currency, metals, interest rate swaps and cross currency swaps. The values are determined using pricing models based upon observable market inputs, such as market spot and futures prices on over-the-counter derivative instruments, market interest rates, and consideration of counterparty credit risk.
Available for sale equity securities - Available for sale equity securities classified as Level 1 assets are measured using quoted market prices at the reporting date multiplied by the quantity held.
Long-term contingent consideration - The long-term contingent consideration represented a potential liability of up to $100 million tied to the achievement of certain common stock trading price performance metrics and Adjusted EBITDA targets over a seven-year period ending December 2020 in connection with the MacDermid Acquisition. In the first quarter of 2019, the Company paid $40.0 million of this liability related to the achievement of common stock performance targets, reducing the potential contingent consideration liability to $60.0 million. Of the $40.0 million paid in 2019, $30.9 million was reflected as a cash outflow from Operating Activities and $9.1 million was reflected as a cash outflow from Financing Activities on the Condensed Consolidated Statements of Cash Flows. The amount reflected as Financing Activities represented the initial amount recorded in purchase accounting.
The estimated fair value of the Adjusted EBITDA performance metric is derived using the income approach with unobservable inputs, based on present value and multi-year forecast assumptions, which include a discount rate of 10.50% and probability weighted Adjusted EBITDA assessments of expected future payment values of $0.0 million, $30.0 million and $60.0 million. At June 30, 2019, based on the most recent multi-year forecast, the Company continues to determine there is a higher probability of achieving the Adjusted EBITDA target that will result in an expected payment of $30.0 million. An increase or a decrease in the probability weighted Adjusted EBITDA assessments of future payment values of 10.0% changes the estimated fair value measure of the performance metric by approximately $2.3 million.


15

ELEMENT SOLUTIONS INC AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements
(Unaudited)



Changes in the estimated fair value of the long-term contingent consideration are recorded in the Condensed Consolidated Statements of Operations as "Selling, technical, general and administrative" expenses.
There were no significant transfers between the fair value hierarchy levels for the three and six months ended June 30, 2019.
The carrying value and estimated fair value of the Company’s long-term debt totaled $1.52 billion and $1.58 billion, respectively, at June 30, 2019. At December 31, 2018, the carrying value and estimated fair value each totaled $5.35 billion. The carrying values noted above include unamortized premiums, discounts and debt issuance costs. The estimated fair value of long-term debt is measured using quoted market prices at the reporting date multiplied by the gross carrying amount of the related debt, which excludes unamortized premiums, discounts and debt issuance costs. Such instruments are valued using Level 2 inputs.
9. STOCKHOLDERS’ EQUITY
Preferred Stock
The Company is authorized to issue 5,000,000 shares of preferred stock. The Board has designated 2,000,000 of those shares as "Series A Preferred Stock." At June 30, 2019 and December 31, 2018, a total of 2,000,000 shares of Series A Preferred Stock were issued and outstanding. Shares of preferred stock have no voting rights, except in respect of any amendment to the Company's Certificate of Incorporation, as amended, that would alter or change their rights or privileges. Each share of Series A Preferred Stock is convertible into one share of the Company's common stock at the option of the holders until December 31, 2020. All outstanding shares of Series A Preferred Stock will be automatically converted into shares of the Company's common stock on a one-for-one basis (i) in the event of a change of control of the Company or (ii) on December 31, 2020 (which may be extended by the Board for three additional years).
As holders of the Series A Preferred Stock, the Founder Entities are entitled to receive dividends in the form of shares of the Company's common stock. The dividend amount is calculated based on the appreciated stock price compared to the highest dividend price previously used in calculating the Series A Preferred Stock dividends, which is currently $22.85 per share.
Non-Controlling Interest
In connection with the MacDermid Acquisition, approximately $97.5 million was raised in new equity consisting of 8,774,527 shares of common stock of PDH. The shares of common stock of PDH were recorded in the Condensed Consolidated Balance Sheets as "Non-controlling interests." On March 29, 2019, the Company completed the merger of PDH with and into Element Solutions, with Element Solutions continuing as the surviving entity. As a result of this merger and without any action on the part of the Retaining Holders, each share of common stock of PDH outstanding at March 29, 2019 was converted into the right to receive one share of the Company's common stock, and all shares of common stock of PDH were subsequently converted.
As a result of the merger, there was no allocation of net income to the Retaining Holders for the three months ended June 30, 2019. For the three months ended June 30, 2018, approximately $0.6 million of net loss had been allocated to the Retaining Holders, as included in the Condensed Consolidated Statements of Operations. For the six months ended June 30, 2019 and 2018, approximately $0.5 million and $0.6 million, respectively, of net income had been allocated to the Retaining Holders, as included in the Condensed Consolidated Statements of Operations.
Repurchases of Common Stock
On February 8, 2019, as part of the Company's previously-announced share repurchase program, the Company repurchased 37 million shares of its common stock for a per share purchase price of $11.72, the last sale price reported for the Company's shares as of the 4 pm close of trading on the NYSE on Friday, February 1, 2019, or an aggregate purchase price of $434 million. These repurchased shares, which represented approximately 13% of the Company's then outstanding common stock, were retired on the repurchase date. The repurchases were funded from cash on hand and borrowings under the New Credit Agreement.
During the three months ended June 30, 2019, the Company repurchased approximately 1.2 million shares of its common stock under the share repurchase program for approximately $11.4 million, at an average price of $9.89 per share. The repurchases were allocated to treasury shares and were funded from cash on hand.


16

ELEMENT SOLUTIONS INC AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements
(Unaudited)



The remaining authorization under the share repurchase program was approximately $305 million at June 30, 2019.
10.  EARNINGS (LOSS) PER SHARE
Basic and diluted earnings per share are based on the weighted average number of shares of common stock and potential common stock outstanding during the period. Potential common stock, for purposes of determining diluted earnings per share, assumes the issuance of all potentially dilutive share equivalents using the if-converted or treasury stock method.
A computation of earnings (loss) per share from continuing operations and weighted average shares of the Company's common stock outstanding for the three and six months ended June 30, 2019 and 2018 is as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 (dollars in millions, except per share amounts)
2019
 
2018
 
2019
 
2018
Net income (loss) from continuing operations
$
14.7

 
$
(49.6
)
 
$
11.2

 
$
(58.5
)
Net loss (income) attributable to the non-controlling interests

 
0.6

 
(0.6
)
 
(0.7
)
Net income (loss) from continuing operations attributable to common stockholders
$
14.7

 
$
(49.0
)
 
$
10.6

 
$
(59.2
)
 
 
 
 
 
 
 
 
Basic weighted average common shares outstanding
257.3

 
288.2

 
262.7

 
288.0

Denominator adjustments for diluted EPS:
 
 
 
 
 
 
 
Number of shares issuable upon conversion of founder preferred stock
2.0

 

 
2.0

 

Number of stock options, RSUs and shares issued through ESPP
0.3

 

 
0.6

 

Denominator adjustments for diluted EPS
2.3

 

 
2.6

 

Diluted weighted average common shares outstanding
259.6

 
288.2

 
265.3

 
288.0

 
 
 
 
 
 
 
 
Earnings (loss) per share from continuing operations attributable to common stockholders:
 

 
 

 
 

 
 

Basic
$
0.06

 
$
(0.17
)
 
$
0.04

 
$
(0.21
)
Diluted
$
0.06

 
$
(0.17
)
 
$
0.04

 
$
(0.21
)

For the three and six months ended June 30, 2019 and 2018, the following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because performance targets were not yet achieved for RSUs contingent upon performance:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 (shares in millions)
2019
 
2018
 
2019
 
2018
Shares issuable for the contingent consideration
5.0

 
7.4

 
5.1

 
8.0

Shares issuable upon conversion of Series A Preferred Stock

 
2.0

 

 
2.0

Shares issuable upon vesting of RSUs
0.6

 
1.5

 
0.5

 
1.3

Shares issuable upon conversion of the shares of common stock of PDH

 
4.1

 

 
4.2

 Total
5.6

 
15.0

 
5.6

 
15.5


11.  LEASES
The Company determines if an arrangement is a lease at inception. Right-of-Use (ROU) assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. The Company uses its incremental borrowing rate based on the information available at the beginning of each fiscal quarter in determining the present value of future payments as most of its leases do not provide an implicit rate. ROU assets also include any lease payments made and exclude lease incentives and initial direct costs incurred. The Company’s lease terms may include options to extend or terminate


17

ELEMENT SOLUTIONS INC AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements
(Unaudited)



the lease when it is reasonably certain that it will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.
ROU assets, current and non-current lease liabilities are reported as "Other assets," " Accrued expenses and other current liabilities" and "Other liabilities" in the Condensed Consolidated Balance Sheets, respectively. Finance leases are not material and are included in the Condensed Consolidated Balance Sheets as "Property, plant and equipment, net" and "Debt and lease obligations."
For the three and six months ended June 30, 2019, operating lease expense are primarily included in "Selling, technical, general and administrative" in the Condensed Consolidated Statements of Operations and totaled $5.2 million and $10.3 million, respectively.
 
Six Months Ended June 30,
 (dollars in millions)
2019
Supplemental Cash Flow Information for Operating Leases
 
Cash paid for amounts included in the measurement of lease liabilities:
 
Operating cash flows from operating leases
$
10.4

 
 
ROU assets obtained in exchange for operating lease obligations
$
2.5

Weighted average remaining lease term
8 years
Weighted average discount rate
5.3%

Maturities of lease liabilities by fiscal year for operating leases at June 30, 2019 were as follows:
 (dollars in millions)
 
Remainder of 2019
$
9.6

2020
15.2

2021
12.3

2022
10.4

2023
7.2

Thereafter
25.0

Total future minimum lease payments
79.7

Less: imputed interest
(15.5
)
Present value of lease liabilities
$
64.2


Minimum future non-cancelable operating lease commitments at December 31, 2018 were as follows:
 (dollars in millions)
 
2019
$
19.2

2020
15.5

2021
11.9

2022
9.7

2023
7.7

Thereafter
27.9

Total
$
91.9




18

ELEMENT SOLUTIONS INC AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements
(Unaudited)



12. CONTINGENCIES, ENVIRONMENTAL AND LEGAL MATTERS
Environmental Matters
The Company is involved in various claims relating to environmental matters at current and former plants and waste management sites. The Company engages or participates in remedial and other environmental compliance activities at certain of these sites. At other sites, it has been named as a potential responsible party pursuant to the federal Superfund Act and/or state Superfund laws comparable to the federal law for site remediation. The Company analyzes each individual site, considering the number of parties involved, the level of its potential liability or contribution relating to the other parties, the nature and magnitude of the hazardous wastes involved, the method and extent of remediation, the potential insurance coverage, the estimated legal and consulting expense with respect to each site and the time period over which costs are likely to be incurred. Based on this analysis, the Company estimates the clean-up costs and related claims for each site. The estimates are based in part on discussions with other potential responsible parties, governmental agencies and engineering firms.
The Company accrues for environmental matters when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current laws and existing technologies. The accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. The Company's environmental liabilities, which are included in the Condensed Consolidated Balance Sheets as "Accrued expenses and other current liabilities" and "Other liabilities," totaled $16.5 million and $18.3 million at June 30, 2019 and December 31, 2018, respectively, primarily driven by environmental remediation, clean-up costs and monitoring of sites that were either closed or disposed of in prior years. While uncertainty exists with respect to the amount and timing of its ultimate environmental liabilities, the Company does not currently anticipate any material losses in excess of the amount recorded. However, it is possible that new information about the sites, such as results of investigations, could make it necessary for the Company to reassess its potential exposure related to these environmental matters.
As of the date of this Quarterly Report, the Company believes it is not possible to develop an estimate of the range of reasonably possible environmental losses in excess of the Company's recorded liabilities and is unable to ascertain the ultimate aggregate amount of monetary liabilities or financial impacts with respect to these matters.
Legal Matters
From time to time, the Company is involved in various legal proceedings, investigations and/or claims in the normal course of its business. Although it cannot predict with certainty the ultimate resolution of these matters, which involve judgments that are inherently subjective, the Company believes that their resolutions, to the extent not covered by insurance, will not, individually or in the aggregate, have a material adverse effect on its consolidated financial position, results of operations or cash flows.
13. INCOME TAXES
The Company's quarterly income tax provision is measured using an estimate of its consolidated annual effective tax rate, adjusted in the current period for discrete income tax items, within the periods presented. The comparison of the Company's income tax provision between periods is significantly impacted by the level and mix of earnings and losses by tax jurisdiction, foreign income tax rate differentials and discrete items.
For the three months ended June 30, 2019, the Company recognized an income tax benefit of $6.8 million, as compared to an income tax expense of $30.0 million in the prior year. The tax benefit for the three months ended June 30, 2019 represented a benefit on the Company's pre-tax income based on its estimated full year annual effective tax rate, which includes the negative impact of U.S. global intangible low-taxed income provisions and an accrual of a valuation allowance on interest limitation carryforwards, and a benefit from the release of a valuation allowance in a non-U.S. jurisdiction. The tax provision for the three months ended June 30, 2018 was negatively impacted by the country mix of earnings and the Company's inability to recognize additional deferred tax assets in various jurisdictions related to its current-year operating results, primarily the United States.
For the six months ended June 30, 2019, the Company recognized an income tax benefit of $17.2 million, as compared to an income tax expense of $39.9 million in the prior year. The tax benefit for the six months ended June 30, 2019 represented a benefit


19

ELEMENT SOLUTIONS INC AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements
(Unaudited)



on the Company's pre-tax loss based on its estimated full year annual effective tax rate, which includes the negative impact of U.S. global intangible low-taxed income provisions, an accrual of a valuation allowance on interest limitation carryforwards and a benefit from the release of a valuation allowance in a non-U.S. jurisdiction. The tax provision for the six months ended June 30, 2018 was negatively impacted by the country mix of earnings and the Company's inability to recognize additional deferred tax assets in various jurisdictions related to its current-year operating results, primarily the United States.
As a result of the Arysta Sale, the deferred tax assets, valuation allowance and deferred tax liabilities of discontinued operations of $173 million, $75 million and $450 million, respectively, at December 31, 2018 were written off as part of the sale.
14. RELATED PARTY TRANSACTIONS
The Company is a party to an Advisory Services Agreement with Mariposa Capital, LLC, an affiliate of one of its founder directors, whereby Mariposa Capital, LLC is entitled to receive an annual fee, which is accrued quarterly and payable in quarterly installments, and reimbursement for expenses. This agreement is automatically renewed for successive one-year terms unless either party notifies the other party in writing of its intention not to renew no later than 90 days prior to the expiration of the applicable term. Effective February 1, 2019, Mariposa Capital, LLC's annual advisory fee was increased from $2.0 million to $3.0 million. This fee is recorded in the Condensed Consolidated Statements of Operations as "Selling, technical, general and administrative" expense.
15. SEGMENT INFORMATION
The Company's operations are organized into two reportable segments: Electronics and Industrial & Specialty. These segments represent businesses for which separate financial information is utilized by the chief operating decision maker, or CODM, for purposes of allocating resources and evaluating performance.
The Company allocates resources and evaluates the performance of its operating segments based primarily on net sales and Adjusted EBITDA. Adjusted EBITDA for each segment is defined as earnings before interest, taxes, depreciation and amortization, as further adjusted for additional items included in GAAP earnings which the Company believes are not considered to be representative or indicative of each of its segments' ongoing business or are considered to be associated with its capital structure. Adjusted EBITDA for each segment also includes an allocation of corporate costs, such as compensation expense and professional fees.


20

ELEMENT SOLUTIONS INC AND SUBSIDIARIES
Notes to the Condensed Consolidated Financial Statements
(Unaudited)



Results of Operations
The following table summarizes financial information regarding each reportable segment’s results of operations, including disaggregated external net sales by product category:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 (dollars in millions)
2019
 
2018
 
2019
 
2018
Net Sales:
 
 
 
 
 
 
 
Electronics
 
 
 
 
 
 
 
Assembly Solutions
$
137.4

 
$
149.8

 
$
270.4

 
$
289.6

Circuitry Solutions
92.2

 
102.1

 
183.0

 
208.1

Semiconductor Solutions
38.3

 
43.8

 
80.4

 
86.0

     Total Electronics
267.9

 
295.7

 
533.8

 
583.7

Industrial & Specialty
 
 
 
 
 
 
 
Industrial Solutions
132.5

 
142.0

 
270.5

 
287.5

Graphics Solutions
37.3

 
40.7

 
73.0

 
79.4

Energy Solutions
19.0

 
23.2

 
39.2

 
43.5

     Total Industrial & Specialty
188.8

 
205.9

 
382.7

 
410.4

Total net sales
$
456.7

 
$
501.6

 
$
916.5

 
$
994.1

 
 
 
 
 
 
 
 
Adjusted EBITDA:
 

 
 

 
 

 
 

Electronics
$
60.4

 
$
65.0

 
$
116.8

 
$
125.1

Industrial & Specialty
40.1

 
44.4

 
82.3

 
88.4

Total Adjusted EBITDA
$
100.5

 
$
109.4

 
$
199.1

 
$
213.5

The following table reconciles "Net income attributable to common stockholders" to Adjusted EBITDA:
 
Three months ended June 30,
 
Six Months Ended June 30,
 (dollars in millions)
2019
 
2018
 
2019
 
2018
Net income attributable to common stockholders
$
1.5

 
$
12.0

 
$
24.7

 
$
49.3

Add (subtract):
 
 
 
 
 
 
 
Net (loss) income attributable to the non-controlling interests
(0.1
)

(0.2
)

0.6


0.5

Loss (income) from discontinued operations, net of tax
13.3

 
(61.4
)
 
(14.1
)
 
(108.3
)
Income tax (benefit) expense
(6.8
)

30.0


(17.2
)

39.9

Interest expense, net
18.2

 
78.3

 
56.3

 
155.5

Depreciation expense
10.4

 
11.2

 
20.7

 
22.9

Amortization expense
28.4

 
28.4

 
56.8

 
56.9

EBITDA
64.9


98.3


127.8


216.7

Adjustments to reconcile to Adjusted EBITDA:
 
 
 
 
 
 
 
Restructuring expense
2.8


1.6


4.0


3.3

Integration costs
0.3


3.5


1.7


4.5

Foreign exchange loss (gain) on foreign denominated external and internal long-term debt
28.7


4.6


0.4


(3.1
)
Debt refinancing costs
0.3

 

 
61.0

 

Change in fair value of contingent consideration
0.5

 
1.0

 
2.9

 
1.5

Gain on sale of equity investment

 

 

 
(11.3
)
Other, net
3.0


0.4


1.3


1.9

Adjusted EBITDA
$
100.5


$
109.4


$
199.1


$
213.5



21


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
This Management's Discussion and Analysis of Financial Condition and Results of Operations section should be read in conjunction with the unaudited Condensed Consolidated Financial Statements and related notes included in this Quarterly Report, and the Consolidated Financial Statements, related notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations section and other disclosures contained in our 2018 Annual Report. This discussion contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements. Factors that might cause a difference include, but are not limited to, those discussed under the "Forward-Looking Statements” section of this Quarterly Report and in Part I, Item 1A, "Risk Factors" of our 2018 Annual Report.
Overview
Our Business
Element Solutions Inc, incorporated in Delaware in January 2014, is a leading global specialty chemicals company whose operating businesses formulate a broad range of solutions that enhance the performance of products people use every day. Developed in multi-step technological processes, the innovative solutions of our businesses enable customers' manufacturing processes in several key industries, including electronic circuitry, semiconductor, communications infrastructure, automotive systems, industrial surface finishing, consumer packaging and offshore energy. Substantially all of our businesses' products are consumed by our customers as part of their production process, providing us with reliable and recurring revenue streams as the products are replenished in order to continue production. Those customers use our innovations as competitive advantages, relying on us to help them navigate through fast-paced, high-growth markets. Our product development and product extensions are expected to continue to drive sales growth in both new and existing markets, while expanding margins, by continuing to offer high customer value propositions.
We generate revenue through the formulation and sale of our businesses' dynamic chemistry solutions and by providing highly technical service to our customers and OEMs through our extensive global network of specially-trained scientists and engineers. While our dynamic chemistries typically represent only a small portion of our customers’ costs, they are integral to our customers' manufacturing processes and overall product performance. We leverage these close relationships with our customers and OEMs to execute our growth strategy and identify opportunities for new products. These new products are developed and created by drawing upon our intellectual property portfolio and technical expertise.  We believe that our customers place significant value on the consistency and quality represented by our brands, which we capitalize on through significant market share, customer loyalty and supply chain access. Lastly, operational risks and switching costs make it difficult for our customers to change suppliers which allows us to retain customers and maintain our market positions.
Our Operations
Our operations are organized into two reportable segments: Electronics and Industrial & Specialty, which are each described below:
Electronics – The Electronics segment researches, formulates and delivers specialty chemicals and materials for all types of electronics hardware, from complex printed circuit board designs to new interconnection materials. In mobile communications, computers, automobiles and aerospace equipment, its products are an integral part of the electronics manufacturing process and the functionality of their goods. The segment's "wet chemistries" for metallization, surface treatments and solderable finishes form physical circuitry pathways and its "assembly materials," such as solders, pastes, fluxes and adhesives, join those pathways together.


22


The segment provides specialty chemical solutions through the following businesses:
Assembly Solutions
 
As a global supplier of solder technologies, fluxes, cleaners and other attachment materials for the electronics assembly industry, we develop innovative materials that join electronic circuits in high volume device manufacturing. Our high-performing interconnect materials are used to assemble consumer electronics from circuit boards, discrete electronic components, connectors and integrated circuit substrates.
Circuitry Solutions
 
As a global supplier of chemical formulations to the electronics industry, we design and manufacture proprietary liquid chemical processes ("bath") used by our customers to manufacture printed circuit boards. Our product portfolio is focused on specialized consumable chemical processes, such as surface treatments, circuit formation, primary metallization, electroplate and final finishes.
Semiconductor Solutions
 
As a global supplier of semiconductor materials and packaging technologies, we provide advanced copper interconnects, die attachment, wafer bump processes and photomask technologies to our customers for integrated circuit fabrication and semiconductor packaging.
Industrial & Specialty – The Industrial & Specialty segment provides customers with Industrial Solutions, which include chemical systems that protect and decorate metal and plastic surfaces; Graphics Solutions, which include consumable chemicals that enable printing image transfer on flexible packaging materials; and Energy Solutions, which include dynamic chemistries used in water-based hydraulic control fluids for offshore deep-water drilling. Its fully consumable products are used in the aerospace, automotive, construction, consumer electronics, consumer packaged goods and oil and gas production end markets.
The segment provides specialty chemical solutions through the following businesses:
Industrial Solutions
 
As a global supplier of industrial metal and plastic finishing chemistries, our chemical systems protect and decorate metal and plastic surfaces. Some of our precisely formulated high-performance coatings have functional uses, including improving wear and tear, such as hard chrome plating of shock absorbers for cars and special drills used for oil and gas exploration, while others provide corrosion resistance for appliance parts. Alternatively, our chemistries may have decorative performance, such as the application of gloss finishes for parts used in automotive interiors or fashion finishes used on jewelry surfaces.
Graphics Solutions
 
As a supplier of consumable materials used to transfer images to printed substrates, our products are used to improve print quality and printing productivity. We produce and market photopolymers through an extensive line of flexographic plates that are used in the commercial packaging and printing industries.
Energy Solutions
 
As a global supplier of specialized fluids to the offshore energy industry, we produce, market and support water-based hydraulic control fluids for major oil and gas companies and drilling contractors for offshore deep-water production and drilling applications.
Recent Developments
Arysta Sale
The Arysta Sale was completed on January 31, 2019 for net cash proceeds of approximately $4.28 billion, after post-closing adjustments. The proceeds of the Arysta Sale were primarily used to pay down our then existing credit facilities, including the first lien credit facility and the revolving credit facility under our second amended and restated credit agreement, dated August 6, 2014, as further amended and restated.
Recapitalization
On the closing date of the Arysta Sale, we paid down our then existing credit facilities with the proceeds of the Arysta Sale, as indicated above, and entered into the New Credit Agreement, which provides for new senior secured credit facilities in an aggregate principal amount of $1.08 billion. On the closing date of the Arysta Sale, the $750 million term loan was borrowed under the New Credit Agreement. In addition, on February 1, 2019, we used a portion of the net proceeds from the Arysta Sale and a portion of borrowings under the New Credit Agreement to redeem all outstanding Prior Senior Notes. The 5.875% USD Notes due 2025 were not redeemed and remain outstanding.


23


Repurchases of our common stock
During the six months ended June 30, 2019, as part of our previously-announced share repurchase program, we repurchased approximately 38.2 million shares of our common stock for an aggregate purchase price of approximately $445 million. The remaining authorization under the share repurchase program was approximately $305 million at June 30, 2019. The repurchases were funded from cash on hand and proceeds from borrowings under the New Credit Agreement.
Recent Accounting Pronouncements
A summary of recent accounting pronouncements is included in Note 2, Recent Accounting Pronouncements, to our unaudited Condensed Consolidated Financial Statements included in this Quarterly Report.
Non-GAAP Financial Measures
To supplement our financial results presented in accordance with GAAP in this Management’s Discussion and Analysis of Financial Condition and Results of Operations section, we present certain non-GAAP financial measures, such as operating results on a constant currency and organic basis and Adjusted EBITDA. Management internally reviews each of these non-GAAP measures to evaluate performance on a comparative period-to-period basis in terms of absolute performance, trends and expected future performance with respect to our business. We believe these non-GAAP financial measures, which are each further described below, provide investors with an additional perspective on trends and underlying operating results on a period-to-period comparable basis. We also believe that investors find this information helpful in understanding the ongoing performance of our operations separate from items that may have a disproportionate positive or negative impact on our financial results in any particular period.
These non-GAAP financial measures, however, have limitations as analytical tools and should not be considered in isolation from, a substitute for, or superior to, the related financial information that we report in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in our financial statements and may not be comparable to similarly titled measures of other companies due to potential differences in calculation methods. In addition, these measures are subject to inherent limitations as they reflect the exercise of judgment by management about which items are excluded or included in determining these non-GAAP financial measures. Investors are encouraged to review the reconciliations of these non-GAAP financial measures to their most comparable GAAP financial measures included in this Quarterly Report and not to rely on any single financial measure to evaluate our business.
Constant Currency
We disclose operating results, from net sales through operating profit and Adjusted EBITDA, on a constant currency basis by adjusting to exclude the impact of changes due to the translation of foreign currencies of our international locations into U.S. dollars. Management believes this non-GAAP financial information facilitates period-to-period comparison in the analysis of trends in business performance, thereby providing valuable supplemental information regarding our results of operations, consistent with how we internally evaluate our financial results.
The impact of foreign currency translation is calculated by converting our current-period local currency financial results into U.S. dollars using the prior period's exchange rates and comparing these adjusted amounts to our prior period reported results. The difference between actual growth rates and constant currency growth rates represents the impact of foreign currency translation.


24


Organic Net Sales Growth
Organic net sales growth is defined as net sales excluding the impact of foreign currency translation, changes due to the pass-through pricing of certain metals and acquisitions and/or divestitures, as applicable. Management believes this non-GAAP financial measure provides investors with a more complete understanding of the underlying net sales trends by providing comparable net sales over differing periods on a consistent basis.
For a reconciliation of reported net sales growth to organic net sales growth, see "Net Sales" within the "Results of Operations" section below.
Adjusted EBITDA
We define Adjusted EBITDA as EBITDA (earnings before interest, provision for income taxes, depreciation and amortization), excluding the impact of additional items included in GAAP earnings which we believe are not representative or indicative of our ongoing business or are considered to be associated with our capital structure. Management believes Adjusted EBITDA provides investors with a more complete understanding of the long-term profitability trends of our business and facilitates comparisons of our profitability to prior and future periods.
For a reconciliation of "Net income attributable to common stockholders" to Adjusted EBITDA, and more information about the adjustments made, see Note 15, Segment Information, to the unaudited Condensed Consolidated Financial Statements included in this Quarterly Report.


25


Results of Operations
Three and six months ended June 30, 2019 as compared to the three and six months ended June 30, 2018
The following table summarizes our results of operations for the three and six months ended June 30, 2019 and 2018
 
Three Months Ended
June 30,
 
% Change
 
Six Months Ended June 30,
 
% Change
 (dollars in millions)
2019
 
2018
 
Reported
 
Constant Currency
 
Organic
 
2019
 
2018
 
Reported
 
Constant Currency
 
Organic
Net sales
$
456.7

 
$
501.6

 
(9)%
 
(5)%
 
(6)%
 
$
916.5

 
$
994.1

 
(8)%
 
(4)%
 
(4)%
Cost of sales
263.7

 
286.9

 
(8)%
 
(4)%
 
 
 
525.2

 
568.3

 
(8)%
 
(3)%
 
 
Gross profit
193.0

 
214.7

 
(10)%
 
(7)%
 
 
 
391.3

 
425.8

 
(8)%
 
(4)%
 
 
Gross margin
42.3
%
 
42.8
%
 
(50) bps
 
(70) bps
 
 
 
42.7
%
 
42.8
%
 
(10) bps
 
(30) bps
 
 
Operating expenses
137.5

 
155.5

 
(12)%
 
(9)%
 
 
 
290.7

 
307.7

 
(6)%
 
(2)%
 
 
Operating profit
55.5

 
59.2

 
(6)%
 
(1)%
 
 
 
100.6

 
118.1

 
(15)%
 
(9)%
 
 
Operating margin
12.2
%
 
11.8
%
 
40bps
 
50bps
 
 
 
11.0
%
 
11.9
%
 
(90)bps
 
(70)bps
 
 
Other expense, net
(47.6
)
 
(78.8
)
 
(40)%
 

 
 
 
(106.6
)
 
(136.7
)
 
(22)%
 

 
 
Income tax benefit (expense)
6.8

 
(30.0
)
 
(nm)
 

 
 
 
17.2

 
(39.9
)
 
(nm)
 

 
 
Net income (loss) from continuing operations
14.7

 
(49.6
)
 
(nm)
 

 
 
 
11.2

 
(58.5
)
 
(nm)
 

 
 
(Loss) income from discontinued operations, net of tax
(13.3
)
 
61.4

 
(122)%
 

 
 
 
14.1

 
108.3

 
(87)%
 

 

Net income
$
1.4

 
$
11.8

 
(88)%
 

 
 
 
$
25.3

 
$
49.8

 
(49)%
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA
$
100.5

 
$
109.4

 
(8)%
 
(4)%
 
 
 
$
199.1

 
$
213.5

 
(7)%
 
(2)%
 
 
Adjusted EBITDA margin
22.0
%
 
21.8
%
 
20bps
 
30bps
 
 
 
21.7
%
 
21.5
%
 
20bps
 
30bps
 
 
(nm)
Calculation not meaningful.


26


Net Sales
Net sales in the second quarter of 2019 decreased by 9% on a reported basis, 5% on a constant currency basis and 6% on an organic basis. Electronics and our consolidated results were positively impacted by $1.0 million of acquisitions and $0.7 million of pass-through metals pricing.
The following table reconciles GAAP net sales growth to constant currency and organic net sales growth:
 
Three Months Ended June 30,
 
% Change
 (dollars in millions)
2019
 
2018
 
Reported Net Sales Growth
 
Impact of Currency
 
Constant Currency
 
Pass-Through Metals Pricing
 
Acquisitions/Dispositions
 
Organic Net Sales Growth
Electronics:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assembly Solutions
$
137.4

 
$
149.8

 
(8)%
 
4%
 
(4)%
 
0%
 
(1)%
 
(5)%
Circuitry Solutions
92.2

 
102.1

 
(10)%
 
4%
 
(6)%
 
—%
 
—%
 
(6)%
Semiconductor Solutions
38.3

 
43.8

 
(13)%
 
1%
 
(11)%
 
—%
 
—%
 
(11)%
Total
$
267.9

 
$
295.7

 
(9)%
 
4%
 
(6)%
 
0%
 
0%
 
(6)%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Industrial & Specialty:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Industrial Solutions
$
132.5

 
$
142.0

 
(7)%
 
4%
 
(3)%
 
—%
 
—%
 
(3)%
Graphics Solutions
37.3

 
40.7

 
(8)%
 
2%
 
(6)%
 
—%
 
—%
 
(6)%
Energy Solutions
19.0

 
23.2

 
(18)%
 
3%
 
(15)%
 
—%
 
—%
 
(15)%
Total
$
188.8

 
$
205.9

 
(8)%
 
4%
 
(5)%
 
—%
 
—%
 
(5)%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total
$
456.7

 
$
501.6

 
(9)%
 
4%
 
(5)%
 
0%
 
0%
 
(6)%
Electronics' net sales in the second quarter of 2019 declined by 9% on a reported basis and 6% on an organic basis.
Assembly Solutions: net sales declined by 8% on a reported basis and 5% on an organic basis. The decrease was primarily due to weakness in both the mobile phone markets in Asia, primarily China and Taiwan, and automotive markets in North America, partially offset by increased demand for assembly products in electronic vehicles.
Circuitry Solutions: net sales declined by 10% on a reported basis and 6% on an organic basis. The decrease was due to continued weakness within the mobile phone markets in Asia, primarily China and Taiwan, as well as lower demand from memory disk customers.
Semiconductor Solutions: net sales declined 13% on a reported basis and 11% on an organic basis. The decrease was due to weakness in the semiconductor market, partially offset by continued strength in advanced assembly products.
Industrial & Specialty's net sales in the second quarter of 2019 declined by 8% on a reported basis and 5% on an organic basis.
Industrial Solutions: net sales declined by 7% on a reported basis and 3% on an organic basis. The decrease was primarily due to softness in the European industrial and automotive markets partially offset by increased sales of Fernox products primarily in the United Kingdom.
Graphics Solutions: net sales declined by 8% on a reported basis and 6% on an organic basis. The decrease was primarily due to lower newspaper revenues and weakness in North America.
Energy Solutions: net sales declined 18% on a reported basis and 15% on an organic basis. The decrease was primarily due to the loss of certain business with a specific customer in the first quarter which had a negative impact of approximately 10% on organic net sales growth, as well as weakness in North America, partially offset by growth in Europe, including lower net fill activity in the current period.


27


On a year-to-date basis, net sales decreased by 8% on a reported basis and 4% on both a constant currency and organic basis. Electronics and our consolidated results were positively impacted by $3.6 million of acquisitions and $1.6 million of pass-through metals pricing.
The following table reconciles GAAP net sales growth to constant currency and organic net sales growth:
 
Six Months Ended June 30,
 
% Change
 (dollars in millions)
2019
 
2018
 
Reported Net Sales Growth
 
Impact of Currency
 
Constant Currency
 
Pass-Through Metals Pricing
 
Acquisitions/Dispositions
 
Organic Net Sales Growth
Electronics:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assembly Solutions
$
270.4

 
$
289.6

 
(7)%
 
5%
 
(2)%
 
(1)%
 
(1)%
 
(4)%
Circuitry Solutions
183.0

 
208.1

 
(12)%
 
4%
 
(8)%
 
—%
 
—%
 
(8)%
Semiconductor Solutions
80.4

 
86.0

 
(6)%
 
1%
 
(5)%
 
—%
 
—%
 
(5)%
Total
$
533.8

 
$
583.7

 
(9)%
 
4%
 
(5)%
 
0%
 
(1)%
 
(6)%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Industrial & Specialty:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Industrial Solutions
$
270.5

 
$
287.5

 
(6)%
 
5%
 
(1)%
 
—%
 
—%
 
(1)%
Graphics Solutions
73.0

 
79.4

 
(8)%
 
3%
 
(5)%
 
—%
 
—%
 
(5)%
Energy Solutions
39.2

 
43.5

 
(10)%
 
5%
 
(5)%
 
—%
 
—%
 
(5)%
Total
$
382.7

 
$
410.4

 
(7)%
 
4%
 
(2)%
 
—%
 
—%
 
(2)%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total
$
916.5

 
$
994.1

 
(8)%
 
4%
 
(4)%
 
0%
 
0%
 
(4)%
On a year-to-date basis, Electronics' net sales declined by 9% on a reported basis and 6% on an organic basis.
Assembly Solutions: net sales declined by 7% on a reported basis and 4% on an organic basis. The decrease was due to weakness in the mobile phone markets in Asia, primarily China and Taiwan, partially offset by increased demand for assembly products in electronic vehicles.
Circuitry Solutions: net sales declined by 12% on a reported basis and 8% on an organic basis. The decrease was due to weakness within the mobile phone markets in Asia, primarily China and Taiwan, as well as lower demand from memory disk customers.
Semiconductor Solutions: net sales declined 6% on a reported basis and 5% on an organic basis. The decrease was due to weakness in the semiconductor market and mobile phone market, partially offset by continued strength in advanced assembly products.
Industrial & Specialty's net sales declined by 7% on a reported basis and 2% on an organic basis.
Industrial Solutions: net sales declined by 6% on a reported basis and 1% on an organic basis. The decrease was due to softness in the European industrial markets and Asian automotive markets, partially offset by increased sales of Fernox products primarily in the United Kingdom.
Graphics Solutions: net sales declined by 8% on a reported basis and 5% on an organic basis. The decrease was primarily due to lower newspaper revenues and weakness in North America.
Energy Solutions: net sales declined 10% on a reported basis and 5% on an organic basis. The decrease was primarily due to the loss of certain business with a specific customer in the first quarter which had a negative impact of approximately 7% on organic net sales growth, as well as weakness in North America, partially offset by growth in Europe, including lower net fill activity. The loss of certain business with a specific customer is expected to negatively impact organic net sales growth for the remainder of 2019.


28


Gross Profit
 
Three Months Ended June 30,
 
% Change
 
Six Months Ended June 30,
 
% Change
 (dollars in millions)
2019
 
2018
 
Reported
 
Constant Currency
 
2019
 
2018
 
Reported
 
Constant Currency
Gross profit
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Electronics
$
108.1

 
$
118.9

 
(9)%
 
(6)%
 
$
217.7

 
$
234.2

 
(7)%
 
(4)%
Industrial & Specialty
84.9

 
95.8

 
(11)%
 
(8)%
 
173.6

 
191.6

 
(9)%
 
(5)%
Total
$
193.0

 
$
214.7

 
(10)%
 
(7)%
 
$
391.3

 
$
425.8

 
(8)%
 
(4)%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gross margin
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Electronics
40.4
%
 
40.2
%
 
20 bps
 
 
40.8
%
 
40.1
%
 
70 bps
 
40 bps
Industrial & Specialty
44.9
%
 
46.5
%
 
(160) bps
 
(170) bps
 
45.4
%
 
46.7
%
 
(130) bps
 
(140) bps
Total
42.3
%
 
42.8
%
 
(50) bps
 
(70) bps
 
42.7
%
 
42.8
%
 
(10) bps
 
(30) bps
Electronics' gross profit in the second quarter of 2019 decreased by 9% on a reported basis and 6% on a constant currency basis. The constant currency decrease in gross profit was primarily driven by lower net sales volumes. The change in gross margin for the period was relatively flat as the decline in gross profit was at a similar rate as the decline in net sales.
Industrial & Specialty's gross profit in the second quarter of 2019 decreased by 11% on a reported basis and 8% on a constant currency basis. The constant currency decrease in gross profit was primarily driven by lower net sales volumes. The decrease in gross margin was primarily due to lower net sales in Energy Solutions, which products have higher gross margins.
On a year-to-date basis, Electronics' gross profit decreased by 7% on a reported basis and 4% on a constant currency basis. The constant currency decrease in gross profit was primarily driven by lower net sales partially offset by favorable product mix.
On a year-to-date basis, Industrial & Specialty's gross profit decreased by 9% on a reported basis and 5% on a constant currency basis. The constant currency decrease in gross profit was driven by lower net sales volumes. The decrease in gross margin was primarily due to lower net sales in Energy Solutions, which products have higher gross margins.
Operating Expenses
 
Three Months Ended June 30,
 
% Change
 
Six Months Ended June 30,
 
% Change
 (dollars in millions)
2019
 
2018
 
Reported
 
Constant Currency
 
2019
 
2018
 
Reported
 
Constant Currency
Selling, technical, general and administrative
$
126.4

 
$
144.3

 
(12)%
 
(10)%
 
$
268.8

 
$
285.1

 
(6)%
 
(2)%
Research and development
11.1

 
11.2

 
(1)%
 
—%
 
21.9

 
22.6

 
(3)%
 
(2)%
Total
$
137.5

 
$
155.5

 
(12)%
 
(9)%
 
$
290.7

 
$
307.7

 
(6)%
 
(2)%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating Expenses as % of Net Sales
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Selling, technical, general and administrative
27.7
%
 
28.8
%
 
(110) bps
 
(140) bps
 
29.3
%
 
28.7
%
 
60 bps
 
30 bps
Research and development
2.4
%
 
2.2
%
 
20 bps
 
20 bps
 
2.4
%
 
2.3
%
 
10 bps
 
Total
30.1
%
 
31.0
%
 
(90) bps
 
(120) bps
 
31.7
%
 
31.0
%
 
70 bps
 
30 bps
Operating expenses in the second quarter of 2019 decreased 12% on a reported basis and 9% on a constant currency basis, driven primarily by lower corporate expenses, including personnel and professional fees, as we continue to realize the benefits relating to our corporate structure reorganization. In addition, operating expenses in the current period benefited from lower incentive compensation expenses and the implementation of cost containment initiatives in the business.


29


On a year-to-date basis, operating expenses decreased 6% on a reported basis and 2% on a constant currency basis, driven primarily by lower corporate expenses, including personnel and professional fees, as we continue to realize the benefits relating to our corporate structure reorganization. In addition, operating expenses in the current period benefited from lower incentive compensation expenses and the implementation of cost containment initiatives in the business. These were partially offset by nonrecurring expenses related to the closing of the Arysta Sale that do not qualify for discontinued operations, share-based compensation expense of $4.0 million associated with the retirement of our former CEO and $2.0 million of expense associated with the payment of a long-term contingent consideration liability.
Other (Expense) Income
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 (dollars in millions)
2019
 
2018
 
2019
 
2018
Other (expense) income
 
 
 
 
 
 
 
Interest expense, net
$
(18.2
)
 
$
(78.3
)
 
$
(56.3
)
 
$
(155.5
)
Foreign exchange (loss) gains
(28.3
)
 
(2.4
)
 
(1.2
)
 
5.1

Other (expense) income, net
(1.1
)
 
1.9

 
(49.1
)
 
13.7

Total
$
(47.6
)
 
$
(78.8
)
 
$
(106.6
)
 
$
(136.7
)
Interest Expense, Net
For the three and six months ended June 30, 2019, net interest expense decreased $60.1 million and $99.2 million, respectively, primarily due to the pay down of our existing credit facilities on January 31, 2019, in connection with the Arysta Sale. Lower interest expense, as compared to 2018, is expected to continue as we realize the benefits associated with the deleveraging of our balance sheet as a result of the Arysta Sale.
Foreign Exchange (Loss) Gain
For the three months ended June 30, 2019, foreign exchange loss increased $25.9 million primarily due to the remeasurement of euro and British pound denominated intercompany balances.

For the six months ended June 30, 2019, the foreign exchange loss of $1.2 million was primarily due to the remeasurement of euro-denominated external debt into U.S. dollar. For the six months ended June 30, 2018, the foreign exchange gain of $5.1 million was primarily due to the remeasurement of euro-denominated external debt into U.S. dollar, which was partially offset by British pound denominated intercompany balances.
Other (Expense) Income, Net
For the six months ended June 30, 2019, other expense, net of $49.1 million included $61.0 million of debt refinancing costs related to the pay down of our then existing credit facilities in connection with the Arysta Sale, partially offset by a $11.7 million gain on derivative contracts, associated with the refinancing of our non-U.S. dollar denominated third-party debt in the first quarter. For the six months ended June 30, 2018, other income, net of $13.7 million, included a $11.3 million gain on a sale of an equity investment.
Income Tax
The comparison of the Company's income tax provision between periods is significantly impacted by the level and mix of earnings and losses by tax jurisdiction, foreign income tax rate differentials and discrete items.
For the three months ended June 30, 2019, the Company recognized an income tax benefit of $6.8 million, as compared to an income tax expense of $30.0 million in the prior year. The tax benefit for the three months ended June 30, 2019 represented a benefit on the Company's pre-tax income based on its estimated full year annual effective tax rate, which includes the negative


30


impact of U.S. global intangible low-taxed income provisions and an accrual of a valuation allowance on interest limitation carryforwards, and a benefit from the release of a valuation allowance in a non-U.S. jurisdiction. The tax provision for the three months ended June 30, 2018 was negatively impacted by the country mix of earnings and the Company's inability to recognize additional deferred tax assets in various jurisdictions related to its current-year operating results, primarily the United States.
For the six months ended June 30, 2019, the Company recognized an income tax benefit of $17.2 million, as compared to an income tax expense of $39.9 million in the prior year. The tax benefit for the six months ended June 30, 2019, represented a benefit on the Company's pre-tax loss based on its estimated full year annual effective tax rate, which includes the negative impact of U.S. global intangible low-taxed income provisions, an accrual of a valuation allowance on interest limitation carryforwards and a benefit from the release of a valuation allowance in a non-U.S. jurisdiction. The tax provision for the six months ended June 30, 2018, was negatively impacted by the country mix of earnings and the Company's inability to recognize additional deferred tax assets in various jurisdictions related to its current-year operating results, primarily the United States.
Income from Discontinued Operations, Net of Tax
Net loss from discontinued operations was $13.3 million for the three months ended June 30, 2019, which primarily represents the settlement of certain post-closing adjustments. See Note 3, Discontinued Operations, for further information regarding the Arysta discontinued operations.
Other Comprehensive Income
Other comprehensive loss for the three months ended June 30, 2019, totaled $18.3 million, as compared to loss of $375 million in the prior year. The change was driven primarily by foreign currency translation loss in the second quarter of 2018 associated with the Brazilian real, euro, Chinese yuan and Japanese yen, partially offset by gains associated with the British pound.
Other comprehensive income for the six months ended June 30, 2019, totaled $539 million, as compared to loss of $310 million in the prior year. The change was driven primarily by realized foreign currency translation losses resulting from the Arysta Sale of $480 million, as well as foreign currency translation gains associated with the Brazilian real, euro and Chinese yuan, partially offset by loss associated with the British pound.
Segment Adjusted EBITDA Performance
 
Three Months Ended June 30,
 
% Change
 
Six Months Ended June 30,
 
% Change
 (dollars in millions)
2019
 
2018
 
Reported
 
Constant Currency
 
2019
 
2018
 
Reported
 
Constant Currency
Adjusted EBITDA:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Electronics
$
60.4

 
$
65.0

 
(7)%
 
(3)%
 
$
116.8

 
$
125.1

 
(7)%
 
(2)%
Industrial & Specialty
40.1

 
44.4

 
(10)%
 
(6)%
 
82.3

 
88.4

 
(7)%
 
(2)%
Total
$
100.5

 
$
109.4

 
(8)%
 
(4)%
 
$
199.1

 
$
213.5

 
(7)%
 
(2)%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA margin:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Electronics
22.5%
 
22.0%
 
50 bps
 
70 bps
 
21.9%
 
21.4%
 
50 bps
 
60 bps
Industrial & Specialty
21.2%
 
21.6%
 
(40) bps
 
(40) bps
 
21.5%
 
21.5%
 
 
10 bps
Total
22.0%
 
21.8%
 
20 bps
 
30 bps
 
21.7%
 
21.5%
 
20 bps
 
30 bps
For the three months ended June 30, 2019, Electronics' Adjusted EBITDA decreased 7% on a reported basis and 3% on a constant currency basis. The constant currency decrease was driven primarily by lower gross profit, partially offset by lower general and administrative expenses. Industrial & Specialty's Adjusted EBITDA decreased 10% on a reported basis and 6% on a constant


31


currency basis. The constant currency decrease was driven primarily by lower gross profit, partially offset by lower general and administrative expenses.
For the six months ended June 30, 2019, Electronics' Adjusted EBITDA decreased 7% on a reported basis and 2% on a constant currency basis. The constant currency decrease was driven primarily by lower gross profit, partially offset by lower general and administrative expenses. Industrial & Specialty's Adjusted EBITDA decreased 7% on a reported basis and 2% on a constant currency basis. The constant currency decrease was driven primarily by lower gross profit, partially offset by lower general and administrative expenses.
On a consolidated basis for the three and six months ended June 30, 2019, the relatively stable gross margins and the decrease in overall operating expenses, at a rate higher than the decline in net sales, led to Adjusted EBITDA margin expansion compared to the prior periods.
Liquidity and Capital Resources 
The Arysta Sale was completed on January 31, 2019, for net cash proceeds of approximately $4.28 billion, after certain post-closing adjustments relating to, among other things, cash, indebtedness and working capital, as finalized with UPL on May 17, 2019.
Our primary sources of liquidity during the six months ended June 30, 2019, were the proceeds of the Arysta Sale as well as the $750 million term loan under the New Credit Agreement, periodic borrowings under the revolving credit facilities under the Company's second amended and restated credit agreement until January 31, 2019 and, subsequently, the New Credit Agreement, and available cash generated from operations. Our primary uses of cash and cash equivalents were to fund operations, working capital, capital expenditures and debt service obligations as well as to pay down approximately $4.60 billion of debt outstanding on the closing date of the Arysta Sale and to fund our $445 million of repurchases of our common stock. In the first quarter of 2019, we also paid $40.0 million of contingent consideration related to the achievement of certain common stock trading targets set in connection with the MacDermid Acquisition. The expected interest payments on our new existing debt, consisting of the 5.875% USD Notes due 2025 and the new term loan under the New Credit Agreement, are expected to total approximately $70 million per year over the next three years, taking into account the effect of interest rate swaps and cross-currency swaps, excluding any potential additional borrowings under the New Credit Agreement, with the first significant principal payment, totaling $800 million due in 2025.
We believe that our cash and cash equivalents and cash generated from operations, supplemented by our availability under our lines of credit, including our revolving credit facility under the New Credit Agreement, will be sufficient to meet our working capital needs, interest payments, capital expenditures and other business requirements for at least the next twelve months. However, working capital cycles and/or future repurchases of our common stock and/or acquisitions may require additional funding, which may include future debt and/or equity offerings.  On August 2, 2019, we filed a universal shelf registration statement on Form S-3 with the SEC. Under this universal shelf, we may offer and sell various types of securities in amounts, at prices and on terms announced, if and when the securities are offered during the three-year period that commenced upon its filing. Our long-term liquidity may be influenced by our ability to borrow additional funds, renegotiate existing debt and raise equity under terms that are favorable to us.
We may from time to time seek to repurchase our equity and/or to retire or repurchase our outstanding debt through cash purchases and/or exchanges for equity, in open market purchases, privately negotiated transactions or otherwise. Such repurchases or exchanges, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions, applicable restrictions under our various financing arrangements and other factors.
During the six months ended June 30, 2019, approximately 75% of our net sales were generated from non-U.S. operations, and we expect a large portion of our net sales to continue to be generated outside of the United States. As a result, our foreign subsidiaries will likely continue to hold a substantial portion of our cash. We expect to manage our worldwide cash requirements based on available funds among the many subsidiaries through which we conduct business and the cost effectiveness with which those funds can be accessed. We may transfer cash from certain international subsidiaries to the United States and other international subsidiaries when we believe it is cost effective to do so.


32


We continually review our domestic and foreign cash profile, expected future cash generation and investment opportunities, which support our current designation of a portion of these funds as being indefinitely reinvested, and reassess whether there are demonstrated needs to repatriate a portion of these funds being held internationally. If, as a result of our review, we determine that all or a portion of the funds require repatriation, we may be required to accrue additional foreign taxes. Of our $248 million of cash and cash equivalents at June 30, 2019, $229 million were held by our foreign subsidiaries. In 2019, domestic cash was primarily used to fund repurchases of our common stock and repayments of existing revolving credit facilities.
The following is a summary of our cash flows provided by (used in) operating, investing, and financing activities of continuing operations during the periods indicated:
 
Six Months Ended June 30,
 (dollars in millions)
2019
 
2018
Cash provided by (used in) operating activities
$
5.3

 
$
(12.7
)
Cash provided by (used in) investing activities
$
4,278.3

 
$
(11.8
)
Cash (used in) provided by financing activities
$
(4,322.2
)
 
$
59.1

Operating Activities
The decrease was driven primarily by higher cash operating profits (net loss adjusted for non-cash items), including $54.2 million of lower interest payments and lower net build of accounts receivable, inventories and accounts payable due to lower revenue, partially offset by the payment of contingent consideration liability of $30.9 million.
Investing Activities
The increase was primarily driven by the Arysta Sale, which generated $4.28 billion, after certain post-closing adjustments. Investing cash inflows from the prior year include $25.0 million of proceeds from the sale of an equity investment, which was offset by an acquisition for $28.2 million.
Financing Activities
The increase was primarily driven by the pay down of approximately $4.60 billion of debt from a combination of proceeds of the Arysta Sale and a $750 million term loan under the New Credit Agreement. These cash inflows were also used to fund the repurchases of our common stock for an aggregate purchase price of $445 million. In addition, $39.5 million was used to fund the repurchase and extinguishment fees related to our debt pay down and to fund the deferred financing fees associated with the New Credit Agreement. Cash inflows from borrowings under our lines of credit totaled $25.1 million during 2019, as compared to $60.0 million in 2018.
Financial Borrowings
Credit Facilities
At June 30, 2019, we had $1.57 billion of indebtedness, net of unamortized premiums, discounts and debt issuance costs, which primarily included:
$786 million of 5.875% USD Notes due 2025; and
$736 million of term debt arrangements outstanding under the first lien credit facility of the New Credit Agreement.
Availability under the revolving credit facility of the New Credit Agreement and various lines of credit and overdraft facilities totaled approximately $303 million at June 30, 2019, net of outstanding letters of credit.


33


Covenants
At June 30, 2019, we were in compliance with the customary affirmative and negative covenants, events of default and other customary provisions which govern our 5.875% USD Notes Indenture, as well as the debt covenants contained in the credit facilities of the New Credit Agreement.
Off-Balance Sheet Transactions
We use customary off-balance sheet arrangements, such as letters of credit. For additional information regarding letters of credit, see Note 7, Debt, to our unaudited Condensed Consolidated Financial Statements included in this Quarterly Report.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
The quantitative and qualitative disclosures about market risk required by this item have not changed materially from those disclosed in our 2018 Annual Report. For a discussion of our exposure to market risk, refer to Part II, Item 7A, Quantitative and Qualitative Disclosures about Market Risk, contained in our 2018 Annual Report.
Item 4. Controls and Procedures
(a) Evaluation of Disclosure Controls and Procedures
Our management is responsible for establishing and maintaining disclosure controls and procedures as defined in Rules 13a-15 (e) and 15d-15(e) under the Exchange Act. As required by Rule 13a-15(b) of the Exchange Act, management, including our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, our CEO and CFO have concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report.
(b) Changes to Internal Control Over Financial Reporting
As required by Rule 13a-15(d) under the Exchange Act, our management, including our CEO and CFO, has evaluated the Company’s internal control over financial reporting to determine whether any changes occurred during the quarter covered by this Quarterly Report have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
There have been no changes in our internal control over financial reporting that occurred during the quarter covered by this Quarterly Report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.


34



PART II. OTHER INFORMATION



Item 1. Legal Proceedings
From time to time, we are involved in legal proceedings, investigations and/or claims that are incidental to the operation of our businesses. In particular, we are involved in various claims relating to environmental matters at a number of current and former plant sites and waste management sites. See Note 12, Contingencies, Environmental and Legal Matters, to the unaudited Condensed Consolidated Financial Statements included in this Quarterly Report for more information and updates.
Item 1A. Risk Factors
There have been no material changes in the risk factors from those set forth in Part I, Item 1A, Risk Factors, of our 2018 Annual Report.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Recent Purchases of Equity Securities by the Issuer and Affiliated Purchases
The following table provides information about purchases by the Company during the three months ended June 30, 2019 of equity securities of the Company:
 
Total Number of Shares Purchased
 
Average Price Paid Per Share
 
Total Number of Shares Purchased as Part of a Publicly Announced Repurchase Program
 
Approximate Dollar Value of Shares that May Yet be Purchased Under the Repurchase Program(1) (in millions)
Period
 
 
 
 
 
 
 
April 1 - April 30

 
$

 

 
 
May 1 - May 31
742,391

 
9.70

 
742,391

 
 
June 1 - June 30
412,194

 
10.21

 
412,194

 
 
Total
1,154,585

 
$
9.89

 
1,154,585

 
$
305

(1)
In July 2018, the Board authorized a program to repurchase up to $750 million of the Company’s common stock, of which $445 million had been utilized as of June 30, 2019. The Company’s share repurchase program does not require the repurchase of any specific number of shares, and shares repurchases are made opportunistically at the discretion of the Company.
Item 3. Defaults Upon Senior Securities
None
Item 4. Mine Safety Disclosures
None
Item 5. Other Information
None


35


Item 6.    Exhibits                             
The following exhibits are filed or furnished as part of this Quarterly Report:
Exhibit
Number
Description
3.1(a)
Certificate of Incorporation dated January 22, 2014 (filed as Exhibit 3.1 of Post-Effective Amendment No. 1 to the Registration Statement on Form S-4 (File No. 333-192778) filed on January 24, 2014, and incorporated herein by reference)
3.1(b)
Certificate of Amendment of Certificate of Incorporation dated June 12, 2014 (filed as Exhibit 3.1 of the Current Report on Form 8-K filed on June 13, 2014, and incorporated herein by reference)
3.1(c)
Certificate of Amendment of Certificate of Incorporation dated January 31, 2019 (filed as Exhibit 3.1 of the Current Report on Form 8-K filed on February 5, 2019, and incorporated herein by reference)
3.2
Amended and Restated By-laws (filed as Exhibit 3.2 of the Current Report on Form 8-K filed on February 5, 2019, and incorporated herein by reference)
10.1*
10.2*†
10.3*†
31.1*
31.2*
32.1**
101.SCH**
XBRL Taxonomy Extension Schema Document
101.CAL**
XBRL Extension Calculation Linkbase Document
101.DEF**
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB**
XBRL Taxonomy Extension Label Linkbase Document
101.PRE**
XBRL Taxonomy Extension Presentation Linkbase Document
101. INS**
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
*    Filed herewith.
**     Furnished herewith.
†    This Exhibit represents a management contract or a compensatory plan.    



36


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized this August 2, 2019.
 
 
ELEMENT SOLUTIONS INC
 
 
 
 
By:
/s/ Michael Russnok
 
 
Michael Russnok
 
 
Chief Accounting Officer
 
 
(Principal Accounting Officer)


37


Exhibit 10.1
ESI8KCAOAPPOINTMENTIMAGE1.JPG

June 21, 2019

John David Tolbert
[Address]
[Address]

Dear Dave,
This letter agreement and release (the "Agreement") confirms the agreement entered into between you and your Employer regarding the termination of your employment effective July 1, 2019 ("Termination Date") and explains the package of separation pay and benefits that has been specially developed for you in consideration of a fully bargained for release and settlement of any and all claims that you have presently, may have or have had in the past arising from your employment with and termination of your employment from the Employer up to and including the date you execute this Agreement. You acknowledge that from and after March 12, 2019, you ceased to be Chief Human Resources Officer of the Employer and are no longer an "officer" of the Employer as that term is defined in Rule 16a-1(f), or an "executive officer" as that term is defined in Rule 3b-7, in each case as such rules are promulgated under the Securities Exchange Act of 1934, as amended. Additionally, pursuant to this Agreement, you are releasing all claims against the Company. For purposes of this Agreement, the term "Employer" shall mean Element Solutions Inc. The term "Company" shall mean the Employer and any of its direct or indirect parent or subsidiary corporations or companies, and any of its or their affiliates, divisions, and business units. "Effective Date" is defined in Section 15.

1.CONSIDERATION IN SETTLEMENT. The consideration provided to you under this Agreement is not required under the Employer's policies or otherwise, except as expressly noted, and you acknowledge that you know of no circumstances other than you agreeing to the terms of this Agreement which would require the Employer to provide such consideration. You acknowledge that no representations of any kind have been made by the Employer to induce your execution of this Agreement and that the only representations made to you in order to obtain your consent to this Agreement are as stated herein. The fact that the Employer is offering to make these payments to you on these terms and conditions imposes no obligation whatsoever on the Employer or the Company to offer to pay any amounts to any employee whose employment is terminated with the Employer or the Company now or in the future. Accordingly, if you execute (and do not revoke) this Agreement you will receive:
(a)SEVERANCE PAY. You will receive severance pay ("Severance Pay"), less applicable withholdings, deductions and offsets, if any, in regular payroll payment(s) over a period of eighteen (18) months (the "Severance Period") at your base salary in effect as of the Termination Date. Notwithstanding the foregoing, the Employer may at its option, at any time while any Severance Pay owed hereunder are still outstanding, pay to the Employee the remaining balance of such outstanding Severance Pay in a lump sum. The Severance Pay will be payable in accordance with the Company's normal payroll procedures starting on the later of your Termination Date and the Effective Date subject to the Offset Section below.
Notwithstanding the foregoing, if subsequent to the commencement of the Severance Period, the Employer discovers that you committed acts while employed with the Employer which constitutes "Cause" (as defined below), the Employer may cease further payments of Severance Pay and other consideration as provided for in this Section and may require you to reimburse the Employer for all payments of Severance Pay and other consideration previously made. For purposes of this Agreement, "Cause" shall mean (i) breach by you of any material provision of any written agreement you may have with the Company or violation in any material respect of any written policy of the Company; (ii) gross negligence or willful misconduct by you in connection with the performance of your duties, or your willful refusal to perform any of your duties or responsibilities; or (iii) fraud, criminal conduct or embezzlement by you.

(b)CONTINUATION OF MEDICAL AND/OR DENTAL INSURANCE BENEFITS. If you elect to continue coverage pursuant to the Employer's medical and/or dental insurance benefit plans as in effect and amended from time to time, pursuant to the provisions of COBRA as described in (c) below, then, subject to the other terms and conditions of this paragraph, your continued participation (for you and your eligible beneficiaries) will be at the contribution level in effect for active employees until the earlier of (i) the end of the Severance Period, (ii) you become eligible for Medicare, or (iii) you become eligible

1



for coverage under medical and/or dental insurance benefit plans, as the case may be, of another employer through future employment. You must immediately notify the Employer when you become eligible for Medicare or for coverage under medical and/or dental insurance benefits plans of another employer through your future employment.
(c)COBRA. To the extent provided by the federal Consolidated Omnibus Budget Reconciliation Act of 1985 law, or if applicable, state insurance laws (collectively "COBRA"), and by the Employer's current group health insurance policies, you will be eligible to continue your group health insurance benefits after the Termination Date at your own expense for up to 18 months at a monthly premium equal to l02% of actual plan cost, subject to the provisions of paragraph (b) above. Within the timing required by law, you will be provided a separate notice describing your COBRA rights and obligations with respect to continued group health insurance under the applicable state and/or federal insurance laws. Such continuation of coverage under the Severance Period will count as total time covered under COBRA. Specific costs and details will be provided to you on a timely basis.
(d)LONG-TERM INCENTIVE EQU1TY AWARDS. During your employment, you were a participant in the Platform Specialty Products Corporation long term incentive program ("LTI'), pursuant to which you received Restricted Stock Unit Agreements ("RSUs") and Performance-Based Restricted Stock Award Agreements ("PRSUs"), in each case representing LTI awards under the Platform Specialty Products Corporation Amended and Restated 2013 Incentive Compensation Plan (the "Plan"). (The RSUs and the PRSUs are referred to herein each as an "Award" and collectively as the "Awards".) The Employer will recommend to the Board of Directors of the Employer at its next scheduled meeting that it approve the vesting, within 90 days after the Effective Date, of an aggregate of 30,791 Shares from the Awards, even though you will not be a full-time, active employee on the date the restrictions would otherwise lapse. The Awards will otherwise continue to be governed by and subject to the terms and conditions of the applicable award agreement and the Plan. Any remaining unvested equity awards not addressed in this paragraph will be forfeited upon termination.
(e)NO MITIGATION. Nothing in this Section 1 or any other provision of this Agreement shall be deemed to require you to mitigate the cost of severance pay and benefits provided hereunder.

2.OTHER BENEFIT PLANS. Effective as of the Termination Date, you acknowledge that you are no longer eligible to participate in any of the Employer's or the Company's other benefit plans including, but not limited to the Employer's 401(k) savings plan (the "401(k) Plan").
3.VACATION AND PAID TIME OFF ("PTO"). As of the Termination Date, no further vacation or PTO shall accrue. You acknowledge and agree that you do not have any accrued and unused PTO as of the Termination Date and will not be entitled to any payment in lieu of any accrued but unused vacation or PTO time.
4.ELECTION. If you decide not to execute this Agreement, you may elect to receive the Severance Pay and/or benefits defined in any employment contract or other written agreement between you and the Employer which may be in effect on your Termination Date and covers your separation with the Employer, if any. The acceptance of Severance Pay and benefits available under this Agreement shall constitute a waiver of any Severance Pay you would have been entitled to under any other agreement.
5.RETURN OF EMPLOYER AND COMPANY PROPERTY. You acknowledge that prior to and as a condition of your receipt of any severance pay and/or consideration as described in this Agreement, you will return all Employer and Company documents (and all copies thereof) and other property, which is in your possession. Subject to the next succeeding sentence, such property includes, but is not limited to office keys. credit cards, computers, computer discs and software, printers, fax machines, cellular phones, all documents, files and other information of the Employer and Company whether or not the property meets the definition of "Confidential Information" or "Trade Secrets" under any applicable policy of the Company, agreement between you and the Company or applicable laws, and other related Employer and Company books, equipment or records. Notwithstanding anything to the contrary in the foregoing, you will be permitted to keep your current Company-provided mobile telephone device; provided, however, you will be solely responsible for paying for any service and maintenance contracts and obtaining any licenses for software used on the mobile telephone device, and the Company will not provide any service or pay for any continued use of such mobile device. You acknowledge that you will not have access to any Company-provided software from and after the Termination date and you agree to allow the Company to copy, move and/or delete any Company files and/or software on any Company-provided computer(s) and mobile device(s).
6.REIMBURSEMENT OF EXPENSES. The Employer shall reimburse you for any and all business expenses for which you are entitled to reimbursement under the Employer's expense reimbursement policies and procedures in effect on the date hereof. All expenses for reimbursement shall be submitted within thirty (30) days from the date of this Agreement, and the

2



Employer shall process such expenses promptly. Any expenses submitted after this thirty (30) day period will not be paid.
7.NON-DUPLICATION OF BENEFITS. The amount of severance payments hereunder shall be reduced on a dollar for dollar basis by any disability, severance, separation or termination pay benefits that the Employer pays or is required to pay you through insurance or otherwise under any plan or contract or under any federal or state law; provided, however, that the severance payment shall never be less than two (2) weeks' base salary, and such amount is acknowledged to be full and adequate consideration for this Agreement.
8.GENERAL RELEASE OF CLAIMS. You agree to release and hold harmless (on behalf of yourself and your family, heirs, executors, successors and assigns) now and forever, the Employer and the Company and any of the foregoing entities' past, present or future parent and subsidiary corporations, affiliates, divisions, successors and assigns (whether or not incorporated) and any of its past, present or future employees, agents, assigns, officers, directors, shareholders and attorneys whether acting in their individual or representative capacity (the "Released Parties") from and waive any claim that you have presently, may have or have had in the past, known or unknown, against the Released Parties upon or by reason of any matter, cause or thing whatsoever, from the beginning of the world through the date you execute this Agreement, including, without limitation, all claims arising from your employment with, or termination of employment from, the Employer and the Company, or otherwise, including but not limited to, any and all claims brought or that could be brought pursuant to or under any federal, state or local statute (including, without limitation, the Age Discrimination in Employment Act of 1967, the 1990 Older Workers Benefit Protection Act, Title VII of the Civil Rights Act of 1964, as amended, the Civil Rights Act of 1991, the Equal Pay Act, the Americans with Disabilities Act of 1990, the Employee Retirement Income Security Act of 1974, the Family and Medical Leave Act of 1993 , the Fair Labor Standards Act, the Worker Adjustment and Retraining Notification Act, as well as any state or local equivalents of any of the foregoing, and all other applicable statutes regulating the terms and conditions of your employment), any regulation or ordinance, under the common law or in equity (including any claims for wrongful discharge, slander, libel or otherwise), or under any policy, agreement, understanding or promise, written or oral, formal or informal, between the Released Parties and you, including, without limitation, any claim you might have for severance, termination or severance pay pursuant to the Employer's severance policies or practices as from time to time in effect, or otherwise (the "Released Claims").
You expressly waive and relinquish all rights and benefits under the section and any law or legal principle of similar effect in any other jurisdiction with respect to your release of any unknown or unsuspected claims herein.

Notwithstanding the foregoing, the following are not included in the Released Claims (the "Excluded Claims"): (i) any rights or claims which are not waivable as a matter of law; and (ii) any claims for breach of this Agreement. You represent and warrant that, other than the Excluded Claims, you are not aware of any claims you have or might have against any of the Released Parties that are not included in the Released Claims.

9.NO PENDING ACTION/COVENANT NOT TO SUE. Except to enforce the terms of this Agreement and as provided below, you agree and covenant not to file any suit or other legal action against the Released Parties with regard to any of the Released Claims. You further represent and warrant that as of the date you sign this Agreement no suits, complaints, charges, or other proceedings are pending against the Released Parties before any court, administrative agency, commission or other forum relating directly or indirectly to the Released Claims.
NOTHING IN THIS AGREEMENT IS INTENDED IN ANY WAY TO LIMIT YOUR RIGHT OR ABILITY TO INITIATE OR PARTICIPATE IN ANY INVESTIGATION OR PROCEEDING CONDUCTED BY ANY FEDERAL, STATE OR LOCAL AGENCY, INCLUDING THE U.S. EQUAL EMPLOYMENT OPPORTUNITY COMMISSION ("EEOC"). NOTWITHSTANDING THE FOREGOING, YOU AGREE TO WAIVE YOUR RIGHT TO RECOVER MONETARY DAMAGES IN ANY SUIT, COMPLAINT, CHARGE OR OTHER PROCEEDING FILED BY YOU OR ANYONE ELSE ON YOUR BEHALF.

10.ADEA WAIVER. You acknowledge that you are knowingly and voluntarily waiving and releasing any rights you may have under the ADEA (the "ADEA Waiver"), and that the consideration given for this ADEA Waiver is in addition to anything of value to which you are already entitled. You further acknowledge that you have been advised, as required by the ADEA, that: (i) your ADEA Waiver does not apply to any rights or claims that may arise after the date that you sign this Agreement; (ii) you should consult with an attorney prior to signing this Agreement (although you may choose voluntarily not to do so); (iii) you have twenty-one (21) days to consider this Agreement (although you may choose voluntarily to sign it earlier); (iv) you have seven (7) days following the date you sign this Agreement to revoke the ADEA Waiver (by providing written notice of your revocation to the Company; and (v) this ADEA Waiver will not be effective until the date upon which the revocation period has expired, which will be the eighth day after the date that this Agreement is signed by you provided that you do not revoke it (the "Effective Date'). You further acknowledge that the Employer has provided you with the ADEA Disclosure information (under Title 29 USC Section 626(f)(l)(H)).

3



11.FUTURE ASSISTANCE. Upon request, you agree to provide such assistance and cooperation in any matter relating to your expertise or experience as the Employer may reasonably request including your attendance and truthful testimony where deemed appropriate by the Employer, to the Employer's defense or prosecution of any existing or future claims or litigations of which the Employer identifies you as potentially having knowledge. The Employer shall pay you reasonable costs and expenses in connection therewith.
12.RIGHT TO COUNSEL. The Employer hereby advises you that you should consult with an attorney prior to execution of this Agreement. You acknowledge that you understand it is in your best interest to have this document reviewed by an attorney of your own choosing and at your own expense, and you hereby acknowledge that you have been afforded not less than twenty-one (21) days during which to consider this Agreement and to have it reviewed by your attorney. To the extent that you decide to execute this Agreement prior to the expiration of the twenty-one (21) day review period, such execution shall constitute a voluntary and knowing valid waiver of such review period.
13.FREE WILL. You are entering into this Agreement of your own free will and without coercion, intimidation or threat of retaliation. You acknowledge and agree that the Employer and/or the Company have not exerted any undue pressure or influence on you in this regard. You acknowledge that you have had reasonable time to determine whether entering into this Agreement is in your best interest and you have read and fully understand the terms set forth in this Agreement. You understand that if you request additional time to review the provisions of this Agreement, a reasonable extension of time will be granted.
14.BREACH OF AGREEMENT/PENALTIES. If you initiate or participate in any lawsuit or other legal action in violation of this Agreement, or if you fail to abide by any of the terms of this Agreement, except to the extent prohibited by law, the Employer may reclaim any amounts paid under this Agreement, without waiving the release granted herein, and terminate any benefit or payments that are due under the Agreement, in addition to any other remedies it may have. In addition, you shall pay the Employer all of its actual attorneys' fees and costs incurred resulting from, or incident to, such violation and you agree to pay such fees and costs within thirty (30) days of the Employer's written demand.
15.REVOCATION AND EFFECTIVE DATE. This Agreement may be revoked by you within the seven (7) days after the date on which you sign this Agreement and it is received by the Employer. You understand that this Agreement shall not become binding or enforceable until this seven (7) day period has expired without you having so revoked. This Agreement shall become effective on the eighth (8th) day following your signing of this Agreement (the "Effective Date") provided that you have not revoked the Agreement prior to such date. Any such revocation must be made in a signed letter executed by you and received by the Employer at the following address no later than 5 p.m. Eastern Standard Time on the seventh day after you have executed this Agreement: Element Solutions Inc, 338 Main Avenue, 6th Floor, Norwalk, Connecticut 06851, Attention: General Counsel. You understand that if you revoke this Agreement, this Agreement will not be effective or enforceable by you and you will not be entitled to any payments or benefits hereunder. You understand and agree that you will not receive the payments and benefits set forth in this Agreement, except for your execution of this Agreement and the fulfillment of your promises set forth herein. Any notice to be given under this Agreement (other than the revocation, if any, set forth above) shall be given in writing and delivered either personally or sent by certified mail to the Employer c/o General Counsel at the above address and to you at your address in the Employer's records or such other address as you may provide to Employer in writing in advance in accordance with this Section 15.
16.CONFIDENTIALITY. In addition to any agreement related to trade secrets, confidential information and/or work products previously executed by you, including, you will not at any time divulge to any other entity or person any information acquired by you concerning the financial affairs of the Employer or the Company, its affiliates and subsidiaries, its officers, directors, employees and/or shareholders or the Employer's or the Company's business processes or methods or research, development or marketing programs or plans, any other of its trade secrets, any information regarding personal matters of any directors, officers, shareholders, employees or agents of the Employer or the Company or their respective family members, any information concerning this Agreement or the terms thereof or any information concerning the circumstances of your employment with and the termination of your employment from the Employer or the Company, or any information regarding discussions related to any of the foregoing or make, write, publish, produce or in any way participate in placing into the public domain any statement, opinion or information with respect to any of the foregoing or which reflects adversely upon or would reasonably impair the reputation or best interests of the Employer or the Company or any of its directors, officers, employees or agents or their respective family members. Confidential information does not include (i) information which is required to be disclosed by court order, subpoena or other judicial process, (ii) information regarding your job responsibilities during your employment with the Employer to prospective employers in connection with an application for employment, (iii) information regarding the financial terms of this Agreement to your spouse or your tax advisor for purposes of obtaining tax advice provided that such persons are made aware of and agree to comply with the confidentiality obligation, or (iv) information which is necessary to be disclosed to your attorney to determine whether you should enter into this Agreement.


4



The foregoing prohibitions shall include, without limitation, directly or indirectly publishing (or causing, participating in, assisting or providing any statement, opinion or information in connection with the publication of) any diary, memoir, letter, story, photograph, interview, article, essay, account or description (whether fictionalized or not) concerning any of the foregoing, publication being deemed to include any presentation or reproduction of any written, verbal or visual material in any communication medium, including any book, magazine, newspaper, theatrical production or movie, or television or radio programming or commercial or any posting on the Internet. In addition to any and all other remedies available to the Employer for any violation of this Section, you agree to immediately remit and disgorge to the Employer any and all payments paid or payable to you in connection with or as a result of engaging in any of the above acts.

Nothing herein is intended to interfere with any disclosure right protected by law.

17.DISCLOSURE OF CONFIDENTIAL INFORMATION. In the event that you are required to make disclosure under any court order, subpoena or other judicial process, you will cooperate with the Employer and provide the Employer with prompt written notice, take all steps requested by the Employer to defend against the compulsory disclosure and permit the Employer to participate with counsel of its choice in any proceeding relating to the compulsory disclosure. You acknowledge that all information, the disclosure of which is prohibited by this Agreement, is of a confidential and proprietary character and of great value to the Employer and/or the Company. You also acknowledge that, to the extent you had access to and became acquainted with confidential information of the Employer and/or the Company, any subsequent employment with a competitor of the Employer and/or the Company would inevitably result in a prohibited disclosure of confidential information.

18.[RESERVED]

19.NON-ADMISSION. Nothing contained in this Agreement shall be deemed or construed as an admission of wrongdoing or liability on the part of the Employer or the Company.
20.SEVERABILITY CLAUSE. The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision or provisions of this Agreement, which shall remain in full force and effect. If any provision of this Agreement is held to be invalid, void or unenforceable in any jurisdiction, any court so holding shall substitute a valid, enforceable provision that preserves, to the maximum lawful extent, the terms and intent of such provisions of this Agreement. If any of the provisions of, or covenants contained in, this Agreement are hereafter construed to be invalid or unenforceable in any jurisdiction, the same shall not affect the remainder of the provisions or the enforceability thereof in any other jurisdiction, which shall be given full effect, without regard to the invalidity or unenforceability in such other jurisdiction. Any such holding shall affect such provision of this Agreement, solely as to that jurisdiction, without rendering that or any other provisions of this Agreement invalid, illegal or unenforceable in any other jurisdiction. If any covenant should be deemed invalid, illegal or unenforceable because its scope is considered excessive, such covenant will be modified so that the scope of the covenant is reduced only to the minimum extent necessary to render the modified covenant valid legal and enforceable.
21.OFFSET. The Employer shall be entitled to offset any sums owed by you to the Employer against the severance pay payable pursuant to Sections 1 and/or 4 including, but not limited to, any Severance Pay and/or Employer contributions to your medical and/or dental coverage provided to you prior to the Effective Date of this Agreement.
22.ASSIGNMENT. This Agreement is personal to you and you may not assign any rights or delegate any responsibilities hereunder.
23.GOVERNING LAW AND CHOICE OF FORUM. This Agreement shall be governed by, and construed pursuant to, the laws of the State of Florida applicable to transactions executed and to be wholly performed in Florida between residents thereof. The parties consent and agree to the exclusive jurisdiction of the Federal and State courts sitting in the State of Florida for all purposes.
24.OTHER UNDERSTANDINGS. For the avoidance of doubt, nothing herein shall affect any rights that you may have to (i) insurance coverage (if any) under any directors' and officers' liability insurance policy of the Employer to the extent such coverage relates to claims by a third party arising from actions taken or alleged to be taken by you within the scope of your employment with the Employer prior to the Termination Date, or (ii) indemnification pursuant to (and subject to the terms and conditions of) Article VI of the Amended and Restated By-Laws of the Employer.
25.ENTIRE AGREEMENT. This Agreement, including Exhibits and documents referenced herein, expressly supersedes any and all previous understandings and agreements between the Employer and/or the Company and you and constitute the sole and exclusive understanding between the Employer and/or the Company and you concerning the subjects set forth herein,

5



other than any agreements related to non­-competition or trade secrets, confidential information and/or work product previously executed by you. This Agreement may not be altered, modified, changed or discharged except in a writing signed by you and agreed to by the Employer. You understand and agree that other than as set forth in this Agreement, you will not receive any compensation, payments or benefits of any kind from the Employer and/or the Company and you expressly agree that you are not entitled and have no right to any additional compensation , payments or benefits other than the payment of vested benefits (if any) under the terms of the Employer's qualified pension plans, as amended from time to time.
To accept the above terms, please execute and return to the undersigned an original of this Agreement in the postage paid envelope included with this letter no later than twenty-one (21) days after the date first written above. Until the Effective Date, you will not receive any of the benefits outlined in this letter.
If you have any questions, please let me know.
Sincerely,


/s/ Benjamin Gliklich
Benjamin Gliklich
Chief Executive Officer
Element Solutions Inc



6



AGREEMENT AND
ACKNOWLEDGMENT

I, John David Tolbert, acknowledge receipt of the Agreement and I agree to all the terms and conditions set forth in the Agreement. I have read and fully understand the terms set forth in the Agreement and enter into such agreement of my own free will and without coercion, intimidation or threat of retaliation. I also acknowledge and understand that I have been afforded twenty-one (21) days to consider the Agreement and to have the Agreement reviewed by my attorney if I so choose. I further understand that I have seven (7) days to revoke the Agreement after the date I sign the Agreement and that the Agreement shall not be effective or enforceable until the expiration of this seven (7) day revocation period without revocation.


Signature: /s/ John David Tolbert        Date: 6/22/19


7


Exhibit 10.2



ELEMENT SOLUTIONS INC
AMENDED AND RESTATED
2013 INCENTIVE COMPENSATION PLAN

 
1.
Purpose
2
 
 
 
2.
Definitions
2
 
 
 
3.
Administration.
6
 
 
 
4.
Shares Subject to Plan.
7
 
 
 
5.
Eligibility; Per-Person Award Limitations
8
 
 
 
6.
Specific Terms of Awards.
8
 
 
 
7.
Certain Provisions Applicable to Awards.
12
 
 
 
8.
Code Section 162(m) Provisions.
14
 
 
 
9.
Change in Control.
15
 
 
 
10.
General Provisions.
17
 


1



Exhibit 10.2

ELEMENT SOLUTIONS INC
AMENDED AND RESTATED
2013 INCENTIVE COMPENSATION PLAN

1.     Purpose.  The purpose of this ELEMENT SOLUTIONS INC AMENDED AND RESTATED 2013 INCENTIVE COMPENSATION PLAN (the “Plan”) is to assist Element Solutions Inc (f/k/a Platform Specialty Products Corporation), a company organized under the laws of the State of Delaware (the “Company”) and its Related Entities (as hereinafter defined) in attracting, motivating, retaining and rewarding high-quality executives and other employees, officers, directors, consultants and other persons who provide services to the Company or its Related Entities by enabling such persons to acquire or increase a proprietary interest in the Company in order to strengthen the mutuality of interests between such persons and the Company's shareholders, and providing such persons with performance incentives to expend their maximum efforts in the creation of shareholder value.
2.     Definitions.  For purposes of the Plan, the following terms shall be defined as set forth below, in addition to such terms defined in Section 1 hereof and elsewhere herein.
(a) “Award” means any Option, Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit Award, Share granted as a bonus or in lieu of another Award, Dividend Equivalent, Other Stock-Based Award or Performance Award, together with any other right or interest, granted to a Participant under the Plan.
(b) “Award Agreement” means any written agreement, contract or other instrument or document evidencing any Award granted by the Committee hereunder.
(c) “Beneficiary” means the person, persons, trust or trusts that have been designated by a Participant in his or her most recent written beneficiary designation filed with the Committee to receive the benefits specified under the Plan upon such Participant's death or to which Awards or other rights are transferred if and to the extent permitted under Section 10(b) hereof.  If, upon a Participant's death, there is no designated Beneficiary or surviving designated Beneficiary, then the term Beneficiary means the person, persons, trust or trusts entitled by will or the laws of descent and distribution to receive such benefits.
(d) “Beneficial Ownerand “Beneficial Ownership” shall have the meaning ascribed to such term in Rule 13d-3 under the Exchange Act and any successor to such Rule.
(e)  “Board” means the Company's Board of Directors.
(f) “Cause” shall, with respect to any Participant, have the meaning specified in the Award Agreement.  In the absence of any definition in the Award Agreement, “Cause” shall have the equivalent meaning or the same meaning as “cause” or “for cause” set forth in any employment, consulting, or other agreement for the performance of services between the Participant and the Company or a Related Entity or, in the absence of any such agreement or any such definition in such agreement, such term shall mean (i) the failure by the Participant to perform, in a reasonable manner, his or her duties as assigned by the Company or a Related Entity, (ii) any violation or breach by the Participant of his or her employment, consulting or other similar agreement with the Company or a Related Entity, if any, (iii) any violation or breach by the Participant of any non-competition, non-solicitation, non-disclosure and/or other similar agreement with the Company or a Related Entity, (iv) any act by the Participant of dishonesty or bad faith with respect to the Company or a Related Entity, (v) use of alcohol, drugs or other similar substances in a manner that adversely affects the Participant’s work performance, or (vi) the commission by the Participant of any act, misdemeanor, or crime reflecting unfavorably upon the Participant or the Company or any

2



Related Entity.  The good faith determination by the Committee of whether the Participant’s Continuous Service was terminated by the Company for “Cause” shall be final and binding for all purposes hereunder.
(g) “Change in Control” means a Change in Control as defined in Section 9(b) of the Plan.
(h) “Code” means the Internal Revenue Code of 1986, as amended from time to time, including regulations thereunder and successor provisions and regulations thereto.
(i) “Committee” means a committee designated by the Board to administer the Plan; provided, however, that if the Board fails to designate a committee or if there are no longer any members on the committee so designated by the Board, or for any other reason determined by the Board, then the Board shall serve as the Committee.  In the event that the Company is a Publicly Held Corporation (as hereinafter defined), then the Committee shall consist of at least two directors, each of whom shall be (i) a “non-employee director” within the meaning of  Rule 16b-3 (or any successor rule) under the Exchange Act, unless administration of the Plan by “non-employee directors” is not then required in order for exemptions under Rule 16b-3 to apply to transactions under the Plan, (ii) an “outside director” within the meaning of Section 162(m) of the Code, and (iii) “Independent”, the failure of the Committee to be so comprised shall not invalidate any Award that otherwise satisfies the terms of the Plan.
(j)  “Consultant” means any Person (other than an Employee or a Director, solely with respect to rendering services in such Person’s capacity as a director), including an independent contractor, who is engaged by the Company or any Related Entity to render consulting, advisory or other services to the Company or such Related Entity.
(k) “Continuous Service” means the uninterrupted provision of services to the Company or any Related Entity in any capacity of Employee, Director, Consultant or other service provider.  Continuous Service shall not be considered to be interrupted in the case of (i) any approved leave of absence, (ii) transfers among the Company, any Related Entities, or any successor entities, in any capacity of Employee, Director, Consultant or other service provider, or (iii) any change in status as long as the individual remains in the service of the Company or a Related Entity in any capacity of Employee, Director, Consultant or other service provider (except as otherwise provided in the Award Agreement).  An approved leave of absence shall include sick leave, military leave, or any other authorized personal leave.
(l) “Director” means a member of the Board or the board of directors of any Related Entity.
(m) “Disability” means, unless otherwise defined in an Award Agreement, for purposes of the exercise of an Incentive Stock Option, a permanent and total disability, within the meaning of Code Section 22(e)(3), and for all other purposes, the Participant's inability to perform the duties of his or her position with the Company, a Parent or a Subsidiary by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than twelve months.
(n) “Dividend Equivalent” means a right, granted to a Participant under Section 6(g) hereof, to receive cash, Shares, other Awards or other property equal in value to regular dividends paid with respect to a specified number of Shares, or other periodic payments.
(o) “Effective Date” means the original effective date of the Plan, which shall be November 1, 2013.  The effective date of the Plan, as amended and restated, shall be the date on which the Company effects its domestication as a corporation incorporated under the laws of the State of Delaware.
(p) “Eligible Person” means each officer, Director, Employee, Consultant and other person who provided bona fide services to the Company or any Related Entity.  The foregoing notwithstanding, only Employees of the Company, or any parent corporation or subsidiary corporation of the Company (as those terms are defined in Sections 424(e) and (f) of the Code, respectively), shall be Eligible Persons for purposes of receiving any Incentive

3



Stock Options.  An Employee on leave of absence may, in the discretion of the Committee, be considered as still in the employ of the Company or a Related Entity for purposes of eligibility for participation in the Plan.
(q) “Employee” means any person, including an officer or Director, who is an employee of the Company or any Related Entity.  The payment of a director’s fee by the Company or a Related Entity shall not be sufficient to constitute “employment” by the Company.
(r)  “Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, including rules thereunder and successor provisions and rules thereto.
(s) “Fair Market Value” means the fair market value of Shares, Awards or other property as determined by the Committee, or under procedures established by the Committee.  Unless otherwise determined by the Committee, the Fair Market Value of a Share as of any given date after which the Company is a Publicly Held Corporation shall be the closing sale price per Share reported on a consolidated basis for stock listed on the principal stock exchange or market on which Shares are traded on the date as of which such value is being determined (or as of such later measurement date as determined by the Committee on the date the Award is authorized by the Committee), or, if there is no sale on that date, then on the last previous day on which a sale was reported.
(t) “Good Reason” shall, with respect to any Participant, have the meaning specified in the Award Agreement.  In the absence of any definition in the Award Agreement, “Good Reason” shall have the equivalent meaning or the same meaning as “good reason” or “for good reason” set forth in any employment, consulting or other agreement for the performance of services between the Participant and the Company or a Related Entity or, in the absence of any such agreement or any such definition in such agreement, such term shall mean (i) the assignment to the Participant of any duties inconsistent in any material respect with the Participant's duties or responsibilities as assigned by the Company or a Related Entity, or any other action by the Company or a Related Entity which results in a material diminution in such duties or responsibilities, excluding for this purpose an isolated, insubstantial and inadvertent action not taken in bad faith or any other action which is remedied by the Company or a Related Entity promptly after receipt of notice thereof given by the Participant; (ii) any material failure by the Company or a Related Entity to comply with its obligations to the Participant as agreed upon, other than an isolated, insubstantial and inadvertent failure not occurring in bad faith or any other failure which is remedied by the Company or a Related Entity promptly after receipt of notice thereof given by the Participant; or (iii) the Company's or Related Entity’s requiring the Participant to be based at any office or location outside of fifty (50) miles from the location of employment or service as of the date of Award, except for travel reasonably required in the performance of the Participant’s responsibilities.
(u) “Group” has the meaning of "persons acting as a group" as defined in paragraph (i)(5)(v)(B) of Treasury Regulation §1.409A-3.
(v) “Incentive Stock Option” means any Option intended to be designated as an incentive stock option within the meaning of Section 422 of the Code or any successor provision thereto.
(w) “Independent”, when referring to either the Board or members of the Committee, shall have the same meaning as used in the rules of the Listing Market.
(x) “Listing Market” means the New York Stock Exchange or any other national securities exchange on which any securities of the Company are listed for trading, and if not listed for trading, by the rules of the Nasdaq Market.
(y) “Option” means a right granted to a Participant under Section 6(b) hereof, to purchase Shares or other Awards at a specified price during specified time periods.
(z) “Optionee” means a person to whom an Option is granted under this Plan or any person who succeeds to the rights of such person under this Plan.

4



(aa) “Other Stock-Based Awards” means Awards granted to a Participant under Section 6(i) hereof.
(bb) “Participant” means a person who has been granted an Award under the Plan which remains outstanding, including a person who is no longer an Eligible Person.
(cc) “Performance Award” means any Award of Performance Shares or Performance Units granted pursuant to Section 6(h) hereof.
(dd) “Performance Period” means that period established by the Committee at the time any Award is granted or at any time thereafter during which any performance goals specified by the Committee with respect to such Award are to be measured.
(ee) “Performance Share” means any grant pursuant to Section 6(h) hereof of a unit valued by reference to a designated number of Shares, which value may be paid to the Participant by delivery of such property as the Committee shall determine, including cash, Shares, other property, or any combination thereof, upon achievement of such performance goals during the Performance Period as the Committee shall establish at the time of such grant or thereafter.
(ff) “Performance Unit” means any grant pursuant to Section 6(h) hereof of a unit valued by reference to a designated amount of property (including cash) other than Shares, which value may be paid to the Participant by delivery of such property as the Committee shall determine, including cash, Shares, other property, or any combination thereof, upon achievement of such performance goals during the Performance Period as the Committee shall establish at the time of such grant or thereafter.
(gg) “Person” shall have the meaning ascribed to such term in Section 3(a)(9) of the Exchange Act and used in Sections 13(d) and 14(d) thereof, and shall include a “group” as defined in Section 13(d) thereof.
(hh)  “Publicly Held Corporation” shall mean a publicly held corporation as that term is used under Section 162(m)(2) of the Code.
(ii) “Related Entity” means any Subsidiary, and any business, corporation, partnership, limited liability company or other entity designated by the Board, in which the Company or a Subsidiary holds a substantial ownership interest, directly or indirectly.
(jj) “Restricted Stock” means any Share issued with the restriction that the holder may not sell, transfer, pledge or assign such Share and with such risks of forfeiture and other restrictions as the Committee, in its sole discretion, may impose (including any restriction on the right to vote such Share and the right to receive any dividends), which restrictions may lapse separately or in combination at such time or times, in installments or otherwise, as the Committee may deem appropriate.
(kk) “Restricted Stock Award” means an Award granted to a Participant under Section 6(d) hereof.
(ll) “Restricted Stock Unit” means a right to receive Shares, including Restricted Stock, cash measured based upon the value of Shares or a combination thereof, at the end of a specified deferral period.
(mm) “Restricted Stock Unit Award” means an Award of Restricted Stock Unit granted to a Participant under Section 6(e) hereof.
(nn) “Restriction Period” means the period of time specified by the Committee that Restricted Stock Awards shall be subject to such restrictions on transferability, risk of forfeiture and other restrictions, if any, as the Committee may impose.
(oo) “Rule 16b-3” means Rule 16b-3, as from time to time in effect and applicable to the Plan and Participants, promulgated by the Securities and Exchange Commission under Section 16 of the Exchange Act.

5



(pp) “Shares” means the shares of common stock of the Company, and such other securities as may be substituted (or resubstituted) for Shares pursuant to Section 10(c) hereof.
(qq) “Stock Appreciation Right” means a right granted to a Participant under Section 6(c) hereof. 
(rr) “Subsidiary” means any corporation or other entity in which the Company has a direct or indirect ownership interest of 50% or more of the total combined voting power of the then outstanding securities or interests of such corporation or other entity entitled to vote generally in the election of directors or in which the Company has the right to receive 50% or more of the distribution of profits or 50% or more of the assets on liquidation or dissolution.
(ss) “Substitute Awards” means Awards granted or Shares issued by the Company in assumption of, or in substitution or exchange for, Awards previously granted, or the right or obligation to make future Awards, by a company (i) acquired by the Company or any Related Entity, (ii) which becomes a Related Entity after the date hereof, or (iii) with which the Company or any Related Entity combines.
3.     Administration.
(a) Authority of the Committee.  The Plan shall be administered by the Committee, provided, however, that except as otherwise expressly provided in this Plan, the Board may exercise any power or authority granted to the Committee under this Plan and in that case, references herein shall be deemed to include references to the Board. The Committee shall have full and final authority, subject to and consistent with the provisions of the Plan, to select Eligible Persons to become Participants, grant Awards, determine the type, number and other terms and conditions of, and all other matters relating to, Awards, prescribe Award Agreements (which need not be identical for each Participant) and rules and regulations for the administration of the Plan, construe and interpret the Plan and Award Agreements and correct defects, supply omissions or reconcile inconsistencies therein, and to make all other decisions and determinations as the Committee may deem necessary or advisable for the administration of the Plan.  In exercising any discretion granted to the Committee under the Plan or pursuant to any Award, the Committee shall not be required to follow past practices, act in a manner consistent with past practices, or treat any Eligible Person or Participant in a manner consistent with the treatment of any other Eligible Persons or Participants.
(b) Manner of Exercise of Committee Authority. In the event that the Company is a Publicly Held Corporation, the Committee, and not the Board, shall exercise sole and exclusive discretion (i) on any matter relating to a Participant then subject to Section 16 of the Exchange Act with respect to the Company to the extent necessary in order that transactions by such Participant shall be exempt under Rule 16b-3 under the Exchange Act, (ii) with respect to any Award that is intended to qualify as “performance-based compensation” under Section 162(m), to the extent necessary in order for such Award to so qualify; and (iii) with respect to any Award to an Independent Director.  Any action of the Committee shall be final, conclusive and binding on all persons, including the Company, its Related Entities, Eligible Persons, Participants, Beneficiaries, transferees under Section 10(b) hereof or other persons claiming rights from or through a Participant, and shareholders.  The express grant of any specific power to the Committee, and the taking of any action by the Committee, shall not be construed as limiting any power or authority of the Committee.  The Committee may delegate to officers or managers of the Company or any Related Entity, or committees thereof, the authority, subject to such terms and limitations as the Committee shall determine, to perform such functions, including administrative functions as the Committee may determine to the extent that such delegation will not result in the loss of an exemption under Rule 16b-3(d)(1) for Awards granted to Participants subject to Section 16 of the Exchange Act in respect of the Company and will not cause Awards intended to qualify as “performance-based compensation” under Code Section 162(m) to fail to so qualify.  The Committee may appoint agents to assist it in administering the Plan, including, without limitation, appointing one or more members of the Company’s management, with the power or authority otherwise granted to the Committee under this Plan with respect to a number of Shares reserved and available for delivery under the Plan, subject to the terms and limitations of such power or authority as determined by the Committee in its sole and absolute discretion.  In no event, however, may an agent appointed by the Committee to assist it in administering the Plan be

6



permitted to grant Awards to, or exercise any discretion with respect to any and all other matters relating to Awards previously granted to, such agent appointed by the Committee to assist it in administering the Plan.
(c) Clawback.  The Committee shall have full authority to implement any policies and procedures that it determines to be necessary or appropriate to comply with applicable securities laws or other laws, including, without limitation, Section 10D of the Exchange Act and any rules promulgated thereunder, including without limitation, including in any Award Agreement, or amending any outstanding Award Agreement, without the consent of any Participant, to include language for the clawback (recapture) by the Company of any benefits under the Award Agreement that the Committee deems necessary or appropriate to comply with that statutory provision and those rules.
(d) Limitation of Liability.  The Committee and the Board, and each member thereof, shall be entitled to, in good faith, rely or act upon any report or other information furnished to him or her by any officer or Employee, the Company's independent auditors, Consultants or any other agents assisting in the administration of the Plan.  Members of the Committee and the Board, and any officer or Employee acting at the direction or on behalf of the Committee or the Board, shall not be personally liable for any action or determination taken or made in good faith with respect to the Plan, and shall, to the extent permitted by law, be fully indemnified and protected by the Company with respect to any such action or determination.
4.     Shares Subject to Plan.
(a) Limitation on Overall Number of Shares Available for Delivery Under Plan.  Subject to adjustment as provided in Section 10(c) hereof, the total number of Shares reserved and available for delivery under the Plan shall be equal to Fifteen Million Five Hundred Thousand (15,500,000).  Any Shares delivered under the Plan may consist, in whole or in part, of authorized and unissued shares or treasury shares.
(b) Application of Limitation to Grants of Awards.  No Award may be granted if the number of Shares to be delivered in connection with such an Award exceeds the number of Shares remaining available for delivery under the Plan, minus the number of Shares deliverable in settlement of or relating to then outstanding Awards.  The Committee may adopt reasonable counting procedures to ensure appropriate counting, avoid double counting (as, for example, in the case of tandem or substitute awards) and make adjustments if the number of Shares actually delivered differs from the number of Shares previously counted in connection with an Award.
(c) Availability of Shares Not Delivered under Awards and Adjustments to Limits.
(i) If any Shares subject to an Award are forfeited, expire or otherwise terminate without issuance of such Shares, or any Award that could have been settled with Shares is settled for cash or otherwise does not result in the issuance of all or a portion of the Shares subject to such Award, the Shares shall, to the extent of such forfeiture, expiration, termination, cash settlement or non-issuance, again be available for delivery with respect to Awards under the Plan, subject to Section 4(c)(iii) below.
(ii) Substitute Awards shall not reduce the Shares authorized for grant under the Plan or authorized for grant to a Participant in any period.  Additionally, in the event that a company acquired by the Company or any Related Entity or with which the Company or any Related Entity combines has shares available under a pre-existing plan approved by its shareholders and not adopted in contemplation of such acquisition or combination, the shares available for delivery pursuant to the terms of such pre-existing plan (as adjusted, to the extent appropriate, using the exchange ratio or other adjustment or valuation ratio or formula used in such acquisition or combination to determine the consideration payable to the holders of common stock of the entities party to such acquisition or combination) may be used for Awards under the Plan and shall not reduce the Shares authorized for delivery under the Plan if and to the extent that the use of such Shares would not require approval of the Company’s shareholders under the rules of the Listing Market.
(iii) Any Share that again becomes available for delivery pursuant to this Section 4(c) shall be added back as one (1) Share.

7



(iv) Notwithstanding anything in this Section 4(c) to the contrary but subject to adjustment as provided in Section 10(c) hereof, the maximum aggregate number of Shares that may be delivered under the Plan as a result of the exercise of the Incentive Stock Options shall be Fifteen Million Five Hundred Thousand (15,500,000) Shares.  In no event shall any Incentive Stock Options be granted under the Plan after the tenth anniversary of the date on which the Board adopts the Plan.
5.     Eligibility; Per-Person Award Limitations.  Awards may be granted under the Plan only to Eligible Persons.  Subject to adjustment as provided in Section 10(c), in any fiscal year of the Company during any part of which the Plan is in effect and the Company is a Publicly Held Corporation, no Participant may be granted (i) Options and/or Stock Appreciation Rights with respect to more than 3,100,000 Shares or (ii) Restricted Stock, Restricted Stock Units, Performance Shares and/or Other Stock-Based Awards denominated in or valued by reference to a designated number of Shares and that are subject to Section 8 hereof, with respect to more than 3,100,000 Shares.  In addition, the maximum dollar value payable to any one Participant with respect to Performance Units that are subject to Section 8 hereof, is (x) $2,000,000 with respect to any 12 month Performance Period (pro-rated for any Performance Period that is less than 12 months based upon the ratio of the number of days in the Performance Period as compared to 365), and (y) with respect to any Performance Period that is more than 12 months, $4,000,000.
6.     Specific Terms of Awards.
(a) General.  Awards may be granted on the terms and conditions set forth in this Section 6.  In addition, the Committee may impose on any Award or the exercise thereof, at the date of grant or thereafter (subject to Section 10(e)), such additional terms and conditions, not inconsistent with the provisions of the Plan, as the Committee shall determine, including terms requiring forfeiture of Awards in the event of termination of the Participant’s Continuous Service and terms permitting a Participant to make elections relating to his or her Award.  Except as otherwise expressly provided herein, the Committee shall retain full power and discretion to accelerate, waive or modify, at any time, any term or condition of an Award that is not mandatory under the Plan.  Except in cases in which the Committee is authorized to require other forms of consideration under the Plan, or to the extent other forms of consideration must be paid to satisfy the requirements of the laws of the State of Delaware, no consideration other than services may be required for the grant (as opposed to the exercise) of any Award.
(b) Options.  The Committee is authorized to grant Options to any Eligible Person on the following terms and conditions:
(i) Exercise Price.  Other than in connection with Substitute Awards, the exercise price per Share purchasable under an Option shall be determined by the Committee, provided that such exercise price shall not be less than 100% of the Fair Market Value of a Share on the date of grant of the Option and shall not, in any event, be less than the par value of a Share on the date of grant of the Option.  If an Employee owns or is deemed to own (by reason of the attribution rules applicable under Section 424(d) of the Code) more than 10% of the combined voting power of all classes of stock of the Company (or any parent corporation or subsidiary corporation of the Company, as those terms are defined in Sections 424(e) and (f) of the Code, respectively) and an Incentive Stock Option is granted to such Employee, the exercise price of such Incentive Stock Option (to the extent required by the Code at the time of grant) shall be no less than 110% of the Fair Market Value of a Share on the date such Incentive Stock Option is granted.  Other than pursuant to Section 10(c)(i) and (ii), the Committee shall not be permitted to (A) lower the exercise price per Share of an Option after it is granted, (B) cancel an Option when the exercise price per Share exceeds the Fair Market Value of the underlying Shares in exchange for another Award (other than in connection with  Substitute Awards), or (C) take any other action with respect to an Option that may be treated as a repricing pursuant to the applicable rules of the Listing Market, without approval of the Company's shareholders.
(ii) Time and Method of Exercise.  The Committee shall determine the time or times at which or the circumstances under which an Option may be exercised in whole or in part (including based on achievement of performance goals and/or future service requirements), the time or times at which Options shall

8



cease to be or become exercisable following termination of Continuous Service or upon other conditions, the methods by which the exercise price may be paid or deemed to be paid (including in the discretion of the Committee a cashless exercise procedure), the form of such payment, including, without limitation, cash, Shares (including without limitation the withholding of Shares otherwise deliverable pursuant to the Award), other Awards or awards granted under other plans of the Company or a Related Entity, or other property (including notes or other contractual obligations of Participants to make payment on a deferred basis provided that such deferred payments are not in violation of the Sarbanes Oxley Act of 2002, as amended, or any rule or regulation adopted thereunder or any other applicable law), and the methods by or forms in which Shares will be delivered or deemed to be delivered to Participants.
(iii) Restrictions on Transfer of Shares.  The Committee may, in its sole discretion, impose in any Award of an Option restrictions on the transferability of the Shares issued upon exercise of such Option. If any such restrictions are imposed, the Committee may require the Participant to enter into an escrow agreement providing that the certificates representing the Shares subject to such transfer restrictions will remain in the physical custody of an escrow holder until such restrictions are removed or have expired. The Committee may require that certificates representing the Shares subject to such restrictions bear a legend making appropriate reference to the restrictions imposed. Subject to any restrictions imposed in accordance with this Section 6(b)(iii), the Participant will have all rights of a shareholder with respect to any such Shares acquired upon an Option exercise, including the right to vote the Shares and receive all dividends and other distributions paid or made with respect thereto.
(iv) Incentive Stock Options.  The terms of any Incentive Stock Option granted under the Plan shall comply in all respects with the provisions of Section 422 of the Code.  Anything in the Plan to the contrary notwithstanding, no term of the Plan relating to Incentive Stock Options (including any Stock Appreciation Right issued in tandem therewith) shall be interpreted, amended or altered, nor shall any discretion or authority granted under the Plan be exercised, so as to disqualify either the Plan or any Incentive Stock Option under Section 422 of the Code, unless the Participant has first requested, or consents to, the change that will result in such disqualification.  Thus, if and to the extent required to comply with Section 422 of the Code, Options granted as Incentive Stock Options shall be subject to the following special terms and conditions:
(A) the Option shall not be exercisable for more than ten years after the date such Incentive Stock Option is granted; provided, however, that if a Participant owns or is deemed to own (by reason of the attribution rules of Section 424(d) of the Code) more than 10% of the combined voting power of all classes of stock of the Company (or any parent corporation or subsidiary corporation of the Company, as those terms are defined in Sections 424(e) and (f) of the Code, respectively) and the Incentive Stock Option is granted to such Participant, the term of the Incentive Stock Option shall be (to the extent required by the Code at the time of the grant) for no more than five years from the date of grant; and
(B) the aggregate Fair Market Value (determined as of the date the Incentive Stock Option is granted) of the Shares with respect to which Incentive Stock Options granted under the Plan and all other option plans of the Company (and any parent corporation or subsidiary corporation of the Company, as those terms are defined in Sections 424(e) and (f) of the Code, respectively) that become exercisable for the first time by the Participant during any calendar year shall not (to the extent required by the Code at the time of the grant) exceed $100,000; and
(C) if shares acquired by exercise of an Incentive Stock Option are disposed of within two years following the date the Incentive Stock Option is granted or one year following the transfer of such Shares to the Participant upon exercise, the Participant shall, promptly following such disposition, notify the Company in writing of the date and terms of such disposition and provide such other information regarding the disposition as the Committee may reasonably require.
(c) Stock Appreciation Rights.  The Committee may grant Stock Appreciation Rights to any Eligible Person in conjunction with all or part of any Option granted under the Plan or at any subsequent time during the term of such Option (a “Tandem Stock Appreciation Right”), or without regard to any Option (a

9



“Freestanding Stock Appreciation Right”), in each case upon such terms and conditions as the Committee may establish in its sole discretion, not inconsistent with the provisions of the Plan, including the following:
(i) Right to Payment.  A Stock Appreciation Right shall confer on the Participant to whom it is granted a right to receive, upon exercise thereof, the excess of (A) the Fair Market Value of one Share on the date of exercise over (B) the grant price of the Stock Appreciation Right as determined by the Committee.  The grant price of a Stock Appreciation Right shall not be less than 100% of the Fair Market Value of a Share on the date of grant.  Other than pursuant to Section 10(c)(i) and (ii), the Committee shall not be permitted to (A) lower the grant price per Share of a Stock Appreciation Right after it is granted, (B) cancel a Stock Appreciation Right when the grant price per Share exceeds the Fair Market Value of the underlying Shares in exchange for another Award (other than in connection with  Substitute Awards), or (C) take any other action with respect to a Stock Appreciation Right that may be treated as a repricing pursuant to the applicable rules of the Listing Market, without shareholder approval.
(ii) Other Terms.  The Committee shall determine at the date of grant or thereafter, the time or times at which and the circumstances under which a Stock Appreciation Right may be exercised in whole or in part (including based on achievement of performance goals and/or future service requirements), the time or times at which Stock Appreciation Rights shall cease to be or become exercisable following termination of Continuous Service or upon other conditions, the method of exercise, method of settlement, form of consideration payable in settlement, method by or forms in which Shares will be delivered or deemed to be delivered to Participants, whether or not a Stock Appreciation Right shall be in tandem or in combination with any other Award, and any other terms and conditions of any Stock Appreciation Right.
(iii) Tandem Stock Appreciation Rights. Any Tandem Stock Appreciation Right may be granted at the same time as the related Option is granted.  Any Tandem Stock Appreciation Right related to an Option may be exercised only when the related Option would be exercisable and the Fair Market Value of the Shares subject to the related Option exceeds the exercise price at which Shares can be acquired pursuant to the Option.  In addition, if a Tandem Stock Appreciation Right exists with respect to less than the full number of Shares covered by a related Option, then an exercise or termination of such Option shall not reduce the number of Shares to which the Tandem Stock Appreciation Right applies until the number of Shares then exercisable under such Option equals the number of Shares to which the Tandem Stock Appreciation Right applies. Any Option related to a Tandem Stock Appreciation Right shall no longer be exercisable to the extent the Tandem Stock Appreciation Right has been exercised, and any Tandem Stock Appreciation Right shall no longer be exercisable to the extent the related Option has been exercised.
(d) Restricted Stock Awards.  The Committee is authorized to grant Restricted Stock Awards to any Eligible Person on the following terms and conditions:
(i) Grant and Restrictions.  Restricted Stock Awards shall be subject to such restrictions on transferability, risk of forfeiture and other restrictions, if any, as the Committee may impose, or as otherwise provided in this Plan during the Restriction Period.  The terms of any Restricted Stock Award granted under the Plan shall be set forth in a written Award Agreement which shall contain provisions determined by the Committee and not inconsistent with the Plan.  The restrictions may lapse separately or in combination at such times, under such circumstances (including based on achievement of performance goals and/or future service requirements), in such installments or otherwise, as the Committee may determine at the date of grant or thereafter.  Except to the extent restricted under the terms of the Plan and any Award Agreement relating to a Restricted Stock Award, a Participant granted Restricted Stock shall have all of the rights of a shareholder, including the right to vote the Restricted Stock and the right to receive dividends thereon (subject to any mandatory reinvestment or other requirement imposed by the Committee).  During the period that the Restricted Stock Award is subject to a risk of forfeiture, subject to Section 10(b) below and except as otherwise provided in the Award Agreement, the Restricted Stock may not be sold, transferred, pledged, hypothecated, margined or otherwise encumbered by the Participant.
(ii) Forfeiture.  Except as otherwise determined by the Committee, upon termination of a Participant's Continuous Service during the applicable Restriction Period, the Participant's Restricted Stock that is at

10



that time subject to a risk of forfeiture that has not lapsed or otherwise been satisfied shall be forfeited and reacquired by the Company; provided that the Committee may provide, by rule or regulation or in any Award Agreement, or may determine in any individual case, that forfeiture conditions relating to Restricted Stock Awards shall be waived in whole or in part in the event of terminations resulting from specified causes, and the Committee may in other cases waive in whole or in part the forfeiture of Restricted Stock.
(iii) Certificates for Stock.  Restricted Stock granted under the Plan may be evidenced in such manner as the Committee shall determine.  If certificates representing Restricted Stock are registered in the name of the Participant, the Committee may require that such certificates bear an appropriate legend referring to the terms, conditions and restrictions applicable to such Restricted Stock, that the Company retain physical possession of the certificates, and that the Participant deliver a stock power to the Company, endorsed in blank, relating to the Restricted Stock. 
(iv) Dividends and Splits.  As a condition to the grant of a Restricted Stock Award, the Committee may require or permit a Participant to elect that any cash dividends paid on a Share of Restricted Stock be automatically reinvested in additional Shares of Restricted Stock or applied to the purchase of additional Awards under the Plan, in each case in a manner that does not violate the requirements of Section 409A of the Code.  Unless otherwise determined by the Committee, Shares distributed in connection with a stock split or stock dividend, and other property distributed as a dividend, shall be subject to restrictions and a risk of forfeiture to the same extent as the Restricted Stock with respect to which such Shares or other property have been distributed.
(e) Restricted Stock Unit Award.  The Committee is authorized to grant Restricted Stock Unit Awards to any Eligible Person on the following terms and conditions:
(i) Award and Restrictions.  Satisfaction of a Restricted Stock Unit Award shall occur upon expiration of the deferral period specified for such Restricted Stock Unit Award by the Committee (or, if permitted by the Committee, as elected by the Participant).  In addition, a Restricted Stock Unit Award shall be subject to such restrictions (which may include a risk of forfeiture) as the Committee may impose, if any, which restrictions may lapse at the expiration of the deferral period or at earlier specified times (including based on achievement of performance goals and/or future service requirements), separately or in combination, in installments or otherwise, as the Committee may determine.  A Restricted Stock Unit Award may be satisfied by delivery of Shares, cash equal to the Fair Market Value of the specified number of Shares covered by the Restricted Stock Units, or a combination thereof, as determined by the Committee at the date of grant or thereafter.  Prior to satisfaction of a Restricted Stock Unit Award, a Restricted Stock Unit Award carries no voting or dividend or other rights associated with Share ownership.
(ii) Forfeiture.  Except as otherwise determined by the Committee, upon termination of a Participant's Continuous Service during the applicable deferral period or portion thereof to which forfeiture conditions apply (as provided in the Award Agreement evidencing the Restricted Stock Unit Award), the Participant's Restricted Stock Unit Award that is at that time subject to a risk of forfeiture that has not lapsed or otherwise been satisfied shall be forfeited; provided that the Committee may provide, by rule or regulation or in any Award Agreement, or may determine in any individual case, that forfeiture conditions relating to a Restricted Stock Unit Award shall be waived in whole or in part in the event of terminations resulting from specified causes, and the Committee may in other cases waive in whole or in part the forfeiture of any Restricted Stock Unit Award.
(iii) Dividend Equivalents.  Unless otherwise determined by the Committee at the date of grant, any Dividend Equivalents that are granted with respect to any Restricted Stock Unit Award shall be either (A) paid with respect to such Restricted Stock Unit Award at the dividend payment date in cash or in Shares of unrestricted stock having a Fair Market Value equal to the amount of such dividends, or (B) deferred with respect to such Restricted Stock Unit Award and the amount or value thereof automatically deemed reinvested in additional Restricted Stock Units, other Awards or other investment vehicles, as the Committee shall determine or permit the Participant to elect.  The applicable Award Agreement shall specify whether any Dividend Equivalents shall be paid at the dividend payment date, deferred or deferred at the election of the Participant.  If the Participant may elect to defer the Dividend Equivalents, such election shall be made within 30 days after the grant date of the Restricted

11



Stock Unit Award, but in no event later than 12 months before the first date on which any portion of such Restricted Stock Unit Award vests (or at such other times prescribed by the Committee as shall not result in a violation of Section 409A of the Code).
(f) Bonus Stock and Awards in Lieu of Obligations.  The Committee is authorized to grant Shares to any Eligible Persons as a bonus, or to grant Shares or other Awards in lieu of obligations to pay cash or deliver other property under the Plan or under other plans or compensatory arrangements, provided that, in the case of Eligible Persons subject to Section 16 of the Exchange Act, the amount of such grants remains within the discretion of the Committee to the extent necessary to ensure that acquisitions of Shares or other Awards are exempt from liability under Section 16(b) of the Exchange Act.  Shares or Awards granted hereunder shall be subject to such other terms as shall be determined by the Committee.
(g) Dividend Equivalents.  The Committee is authorized to grant Dividend Equivalents to any Eligible Person entitling the Eligible Person to receive cash, Shares, other Awards, or other property equal in value to the regular dividends paid with respect to a specified number of Shares, or other periodic payments.  Dividend Equivalents may be awarded on a free-standing basis or in connection with another Award.  The Committee may provide that Dividend Equivalents shall be paid or distributed when accrued or shall be deemed to have been reinvested in additional Shares, Awards, or other investment vehicles, and subject to such restrictions on transferability and risks of forfeiture, as the Committee may specify.  Any such determination by the Committee shall be made at the grant date of the applicable Award. 
(h) Performance Awards.  The Committee is authorized to grant Performance Awards to any Eligible Person payable in cash, Shares, or other Awards, on terms and conditions established by the Committee, subject to the provisions of Section 8 if and to the extent that the Committee shall, in its sole discretion, determine that an Award shall be subject to those provisions.  The performance criteria to be achieved during any Performance Period and the length of the Performance Period shall be determined by the Committee upon the grant of each Performance Award; provided, however, that a Performance Period shall not be shorter than twelve (12) months nor longer than five (5) years.  Except as provided in Section 9 or as may be provided in an Award Agreement, Performance Awards will be distributed only after the end of the relevant Performance Period.  The performance goals to be achieved for each Performance Period shall be conclusively determined by the Committee and may be based upon the criteria set forth in Section 8(b), or in the case of an Award that the Committee determines shall not be subject to Section 8 hereof, any other criteria that the Committee, in its sole discretion, shall determine should be used for that purpose.  The amount of the Award to be distributed shall be conclusively determined by the Committee.  Performance Awards may be paid in a lump sum or in installments following the close of the Performance Period or, in accordance with procedures established by the Committee, on a deferred basis, in each case in a manner that does not violate the requirements of Section 409A of the Code.
(i) Other Stock-Based Awards.  The Committee is authorized, subject to limitations under applicable law, to grant to any Eligible Person such other Awards that may be denominated or payable in, valued in whole or in part by reference to, or otherwise based on, or related to, Shares, as deemed by the Committee to be consistent with the purposes of the Plan.  Other Stock-Based Awards may be granted to Participants either alone or in addition to other Awards granted under the Plan, and such Other Stock-Based Awards shall also be available as a form of payment in the settlement of other Awards granted under the Plan.  The Committee shall determine the terms and conditions of such Awards.  Shares delivered pursuant to an Award in the nature of a purchase right granted under this Section 6(i) shall be purchased for such consideration, (including without limitation loans from the Company or a Related Entity provided that such loans are not in violation of the Sarbanes Oxley Act of 2002, as amended, or any rule or regulation adopted thereunder or any other applicable law) paid for at such times, by such methods, and in such forms, including, without limitation, cash, Shares, other Awards or other property, as the Committee shall determine.
7.     Certain Provisions Applicable to Awards.
(a) Stand-Alone, Additional, Tandem, and Substitute Awards.  Awards granted under the Plan may, in the discretion of the Committee, be granted either alone or in addition to, in tandem with, or in substitution or

12



exchange for, any other Award or any award granted under another plan of the Company, any Related Entity, or any business entity to be acquired by the Company or a Related Entity, or any other right of a Participant to receive payment from the Company or any Related Entity.  Such additional, tandem, and substitute or exchange Awards may be granted at any time.  If an Award is granted in substitution or exchange for another Award or award, the Committee shall require the surrender of such other Award or award in consideration for the grant of the new Award.  In addition, Awards may be granted in lieu of cash compensation, including in lieu of cash amounts payable under other plans of the Company or any Related Entity, in which the value of Shares subject to the Award is equivalent in value to the cash compensation (for example, Restricted Stock or Restricted Stock Units), or in which the exercise price, grant price or purchase price of the Award in the nature of a right that may be exercised is equal to the Fair Market Value of the underlying Shares minus the value of the cash compensation surrendered (for example, Options or Stock Appreciation Right granted with an exercise price or grant price “discounted” by the amount of the cash compensation surrendered), provided that any such determination to grant an Award in lieu of cash compensation must be made in a manner intended to comply with Section 409A of the Code.
(b) Term of Awards.  The term of each Award shall be for such period as may be determined by the Committee; provided that in no event shall the term of any Option or Stock Appreciation Right exceed a period of ten years (or in the case of an Incentive Stock Option such shorter term as may be required under Section 422 of the Code). 
(c) Form and Timing of Payment Under Awards; Deferrals.  Subject to the terms of the Plan and any applicable Award Agreement, payments to be made by the Company or a Related Entity upon the exercise of an Option or other Award or settlement of an Award may be made in such forms as the Committee shall determine, including, without limitation, cash, Shares, other Awards or other property, and may be made in a single payment or transfer, in installments, or on a deferred basis, provided that any determination to pay in installments or on a deferred basis shall be made by the Committee at the date of grant.  Any installment or deferral provided for in the preceding sentence shall, however, be subject to the Company’s compliance with applicable law and all applicable rules of the Listing Market, and in a manner intended to be exempt from or otherwise satisfy the requirements of Section 409A of the Code.  Subject to Section 7(e) hereof, the settlement of any Award may be accelerated, and cash paid in lieu of Shares in connection with such settlement, in the sole discretion of the Committee or upon occurrence of one or more specified events (in addition to a Change in Control).  Any such settlement shall be at a value determined by the Committee in its sole discretion, which, without limitation, may in the case of an Option or Stock Appreciation Right be limited to the amount if any by which the Fair Market Value of a Share on the settlement date exceeds the exercise or grant price.  Installment or deferred payments may be required by the Committee (subject to Section 7(e) of the Plan, including the consent provisions thereof in the case of any deferral of an outstanding Award not provided for in the original Award Agreement) or permitted at the election of the Participant on terms and conditions established by the Committee, all in a manner that is intended to be exempt from or otherwise satisfy the requirements of Section 409A of the Code.  The Committee may, without limitation, make provision for the payment or crediting of a reasonable interest rate on installment or deferred payments or the grant or crediting of Dividend Equivalents or other amounts in respect of installment or deferred payments denominated in Shares.
(d) Exemptions from Section 16(b) Liability. If the Company is a Publicly Held Corporation, it is the intent of the Company that the grant of any Awards to or other transaction by a Participant who is subject to Section 16 of the Exchange Act shall be exempt from Section 16 pursuant to an applicable exemption (except for transactions acknowledged in writing to be non-exempt by such Participant).  Accordingly, if any provision of this Plan or any Award Agreement does not comply with the requirements of Rule 16b-3 then applicable to any such transaction, such provision shall be construed or deemed amended to the extent necessary to conform to the applicable requirements of Rule 16b-3 so that such Participant shall avoid liability under Section 16(b).
(e) Code Section 409A.
(i)           The Award Agreement for any Award that the Committee reasonably determines to constitute a Section 409A Plan, as defined in Section 7(e)(ii) hereof, and the provisions of the Plan applicable to that Award, shall be construed in a manner consistent with the applicable requirements of Section 409A of the Code,

13



and the Committee, in its sole discretion and without the consent of any Participant, may amend any Award Agreement (and the provisions of the Plan applicable thereto) if and to the extent that the Committee determines that such amendment is necessary or appropriate to comply with the requirements of Section 409A of the Code.
(ii)           If any Award constitutes a “nonqualified deferred compensation plan” under Section 409A of the Code (a “Section 409A Plan”), then the Award shall be subject to the following additional requirements, if and to the extent required to comply with Section 409A of the Code:
(A)           Payments under the Section 409A Plan may be made only upon (u) the Participant’s “separation from service”, (v) the date the Participant becomes “disabled”, (w) the Participant’s death, (x) a “specified time (or pursuant to a fixed schedule)” specified in the Award Agreement at the date of the deferral of such compensation, (y) a “change in the ownership or effective control of the corporation, or in the ownership of a substantial portion of the assets” of the Company, or (z) the occurrence of an “unforeseeble emergency”; 
(B)           The time or schedule for any payment of the deferred compensation may not be accelerated, except to the extent provided in applicable Treasury Regulations or other applicable guidance issued by the Internal Revenue Service; 
(C)           Any elections with respect to the deferral of such compensation or the time and form of distribution of such deferred compensation shall comply with the requirements of Section 409A(a)(4) of the Code; and 
(D)           In the case of any Participant who is “specified employee”, a distribution on account of a “separation from service” may not be made before the date which is six months after the date of the Participant’s “separation from service” (or, if earlier, the date of the Participant’s death).
For purposes of the foregoing, the terms in quotations shall have the same meanings as those terms have for purposes of Section 409A of the Code, and the limitations set forth herein shall be applied in such manner (and only to the extent) as shall be necessary to comply with any requirements of Section 409A of the Code that are applicable to the Award.
(iii)           Notwithstanding the foregoing, or any provision of this Plan or any Award Agreement, the Company does not make any representation to any Participant or Beneficiary that any Awards made pursuant to this Plan are exempt from, or satisfy, the requirements of, Section 409A of the Code, and the Company shall have no liability or other obligation to indemnify or hold harmless the Participant or any Beneficiary for any tax, additional tax, interest or penalties that the Participant or any Beneficiary may incur in the event that any provision of this Plan, or any Award Agreement, or any amendment or modification thereof, or any other action taken with respect thereto, is deemed to violate any of the requirements of Section 409A of the Code.
8.     Code Section 162(m) Provisions.
(a) Covered Employees.  If the Company is a Publicly Held Corporation, then, unless otherwise specified by the Committee, the provisions of this Section 8 shall be applicable to any Restricted Stock Award, Restricted Stock Unit Award, Performance Award, or Other Stock-Based Award if it is granted to an Eligible Person who is, or is likely to be, as of the end of the tax year in which the Company would claim a tax deduction in connection with such Award, a Covered Employee, and is intended to qualify as “performance-based compensation” that is exempt from the deduction limitations imposed under Section 162(m) of the Code.
(b) Performance Criteria.  If an Award is subject to this Section 8, then the payment or distribution thereof or the lapsing of restrictions thereon and the distribution of cash, Shares or other property pursuant thereto, as applicable, shall be contingent upon achievement of one or more objective performance goals.  Performance goals shall be objective and shall otherwise meet the requirements of Section 162(m) of the Code and regulations thereunder including the requirement that the level or levels of performance targeted by the Committee result in the achievement of performance goals being “substantially uncertain.”  One or more of the following business criteria

14



for the Company, on a consolidated basis, and/or for Related Entities, or for business or geographical units of the Company and/or a Related Entity (except with respect to the total shareholder return and earnings per share criteria), shall be used by the Committee in establishing performance goals for such Awards: (1) earnings per share; (2) revenues or margins; (3) cash flow; (4) operating margin; (5) return on net assets, investment, capital, or equity; (6) economic value added; (7) direct contribution; (8) net income; pretax earnings; earnings before interest and taxes; earnings before interest, taxes, depreciation and amortization; earnings after interest expense and before extraordinary or special items; operating income or income from operations; income before interest income or expense, unusual items and income taxes, local, state or federal and excluding budgeted and actual bonuses which might be paid under any ongoing bonus plans of the Company; (9) working capital; (10) management of fixed costs or variable costs; (11) identification or consummation of investment opportunities or completion of specified projects in accordance with corporate business plans, including strategic mergers, acquisitions or divestitures; (12) total shareholder return; (13) debt reduction; (14) market share; (15) entry into new markets, either geographically or by business unit; (16) customer retention and satisfaction; (17) strategic plan development and implementation, including turnaround plans; and/or (18) the Fair Market Value of a Share.  Any of the above goals may be determined on an absolute or relative basis or as compared to the performance of a published or special index deemed applicable by the Committee including, but not limited to, the Standard & Poor’s 500 Stock Index or a group of companies that are comparable to the Company.  In determining the achievement of the performance goals, unless otherwise specified by the Committee at the time the performance goals are set, the Committee shall exclude the impact of (i) restructurings, discontinued operations, extraordinary items (as defined pursuant to generally accepted accounting principles), and other unusual or non-recurring charges, (ii) change in accounting standards required by generally accepted accounting principles; or (iii) such other exclusions or adjustments as the Committee specifies at the time the Award is granted.
(c) Performance Period; Timing For Establishing Performance Goals.  Achievement of performance goals in respect of Awards subject to this Section 8 shall be measured over a Performance Period no shorter than twelve (1) months and no longer than five (5) years, as specified by the Committee.  Performance goals shall be established not later than ninety (90) days after the beginning of any Performance Period applicable to Awards subject to this Section 8, or at such other date as may be required or permitted for “performance-based compensation” under Section 162(m) of the Code.
(d) Adjustments.  The Committee may, in its discretion, reduce the amount of a settlement otherwise to be made in connection with Awards subject to this Section 8, but may not exercise discretion to increase any such amount payable to a Covered Employee in respect of an Award subject to this Section 8.  The Committee shall specify the circumstances in which such Awards shall be paid or forfeited in the event of termination of Continuous Service by the Participant prior to the end of a Performance Period or settlement of Awards.
(e) Committee Certification.  No Participant shall receive any payment under the Plan that is subject to this Section 8 unless the Committee has certified, by resolution or other appropriate action in writing, that the performance criteria and any other material terms previously established by the Committee or set forth in the Plan, have been satisfied to the extent necessary to qualify as "performance based compensation" under Section 162(m) of the Code.
9.     Change in Control.
(a) Effect of “Change in Control.”  If and only to the extent provided in any employment or other agreement between the Participant and the Company or any Related Entity, or in any Award Agreement, or to the extent otherwise determined by the Committee in its sole discretion and without any requirement that each Participant be treated consistently, upon the occurrence of a “Change in Control,” as defined in Section 9(b):
(i) Any Option or Stock Appreciation Right that was not previously vested and exercisable as of the time of the Change in Control, shall become immediately vested and exercisable, subject to applicable restrictions set forth in Section 10(a) hereof.

15



(ii) Any restrictions, deferral of settlement, and forfeiture conditions applicable to a Restricted Stock Award, Restricted Stock Unit Award or an Other Stock-Based Award subject only to future service requirements granted under the Plan shall lapse and such Awards shall be deemed fully vested as of the time of the Change in Control, except to the extent of any waiver by the Participant and subject to applicable restrictions set forth in Section 10(a) hereof.
(iii) With respect to any outstanding Award subject to achievement of performance goals and conditions under the Plan, the Committee may, in its discretion, deem such performance goals and conditions as having been met as of the date of the Change in Control.
(iv) Notwithstanding the foregoing or any provision in any Award Agreement to the contrary, and unless the Committee otherwise determines in a specific instance, or as is provided in any employment or other agreement between the Participant and the Company or any Related Entity, each outstanding Option, Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit Award or Other Stock-Based Award shall not be accelerated as described in Sections 9(a)(i), (ii) and (iii), if either (A) the Company is the surviving entity in the Change in Control and the Option, Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit Award or Other Stock-Based Award continues to be outstanding after the Change in Control on the substantially same terms and conditions as were applicable immediately prior to the Change in Control or (B) the successor company assumes or substitutes for the applicable Award, as determined in accordance with Section 10(c)(ii) hereof.   For the purposes of this Agreement, an Option, Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit Award or Other Stock-Based Award shall be considered assumed or substituted for if following the Change in Control the Award confers the right to purchase or receive, for each Share subject to the Option, Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit Award or Other Stock-Based Award immediately prior to the Change in Control, on substantially the same vesting and other terms and conditions as were applicable to the Award immediately prior to the Change in Control, the consideration (whether stock, cash or other securities or property) received in the transaction constituting a Change in Control by holders of Shares for each Share held on the effective date of such transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares); provided, however, that if such consideration received in the transaction constituting a Change in Control is not solely common stock of the successor company or its parent or subsidiary, the Committee may, with the consent of the successor company or its parent or subsidiary, provide that the consideration to be received upon the exercise or vesting of an Option, Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit Award or Other Stock-Based Award, for each Share subject thereto, will be solely common stock of the successor company or its parent or subsidiary substantially equal in fair market value to the per share consideration received by holders of Shares in the transaction constituting a Change in Control.  The determination of such substantial equality of value of consideration shall be made by the Committee in its sole discretion and its determination shall be conclusive and binding. 
(b) Definition of “Change in Control”.  Unless otherwise specified in any employment agreement between the Participant and the Company or any Related Entity, or in an Award Agreement, a “Change in Control” shall mean the occurrence of any of the following:
(i) The acquisition by any Person of Beneficial Ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of more than fifty percent (50%) of either (A) the value of then outstanding equity securities of the Company (the “Outstanding Company Stock”) or (B) the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors (the “Outstanding Company Voting Securities”) (the foregoing Beneficial Ownership hereinafter being referred to as a "Controlling Interest"); provided, however, that for purposes of this Section 9(b), the following acquisitions shall not constitute or result in a Change in Control:  (v) any acquisition directly from the Company; (w) any acquisition by the Company; (x) any acquisition by any Person that as of the Effective Date owns Beneficial Ownership of a Controlling Interest; (y) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any Related Entity; or (z) any acquisition by any entity pursuant to a transaction which complies with clauses (A), (B) and (C) of subsection (iii) below; or

16



(ii) During any period of two (2) consecutive years (not including any period prior to the Effective Date) individuals who constitute the Board on the Effective Date (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the Effective Date whose election, or nomination for election by the Company’s shareholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or
(iii) Consummation of (A) a reorganization, merger, statutory share exchange or consolidation or similar transaction involving (x) the Company or (y) any of its Subsidiaries, but in the case of this clause (y) only if equity securities of the Company are issued or issuable in connection with the transaction (each of the events referred to in this clause (A) being hereinafter referred to as a “Business Reorganization”), or (B) a sale or other disposition of all or substantially all of the assets of the Company, or the acquisition of assets or equity of another entity by the Company or any of its Subsidiaries (each an “Asset Sale”), in each case, unless, following such Business Reorganization or Asset Sale, (1) all or substantially all of the individuals and entities who were the Beneficial Owners, respectively, of the Outstanding Company Stock and Outstanding Company Voting Securities immediately prior to such Business Reorganization or Asset Sale beneficially own, directly or indirectly, more than fifty percent (50%) of the value of the then outstanding equity securities and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of members of the board of directors (or comparable governing body of an entity that does not have such a board), as the case may be, of the entity resulting from such Business Reorganization or Asset Sale (including, without limitation, an entity which as a result of such transaction owns the Company or all or substantially all of the Company’s assets either directly or through one or more subsidiaries) (the “Continuing Entity”) in substantially the same proportions as their ownership, immediately prior to such Business Reorganization or Asset Sale, of the Outstanding Company Stock and Outstanding Company Voting Securities, as the case may be (excluding any outstanding equity or voting securities of the Continuing Entity that such Beneficial Owners hold immediately following the consummation of the Business Reorganization or Asset Sale as a result of their ownership, prior to such consummation, of equity or voting securities of any company or other entity involved in or forming part of such Business Reorganization or Asset Sale other than the Company), (2) no Person (excluding any employee benefit plan (or related trust) of the Company or any Continuing Entity or any entity controlled by the Continuing Corporation or any Person that as of the Effective Date owns Beneficial Ownership of a Controlling Interest) beneficially owns, directly or indirectly, fifty percent (50%) or more of the value of the then outstanding equity securities of the Continuing Entity or the combined voting power of the then outstanding voting securities of the Continuing Entity except to the extent that such ownership existed prior to the Business Reorganization or Asset Sale and (3) at least a majority of the members of the Board of Directors or other governing body of the Continuing Entity were members of the Incumbent Board at the time of the execution of the initial agreement, or of the action of the Board, providing for such Business Reorganization or Asset Sale; or
(iv) Approval by the shareholders of the Company of a complete liquidation or dissolution of the Company.
Notwithstanding anything to the contrary herein, the term “Change in Control” shall not include a sale of assets, a merger or other transaction effected exclusively for the purpose of changing the domicile of the Company, or an initial public offering underwritten on a firm commitment basis pursuant to a registration statement filed with the Securities Exchange Commission
10.     General Provisions.
(a) Compliance With Legal and Other Requirements.  The Company may, to the extent deemed necessary or advisable by the Committee, postpone the issuance or delivery of Shares or payment of other benefits under any Award until completion of such registration or qualification of such Shares or other required action under any federal or state law, rule or regulation, listing or other required action with respect to the Listing Market, or compliance with any other obligation of the Company, as the Committee, may consider appropriate, and may

17



require any Participant to make such representations, furnish such information and comply with or be subject to such other conditions as it may consider appropriate in connection with the issuance or delivery of Shares or payment of other benefits in compliance with applicable laws, rules, and regulations, listing requirements, or other obligations.
(b) Limits on Transferability; Beneficiaries.  No Award or other right or interest granted under the Plan shall be pledged, hypothecated or otherwise encumbered or subject to any lien, obligation or liability of such Participant to any party, or assigned or transferred by such Participant otherwise than by will or the laws of descent and distribution or to a Beneficiary upon the death of a Participant, and such Awards or rights that may be exercisable shall be exercised during the lifetime of the Participant only by the Participant or his or her guardian or legal representative, except that Awards and other rights (other than Incentive Stock Options and Stock Appreciation Rights in tandem therewith) may be transferred to one or more Beneficiaries or other transferees during the lifetime of the Participant, and may be exercised by such transferees in accordance with the terms of such Award, but only if and to the extent such transfers are permitted by the Committee pursuant to the express terms of an Award Agreement (subject to any terms and conditions which the Committee may impose thereon) and are otherwise not inconsistent with the rules as to the use of Form S-8 Registration Statement under the Securities Act of 1933, as amended (or any successor or, at the sole discretion of the Committee, other registration statement pursuant to which Awards, Shares, rights or interests under the Plan are then registered under such Act), if applicable.  A Beneficiary, transferee, or other person claiming any rights under the Plan from or through any Participant shall be subject to all terms and conditions of the Plan and any Award Agreement applicable to such Participant, except as otherwise determined by the Committee, and to any additional terms and conditions deemed necessary or appropriate by the Committee. 
(c) Adjustments.
(i) Adjustments to Awards.  In the event that any extraordinary dividend or other distribution (whether in the form of cash, Shares, or other property), recapitalization, forward or reverse split, reorganization, merger, consolidation, spin-off, combination, repurchase, share exchange, liquidation, dissolution or other similar corporate transaction or event affects the Shares and/or such other securities of the Company or any other issuer, then the Committee shall, in such manner as it may deem equitable, substitute, exchange or adjust any or all of (A) the number and kind of Shares which may be delivered in connection with Awards granted thereafter, (B) the number and kind of Shares by which annual per-person Award limitations are measured under Section 5 hereof, (C) the number and kind of Shares subject to or deliverable in respect of outstanding Awards, (D) the exercise price, grant price or purchase price relating to any Award and/or make provision for payment of cash or other property in respect of any outstanding Award, and (E) any other aspect of any Award that the Committee determines to be appropriate.
(ii) Adjustments in Case of Certain Transactions.  In the event of any merger, consolidation or other reorganization in which the Company does not survive, or in the event of any Change in Control, any outstanding Awards may be dealt with in accordance with any of the following approaches, without the requirement of obtaining any consent or agreement of a Participant as such, as determined by the agreement effectuating the transaction or, if and to the extent not so determined, as determined by the Committee: (A) the continuation of the outstanding Awards by the Company, if the Company is a surviving entity, (B) the assumption or substitution for, as those terms are defined below, the outstanding Awards by the surviving entity or its parent or subsidiary, (C) full exercisability or vesting and accelerated expiration of the outstanding Awards, or (D) settlement of the value of the outstanding Awards in cash or cash equivalents or other property followed by cancellation of such Awards (which value, in the case of Options or Stock Appreciation Rights, shall be measured by the amount, if any, by which the Fair Market Value of a Share exceeds the exercise or grant price of the Option or Stock Appreciation Right as of the effective date of the transaction).  For the purposes of this Plan, an Option, Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit Award or Other Stock-Based Award shall be considered assumed or substituted for if following the applicable transaction the Award confers the right to purchase or receive, for each Share subject to the Option, Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit Award or Other Stock-Based Award immediately prior to the applicable transaction, on substantially the same vesting and other terms and conditions as were applicable to the Award immediately prior to the applicable

18



transaction, the consideration (whether stock, cash or other securities or property) received in the applicable transaction by holders of Shares for each Share held on the effective date of such transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding Shares); provided, however, that if such consideration received in the applicable transaction is not solely common stock of the successor company or its parent or subsidiary, the Committee may, with the consent of the successor company or its parent or subsidiary, provide that the consideration to be received upon the exercise or vesting of an Option, Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit Award or Other Stock-Based Award, for each Share subject thereto, will be solely common stock of the successor company or its parent or subsidiary substantially equal in fair market value to the per share consideration received by holders of Shares in the applicable transaction.  The determination of such substantial equality of value of consideration shall be made by the Committee in its sole discretion and its determination shall be conclusive and binding.  The Committee shall give written notice of any proposed transaction referred to in this Section 10(c)(ii) at a reasonable period of time prior to the closing date for such transaction (which notice may be given either before or after the approval of such transaction), in order that Participants may have a reasonable period of time prior to the closing date of such transaction within which to exercise any Awards that are then exercisable (including any Awards that may become exercisable upon the closing date of such transaction).  A Participant may condition his or her exercise of any Awards upon the consummation of the transaction.
(iii) Other Adjustments.  The Committee (and the Board if and only to the extent such authority is not required to be exercised by the Committee to comply with Section 162(m) of the Code) is authorized to make adjustments in the terms and conditions of, and the criteria included in, Awards (including Awards subject to satisfaction of performance goals, or performance goals and conditions relating thereto) in recognition of unusual or nonrecurring events (including, without limitation, acquisitions and dispositions of businesses and assets) affecting the Company, any Related Entity or any business unit, or the financial statements of the Company or any Related Entity, or in response to changes in applicable laws, regulations, accounting principles, tax rates and regulations or business conditions or in view of the Committee's assessment of the business strategy of the Company, any Related Entity or business unit thereof, performance of comparable organizations, economic and business conditions, personal performance of a Participant, and any other circumstances deemed relevant.  Adjustments permitted hereby may include, without limitation, increasing the exercise price of Options and Stock Appreciation Rights, increasing performance goals, or other adjustments that may be adverse to the Participant.  Notwithstanding the foregoing, no adjustments may be made with respect to any Awards subject to Section 8 if and to the extent that such adjustment would cause the Award to fail to qualify as “performance-based compensation” under Section 162(m) of the Code.
(d) Taxes.  The Company and any Related Entity are authorized to withhold from any Award granted, any payment relating to an Award under the Plan, including from a distribution of Shares, or any payroll or other payment to a Participant, amounts of withholding and other taxes due or potentially payable in connection with any transaction involving an Award not to be in excess of the minimum statutory withholding required, and to take such other action as the Committee may deem advisable to enable the Company or any Related Entity and Participants to satisfy obligations for the payment of withholding taxes and other tax obligations relating to any Award.  This authority shall include authority to withhold or receive Shares or other property and to make cash payments in respect thereof in satisfaction of a Participant's tax obligations not in excess of the minimum statutory withholding required, either on a mandatory or elective basis in the discretion of the Committee.
(e) Changes to the Plan and Awards.  The Board may amend, alter, suspend, discontinue or terminate the Plan, or the Committee's authority to grant Awards under the Plan, without the consent of shareholders or Participants, except that any amendment or alteration to the Plan shall be subject to the approval of the Company's shareholders not later than the annual meeting next following such Board action if such shareholder approval is required by any federal or state law or regulation (including, without limitation, Rule 16b-3 or Code Section 162(m)) or the rules of the Listing Market, and the Board may otherwise, in its discretion, determine to submit other such changes to the Plan to shareholders for approval; provided that, except as otherwise permitted by the Plan or Award Agreement, without the consent of an affected Participant, no such Board action may materially and adversely affect the rights of such Participant under the terms of any previously granted and outstanding Award.  The Committee may waive any conditions or rights under, or amend, alter, suspend, discontinue or

19



terminate any Award theretofore granted and any Award Agreement relating thereto, except as otherwise provided in the Plan; provided that, except as otherwise permitted by the Plan or Award Agreement, without the consent of an affected Participant, no such Committee or the Board action may materially and adversely affect the rights of such Participant under terms of such Award.
(f) Limitation on Rights Conferred Under Plan.  Neither the Plan nor any action taken hereunder or under any Award shall be construed as (i) giving any Eligible Person or Participant the right to continue as an Eligible Person or Participant or in the employ or service of the Company or a Related Entity; (ii) interfering in any way with the right of the Company or a Related Entity to terminate any Eligible Person's or Participant's Continuous Service at any time, (iii) giving an Eligible Person or Participant any claim to be granted any Award under the Plan or to be treated uniformly with other Participants and Employees, or (iv) conferring on a Participant any of the rights of a shareholder of the Company or any Related Entity including, without limitation, any right to receive dividends or distributions, any right to vote or act by written consent, any right to attend meetings of shareholders or any right to receive any information concerning the Company’s or any Related Entity’s business, financial condition, results of operation or prospects, unless and until such time as the Participant is duly issued Shares on the stock books of the Company or any Related Entity in accordance with the terms of an Award.  None of the Company, its officers or its directors shall have any fiduciary obligation to the Participant with respect to any Awards unless and until the Participant is duly issued Shares pursuant to the Award on the stock books of the Company in accordance with the terms of an Award.  Neither the Company, nor any Related Entity, nor any of the their respective officers, directors, representatives or agents are granting any rights under the Plan to the Participant whatsoever, oral or written, express or implied, other than those rights expressly set forth in this Plan or the Award Agreement.
(g) Unfunded Status of Awards; Creation of Trusts.  The Plan is intended to constitute an “unfunded” plan for incentive and deferred compensation.  With respect to any payments not yet made to a Participant or obligation to deliver Shares pursuant to an Award, nothing contained in the Plan or any Award Agreement shall give any such Participant any rights that are greater than those of a general creditor of the Company or Related Entity that issues the Award; provided that the Committee may authorize the creation of trusts and deposit therein cash, Shares, other Awards or other property, or make other arrangements to meet the obligations of the Company or Related Entity under the Plan.  Such trusts or other arrangements shall be consistent with the “unfunded” status of the Plan unless the Committee otherwise determines with the consent of each affected Participant.  The trustee of such trusts may be authorized to dispose of trust assets and reinvest the proceeds in alternative investments, subject to such terms and conditions as the Committee may specify and in accordance with applicable law.
(h) Nonexclusivity of the Plan.  Neither the adoption of the Plan by the Board nor its submission to the shareholders of the Company for approval shall be construed as creating any limitations on the power of the Board or a committee thereof to adopt such other incentive arrangements as it may deem desirable including incentive arrangements and awards which do not qualify under Section 162(m) of the Code.
(i) Payments in the Event of Forfeitures; Fractional Shares.  Unless otherwise determined by the Committee, in the event of a forfeiture of an Award with respect to which a Participant paid cash or other consideration, the Participant shall be repaid the amount of such cash or other consideration.  No fractional Shares shall be issued or delivered pursuant to the Plan or any Award.  The Committee shall determine whether cash, other Awards or other property shall be issued or paid in lieu of such fractional shares or whether such fractional shares or any rights thereto shall be forfeited or otherwise eliminated.
(j) Governing Law.  Except as otherwise provided in any Award Agreement, the validity, construction and effect of the Plan, any rules and regulations under the Plan, and any Award Agreement shall be determined in accordance with the laws of the State of Delaware without giving effect to principles of conflict of laws, and applicable federal law.
(k) Non-U.S. Laws.  The Committee shall have the authority to adopt such modifications, procedures, and subplans as may be necessary or desirable to comply with provisions of the laws of foreign

20



countries in which the Company or its Related Entities may operate to assure the viability of the benefits from Awards granted to Participants performing services in such countries and to meet the objectives of the Plan.
(l) Plan Effective Date and Shareholder Approval; Termination of Plan.  The Plan shall become effective on the Effective Date and, to the extent so required by the rules of any stock exchange or automated quotation system on which the Shares may be listed or quoted, shall be subject to subsequent approval by the shareholders of the Company eligible to vote in the election of directors, by a vote sufficient to meet the requirements of such stock exchange or automated quotation system.  Notwithstanding the foregoing, any Awards granted under the Plan that are intended to be Incentive Stock Options or are intended to be exempt from the deduction limitations contained in Section 162(m) of the Code shall not be exercised and/or settled unless and until the applicable shareholder approval requirements of Sections 422 and/or 162(m) are satisfied.  The Plan shall terminate at the earliest of (a) such time as no Shares remain available for issuance under the Plan, (b) termination of this Plan by the Board, or (c) the tenth anniversary of the Effective Date.  Awards outstanding upon expiration of the Plan shall remain in effect until they have been exercised or terminated, or have expired.

21


Exhibit 10.3
ELEMENT SOLUTIONS INC
2014 EMPLOYEE STOCK PURCHASE PLAN

This Element Solutions Inc 2014 Employee Stock Purchase Plan (the “Plan”) is effective March 6, 2014 (the “Effective Date”), subject to approval by the Company’s stockholders within twelve (12) months after the Effective Date. If stockholder approval is not obtained, then this Plan and any grants made hereunder, shall immediately terminate and be null and void.
1.    Purpose and Structure of the Plan and its Sub-Plans.
1.1    The purpose of this Plan is (a) to provide eligible employees of the Company and Participating Companies who wish to become stockholders in the Company a convenient method of doing so, (b) to encourage employees to work in the best interests of stockholders of the Company, (c) to support recruitment and retention of qualified employees, and (d) to provide employees an advantageous means of accumulating long-term investments. It is believed that employee participation in the ownership of the business will be to the mutual benefit of both the employees and the Company. This Plan document is an omnibus document which includes a sub-plan (“Statutory Plan”) designed to permit offerings of grants to employees of certain Subsidiaries that are Participating Companies where such offerings are intended to satisfy the requirements of Section 423 of the Code (although the Company makes no undertaking nor representation to obtain or maintain qualification under Section 423 for any Subsidiary, individual, offering or grant) and also separate sub-plans (“Non-Statutory Plans”) which permit offerings of grants to employees of certain Participating Companies which are not intended to satisfy the requirements of Section 423 of the Code. Section 6 of the Plan sets forth the maximum number of shares to be offered under the Plan (and its sub-plans), subject to adjustments as permitted under Sections 19 and 20.
1.2    The Statutory Plan shall be a separate and independent plan from the Non-Statutory Plans, provided, however, that the total number of shares authorized to be issued under the Plan applies in the aggregate to both the Statutory Plan and the Non-Statutory Plans. Offerings under the Non-Statutory Plans may be made to achieve desired tax or other objectives in particular locations outside the United States of America or to comply with local laws applicable to offerings in such foreign jurisdictions. Offerings under the Non-Statutory Plans may also be made to employees of entities that are not Subsidiaries.
1.3        All employees who participate in the Statutory Plan shall have the same rights and privileges under such sub-plan except for differences that may be mandated by local law and are consistent with the requirements of Code Section 423(b)(5). The terms of the Statutory Plan shall be those set forth in this Plan document to the extent such terms are consistent with the requirements for qualification under Code Section 423. The Administrator may adopt Non-Statutory Plans applicable to particular Participating Companies or locations that are not participating in the Statutory Plan. The terms of each Non-Statutory Plan may take precedence over other provisions in this document, with the exception of Sections 6, 19 and 20 with respect to the total number of shares available to be offered under the Plan for all sub-plans. Unless otherwise superseded by the terms of such Non-Statutory Plan, the provisions of this Plan document shall govern the operation of such Non-Statutory Plan. Except to the extent expressly set forth herein or where the context suggests otherwise, any reference herein to “Plan” shall be construed to include a reference to the Statutory Plan and the Non-Statutory Plans.
2.    Definitions.
2.1    “Account” means the funds accumulated with respect to an individual employee as a result of deductions from such employee’s paycheck (or otherwise as permitted in certain circumstances under the terms of the Plan) for the purpose of purchasing Common Stock under this Plan. The funds allocated to an employee’s Account shall be deposited in the Company's general corporate accounts and may be used by the Company for any corporate purpose, and the Company shall not be obligated to segregate or otherwise set apart such funds allocated to an employee’s Account from any other corporate funds, except to the extent such commingling may be prohibited by the laws of any applicable jurisdiction.
2.2    “Administrator” means the Committee or the persons acting within the scope of their authority to administer the Plan pursuant to a delegation of authority from the Committee pursuant to Section 22.
2.3    “Affiliate” means an entity, other than a Subsidiary, in which the Company has an equity or other ownership interest.
2.4    “Beneficial Owner” and “Beneficial Ownership” shall have the meaning ascribed to such term in Rule 13d‑3 under the Exchange Act and any successor to such Rule.

1



2.5    “Board” means the Board of Directors of the Company.
2.6    “Change in Control” means, except as otherwise specified in any employment agreement between the Participant and the Company or any Subsidiary or Affiliate, the occurrence of any of the following:
(a)The acquisition by any Person of Beneficial Ownership of more than fifty percent (50%) of either (A) the value of then outstanding equity securities of the Company (the “Outstanding Company Stock”) or (B) the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors (the “Outstanding Company Voting Securities”) (the foregoing Beneficial Ownership hereinafter being referred to as a “Controlling Interest”); provided, however, that for purposes of this Section 2.6, the following acquisitions shall not constitute or result in a Change in Control: (v) any acquisition directly from the Company; (w) any acquisition by the Company; (x) any acquisition by any Person that as of the Effective Date owns Beneficial Ownership of a Controlling Interest; (y) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any Related Entity; or (z) any acquisition by any entity pursuant to a transaction which complies with clauses (1), (2) and (3) of subsection (c) below; or
(b)During any period of two (2) consecutive years (not including any period prior to the Effective Date) individuals who constitute the Board on the Effective Date (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the Effective Date whose election, or nomination for election by the Company’s stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or
(c)Consummation of (A) a reorganization, merger, statutory share exchange or consolidation or similar transaction involving (x) the Company or (y) any of its Subsidiaries, but in the case of this clause (y) only if equity securities of the Company are issued or issuable in connection with the transaction (each of the events referred to in this clause (A) being hereinafter referred to as a “Business Reorganization”), or (B) a sale or other disposition of all or substantially all of the assets of the Company, or the acquisition of assets or equity of another entity by the Company or any of its Subsidiaries (each an “Asset Sale”), in each case, unless, following such Business Reorganization or Asset Sale, (1) all or substantially all of the individuals and entities who were the Beneficial Owners, respectively, of the Outstanding Company Stock and Outstanding Company Voting Securities immediately prior to such Business Reorganization or Asset Sale beneficially own, directly or indirectly, more than fifty percent (50%) of the value of the then outstanding equity securities and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of members of the board of directors (or comparable governing body of an entity that does not have such a board), as the case may be, of the entity resulting from such Business Reorganization or Asset Sale (including, without limitation, an entity which as a result of such transaction owns the Company or all or substantially all of the Company’s assets either directly or through one or more subsidiaries) (the “Continuing Entity”) in substantially the same proportions as their ownership, immediately prior to such Business Reorganization or Asset Sale, of the Outstanding Company Stock and Outstanding Company Voting Securities, as the case may be (excluding any outstanding equity or voting securities of the Continuing Entity that such Beneficial Owners hold immediately following the consummation of the Business Reorganization or Asset Sale as a result of their ownership, prior to such consummation, of equity or voting securities of any company or other entity involved in or forming part of such Business Reorganization or Asset Sale other than the Company), (2) no Person (excluding any employee benefit plan (or related trust) of the Company or any Continuing Entity or any entity controlled by the Continuing Corporation or any Person that as of the Effective Date owns Beneficial Ownership of a Controlling Interest) beneficially owns, directly or indirectly, fifty percent (50%) or more of the value of the then outstanding equity securities of the Continuing Entity or the combined voting power of the then outstanding voting securities of the Continuing Entity except to the extent that such ownership existed prior to the Business Reorganization or Asset Sale and (3) at least a majority of the members of the Board of Directors or other governing body of the Continuing Entity were members of the Incumbent Board at the time of the execution of the initial agreement, or of the action of the Board, providing for such Business Reorganization or Asset Sale; or
(d)Approval by the stockholders of the Company of a complete liquidation or dissolution of the Company.
2.7    “Code” means the Internal Revenue Code of 1986, as amended from time to time.
2.8    “Committee” means the Compensation Committee of the Board. The Committee may delegate its responsibilities as provided in Section 22.

2



2.9    “Common Stock” means the common stock, par value $0.01 per share, of the Company.
2.10    “Company” means Element Solutions Inc (f/k/a Platform Specialty Products Corporation), a Delaware corporation.
2.11    “Compensation” means, unless the Committee establishes otherwise for a future offering, all base pay, inclusive of any employer-paid leave, overtime, cash bonuses, and commissions.
2.12    “Enrollment Agreement” means an agreement between the Company and an employee, in such form as may be established by the Company from time to time, pursuant to which the employee elects to participate in this Plan, or elects changes with respect to such participation as permitted under the Plan.
2.13    “ESPP Broker” means a stock brokerage or other entity designated by the Company to establish accounts for Common Stock purchased under the Plan by participants.
2.14    “Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time.
2.15    “Fair Market Value” means the closing price on the date of determination on the principal national securities exchange on which the Common Stock is listed or admitted to trading, and if there were no trades on such date, on the day on which a trade occurred next preceding such date.
2.16    “Offering Date” as used in this Plan shall be the commencement date of an offering. A different date may be set by the Committee.
2.17    “Participating Company” means the Company and any Subsidiary or Affiliate that has been designated by the Administrator to participate in the Plan. For purposes of participation in the Statutory Plan, only the Company and its Subsidiaries may be considered Participating Companies, and the Administrator shall designate from time to time which Subsidiaries will be Participating Companies in the Statutory Plan. The Administrator shall designate from time to time which Subsidiaries and Affiliates will be Participating Companies in particular Non-Statutory Plans. The foregoing designations and changes in designation by the Administrator shall not require stockholder approval. Notwithstanding the foregoing, the term “Participating Company” shall not include any Subsidiary or Affiliate that offers its employees the opportunity to participate in an employee stock purchase plan covering the Subsidiary’s or Affiliate’s common stock.
2.18    “Plan” means this Element Solutions Inc 2014 Employee Stock Purchase Plan, as may be amended from time to time.
2.19    “Person” shall have the meaning ascribed to such term in Section 3(a)(9) of the Exchange Act and used in Sections 13(d) and 14(d) thereof, and shall include a “group” as defined in Section 13(d) thereof.
2.20    “Purchase Date” means the last day of an offering.
2.21    “Purchase Price” is the price per share of Common Stock of the Company as established pursuant to Section 5 of the Plan.
2.22    “Subsidiary” means any corporation (other than the Company), domestic or foreign, that is in an unbroken chain of corporations beginning with the Company if, on an Offering Date, each of the corporations other than the last corporation in the unbroken chain owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in the chain, as described in Code Section 424(f).
3.    Employees Eligible to Participate. Any employee of a Participating Company who is in the employ of any Participating Company on one or more Offering Dates. Notwithstanding the foregoing, employees of a Participating Company who are citizens or residents of a foreign jurisdiction (without regard to whether they are also citizens of the United States or resident aliens (within the meaning of Section 7701(b)(1)(A) of the Code)) shall not be eligible to participate in the Statutory Plan if: (i) the grant of an option under the Plan to such employee is prohibited under the laws of such jurisdiction; or (ii) compliance with the laws of such foreign jurisdiction would cause the Statutory Plan to violate the requirements of Section 423 of the Code. During paid leaves of absence approved by the Committee and meeting the requirements of the applicable treasury regulations promulgated under the Code, a participant may elect to continue participation in the Plan for three months or for such longer period as permitted under applicable treasury regulations.
4.    Offerings. Subject to the right of the Company in its sole discretion to sooner terminate the Plan or to change the commencement date or term of any offering, commencing June 1, 2014, the Plan will operate with separate consecutive calendar

3



quarter offerings with the following Offering Dates: March 1, June 1, September 1 and December 1; provided, however, that the initial offering period shall be from the date on which the shareholders of the Company approve the Plan through August 31, 2014. Unless a termination of or change to the Plan has previously been made by the Company, the final offering under this Plan shall commence on March 1, 2023 and terminate on May 31, 2024. In order to become eligible to purchase shares, an employee must complete and submit an Enrollment Agreement and any other necessary documents before the Offering Date of the particular offering in which he or she wishes to participate. Participation in one offering under the Plan shall neither limit, nor require, participation in any other offering. Notwithstanding the foregoing, the Committee may establish (i) a different term for one or more future offerings and (ii) different commencing and ending dates for such offerings; provided, however, that in no event shall any offering exceed 27 months. In the event the first or the last day of an offering is not a regular business day, then the first day of the offering shall be deemed to be the next regular business day and the last day of the offering shall be deemed to be the last preceding regular business day.
5.    Price. The Purchase Price per share shall be eighty-five percent (85%) of the lesser of (i) the Fair Market Value of the Common Stock on the Offering Date of such offering and (ii) the Fair Market Value of the Common Stock on the Purchase Date of such offering.
6.    Number of Shares to be Offered. The maximum number of shares that will be offered under the Plan is 5,178,815 shares, subject to adjustment as permitted under Section 20. The shares to be sold to participants under the Plan will be Common Stock of the Company. If the total number of shares for which options are to be granted on any date in accordance with Section 12 exceeds the number of shares then available under the Plan or a given sub-plan (after deduction of all shares for which options have been exercised under the Plan or are then outstanding), the Company shall make a pro rata allocation of the shares remaining available in as nearly a uniform manner as it determines is practicable and equitable. In such event, the payroll deductions to be made pursuant to the authorizations therefor shall be reduced accordingly and the Company shall give written notice of the reduction to each employee affected. Any Shares delivered under the Plan may consist, in whole or in part, of authorized and unissued Shares or treasury shares.
7.    Participation.
7.1    An eligible employee may become a participant by completing an Enrollment Agreement provided by the Company and submitting it to the Company, or with such other entity designated by the Company for this purpose, prior to the commencement of the offering to which it relates. The Enrollment Agreement may be completed at any time after the employee becomes eligible to participate in the Plan, and will be effective as of the Offering Date next following the receipt of a properly completed Enrollment Agreement by the Company (or the Company’s designee for this purpose).
7.2    Payroll deductions for a participant shall commence on the Offering Date as described above and shall continue through subsequent offerings pursuant to Section 10 until the participant’s termination of employment, subject to modification by the employee as provided in Section 8.1, and unless participation is earlier withdrawn or suspended by the employee as provided in Section 9.
7.3    Payroll deduction shall be the sole means of accumulating funds in a participant’s Account, except in foreign countries where payroll deductions are not allowed, in which case the Company may authorize alternative payment methods.
7.4    The Company may require current participants to complete a new Enrollment Agreement at any time it deems necessary or desirable to facilitate Plan administration or for any other reason.
8.    Payroll Deductions.
8.1    At the time an employee files a payroll deduction authorization, the employee shall elect to have deductions made from the employee’s Compensation on each payday during each calendar year, which shall be at least $60 but shall not exceed $10,000 of the participant’s Compensation for such calendar year (or such other amounts as the Committee may establish from time to time for a future offering), subject to the restrictions set forth in the Plan. The amount of payroll withholding for each participant for each pay period shall be generally determined by dividing the annual payroll withholding amount chosen by each participant by the total number of pay periods such participant has in such calendar year, subject to the discretion of the Committee. A participant may elect, at any time during an offering, to (i) increase or decrease the amount to be withheld from his or her Compensation, or (ii) discontinue payroll contributions, by completing and filing with the Company an amended Enrollment Agreement authorizing the increase, decrease or cessation of payroll deductions. The change shall be effective as of the beginning of the next payroll period following the date of filing the amended Enrollment Agreement if the amended Enrollment Agreement is filed at least ten days prior to such date (the “Change Notice Date”) and, if not, as of the beginning of the next succeeding payroll period. All payroll deductions accrued by a participant as of a Change Notice Date shall continue to be applied toward the

4



purchase of Common Stock on the Purchase Date, unless a participant withdraws from an offering or the Plan, pursuant to Section 9. An amended Enrollment Agreement shall remain in effect until the participant changes such Enrollment Agreement in accordance with the terms of the Plan. The Committee may, from time to time, establish (x) limitations on the frequency and/or number of any permitted changes in the amount withheld during an offering, (y) payroll withholding in excess of the amount designated by a Participant in order to adjust for delays or mistakes in the Company’s processing of properly completed withholding elections, and (z) such other limitations or procedures as deemed advisable by the Committee in the Committee’s sole discretion that are consistent with the Plan and in accordance with the requirements of Code Section 423.
8.2    All payroll deductions made for a participant shall be credited to his or her Account under the Plan. A participant may not make any separate cash payment into his or her Account nor may payment for shares be made other than by payroll deduction, except as provided under Section 7.3.
8.3    A participant may withdraw from or suspend his or her participation in the Plan as provided in Section 9. A participant may also make a prospective election, by changing his or her payroll deduction amount to zero as set forth in Section 8.1, to cease participation in the Plan effective as of the next Offering Date.
8.4    Notwithstanding the foregoing, to the extent necessary to comply with Section 423(b)(8) of the Code, Section 21 hereof, or any other applicable law, a participant's payroll deductions may be decreased, including to zero, at such time during any offering which is scheduled to end during the current calendar year that the aggregate of all payroll deductions accumulated with respect to such offering and any other offering ending within the same calendar year are equal to $21,250. Payroll deductions shall recommence at the rate provided in the participant's Enrollment Agreement at the beginning of the following offering which is scheduled to end in the following calendar year, unless the participant withdraws from an offering or the Plan, pursuant to Section 9.
9.    Withdrawal and Suspension.
9.1    An employee may withdraw from an offering, in whole but not in part, at any time during the offering for which such withdrawal is to be effective, or by any other date specified by the Administrator for a future offering, by submitting a withdrawal notice to the Company, in which event the Company will refund the entire balance of his or her Account as soon as practicable thereafter.
9.2    If an employee withdraws or suspends his or her participation pursuant to Section 9.1, he or she shall not participate in a subsequent offering unless and until he or she re-enters the Plan. To re-enter the Plan, an employee who has previously withdrawn or suspended participation by reducing payroll deductions to zero must file a new Enrollment Agreement in accordance with Section 7.1. The employee’s re-entry into the Plan will not become effective before the beginning of the next offering following his or her withdrawal or suspension.
10.    Automatic Re-Enrollment. At the termination of each offering each participating employee who continues to be eligible to participate pursuant to Section 3 shall be automatically re-enrolled in the next offering, unless the employee has advised the Company otherwise. Upon termination of the Plan, any balance in each employee’s Account shall be refunded to him or her.
11.    Interest. No interest will be paid or allowed on any money in the Accounts of participating employees, except to the extent payment of interest is required by the laws of any applicable jurisdiction.
12.    Granting of Option. On each Offering Date, this Plan shall be deemed to have granted to the participant an option for as many shares (which may include a fractional share) as he or she will be able to purchase with the amounts credited to his or her Account during his or her participation in that offering. Notwithstanding the foregoing, no participant may purchase more than 500 shares of Common Stock during any single offering. This number may be adjusted as permitted pursuant to Section 20 of the Plan.
13.    Exercise of Option.
13.1    Each employee who continues to be a participant in an offering on the last business day of that offering shall be deemed to have exercised his or her option on that date and shall be deemed to have purchased from the Company the number of shares (which may include a fractional share) of Common Stock reserved for the purpose of the Plan as the balance of his or her Account on such date will pay for at the Purchase Price.
13.2    In the event that the Administrator determines for a future offering that fractional shares may not be issued, any cash balance remaining in a participant’s Account at the termination of an offering that is not sufficient to purchase a whole share of Common Stock, shall be carried over in the participant’s Account and applied to the purchase of Common Stock in the next

5



offering, provided the participant participates in the next offering and the purchase complies with Section 21. If the Participant does not participate in the next offering, such remaining cash balance shall be refunded to the participant as soon as practical after the Purchase Date.
13.3    Any amount remaining to the credit of a participant’s Account after the purchase of shares by the Participant on a Purchase Date which is sufficient to purchase one or more full shares of Common Stock shall be refunded to the participant as soon as practical after the Purchase Date.
14.    Tax Obligations. To the extent any (i) grant of an option to purchase shares, (ii) purchase of shares, or (iii) disposition of shares purchased under the Plan gives rise to any tax withholding obligation (including, without limitation, income and payroll withholding taxes imposed by any jurisdiction) the Administrator may implement appropriate procedures to ensure that such tax withholding obligations are met. Those procedures may include, without limitation, increased withholding from an employee’s current compensation, cash payments to the Company or another Participating Company by an employee, or a sale of a portion of the Common Stock purchased under the Plan, which sale may be required and initiated by the Company.
15.    Employee’s Rights as a Stockholder. No participating employee shall have any right as a stockholder with respect to any shares until the shares have been purchased in accordance with Section 13 above and the Common Stock has been issued by the Company.
16.    Evidence of Stock Ownership.
16.1    Following the end of each offering, the number of shares of Common Stock purchased by each participant shall be deposited into an account established in the participant’s name at the ESPP Broker.
16.2    A participant shall be free to undertake a disposition (as that term is defined in Section 424(c) of the Code) of the shares in his or her ESPP Broker account at any time, whether by sale, exchange, gift, or other transfer of legal title, but in the absence of such a disposition of the shares, the shares must remain in the participant’s ESPP Broker account until the holding period set forth in Section 423(a) of the Code has been satisfied. With respect to shares for which the Section 423(a) holding period has been satisfied, the participant may move those shares to another brokerage account of participant’s choosing.
16.3    Notwithstanding the above, a participant who is not subject to income taxation under the Code may move his or her shares to another brokerage account of his or her choosing at any time, without regard to the satisfaction of the Section 423(a) holding period.
17.    Rights Not Transferable. No employee shall be permitted to sell, assign, transfer, pledge, or otherwise dispose of or encumber either the payroll deductions credited to his or her Account or an option or any rights with regard to the exercise of an option or rights to receive shares under the Plan other than by will or the laws of descent and distribution, and such right and interest shall not be liable for, or subject to, the debts, contracts, or liabilities of the employee. If any such action is taken by the employee, or any claim is asserted by any other party in respect of such right and interest whether by garnishment, levy, attachment or otherwise, the action or claim will be treated as an election to withdraw funds in accordance with Section 9. During the employee’s lifetime, only the employee can make decisions regarding the participation in or withdrawal from an offering under the Plan.
18.    Termination or Transfer of Employment.
18.1    Upon termination of employment for any reason whatsoever, including but not limited to death or retirement, the balance in the Account of a participating employee shall be paid to the employee or his or her estate. Whether and when employment is deemed terminated for purposes of this Plan shall be determined by the Administrator in its sole discretion and may be determined without regard to statutory notice periods or other periods following termination of active employment.
18.2    In the event that a participant who is an employee of a Participating Company in a Non-Statutory Plan is transferred and becomes an employee of a different Participating Company in a Non-Statutory Plan, during an offering, such individual may, subject to the terms and eligibility of the Non-Statutory Plan of the new employer, become a participant under the Non-Statutory Plan of the new employer for the duration of the offering in effect at that time.  Unless otherwise required under local law, any payroll deductions or other approved contributions may continue to be held by the Participating Company former employer of the participant for the remainder of the offering.  At the next Purchase Date, all payroll deductions and other approved contributions made by or to such Participating Company former employer and/or the employer Participating Company shall be aggregated for the purchase of shares of Common Stock under, and subject to the terms and limitations of, the Non-Statutory Plan of the new employer.

6



18.3    In the event that an employee of a Participating Company in the Statutory Plan and who is a participant in the Statutory Plan is transferred and becomes an employee of a Participating Company in a Non-Statutory Plan during an offering, such individual may, subject to the terms and eligibility of the Non-Statutory Plan of the new employer, become a participant under the Non-Statutory Plan of the new employer for the duration of the offering in effect at that time.  Unless otherwise required under local law, any payroll deductions may continue to be held by the Participating Company former employer for the remainder of the offering. At the next Purchase Date, all payroll deductions and other approved contributions made by or to the Participating Company former employer and/or the employer Participating Company may be aggregated for the purchase of shares of Common Stock under, and subject to the terms and limitations of, the Non-Statutory Plan of the new employer.
19.    Amendment or Discontinuance of the Plan.
19.1    The Board may amend the Plan in such respects as it shall deem advisable; provided, however, that, to the extent required for compliance with Code Section 423 or any applicable law or regulation, stockholder approval will be required for any amendment that will (i) increase the total number of shares as to which options may be granted under the Plan, except as provided in Section 20, (ii) modify the class of employees eligible to receive options, or (iii) otherwise require stockholder approval under any applicable law or regulation; and provided further, that except as provided in this Section 19, no amendment to the Plan shall make any change in any option previously granted which adversely affects the rights of any Participant.
19.2    The Plan shall continue in effect for ten years after the date of its adoption by the Board. Notwithstanding the foregoing, the Board may at any time and for any reason suspend or terminate the Plan. During any period of suspension or upon termination of the Plan, no options shall be granted.
19.3    Except as provided in Section 20, no such termination of the Plan may affect options previously granted, provided that the Plan or an offering may be terminated by the Board on a Purchase Date or by the Board’s setting a new Purchase Date with respect to an offering then in progress if the Board determines that termination of the Plan and/or the offering is in the best interests of the Company and the stockholders or if continuation of the Plan and/or the offering would cause the Company to incur adverse accounting charges as a result of a change after the Effective Date in the generally accepted accounting rules applicable to the Plan.
20.    Changes in Capitalization. In the event of reorganization, recapitalization, stock split, stock dividend, combination of shares, merger, consolidation, offerings of rights, or any other change in the structure of the common shares of the Company, the Committee shall make such adjustment, if any, as it may deem appropriate in the number, kind, and the price of shares available for purchase under the Plan, and in the number of shares which an employee is entitled to purchase including, without limitation, closing an offering early and permitting purchase on the last business day of the reduced offering period, or terminating an offering and refunding participants’ Account balances.
21.    Share Ownership. Notwithstanding anything in the Plan to the contrary, no employee shall be permitted to subscribe for any shares under the Plan if the employee, immediately after such subscription, owns shares (including all shares that may be purchased under outstanding subscriptions under the Plan) possessing 5% or more of the total combined voting power or value of all classes of shares of the Company or of its parent or subsidiary corporations. For the foregoing purposes the rules of Section 424(d) of the Code shall apply in determining share ownership, and shares the employee may purchase under outstanding options shall be treated as owned by the employee. In addition, no employee shall be allowed to subscribe for any shares under the Plan that permit his or her rights to purchase shares under all “employee stock purchase plans” of the Company and its parent or subsidiary corporations to accrue at a rate that exceeds $25,000 of Fair Market Value of such shares (determined at the time such right to subscribe is granted) for each calendar year in which the right to subscribe is outstanding at any time. Notwithstanding the above, lower limitations may be imposed with respect to participants in a Non-Statutory Plan or participants in the Statutory Plan who are subject to laws of another jurisdiction where lower limitations are required.
22.    Administration and Board Authority.
22.1    The Plan shall be administered by the Board. The Board has delegated its full authority under the Plan to the Committee, and the Committee may further delegate any or all of its authority under this Plan to such senior officer(s) of the Company as it may designate, to the extent not prohibited by law or rules of the New York Stock Exchange. Notwithstanding any such delegation of authority, the Board may itself take any action under the Plan in its discretion at any time, and any reference in this Plan document to the rights and obligations of the Committee shall be construed to apply equally to the Board. Any references to the Board mean only the Board. The authority that may be delegated by the Committee includes, without limitation, the authority to (i) establish Non-Statutory Plans and determine the terms of such sub-plans (including, without limitation, rules and procedures regarding handling of payroll deductions or other approved contributions, payment of interest, conversion of local currency, payroll tax, withholding procedures and handling of stock certificates that vary with local requirements and determining the eligible employees

7



that may enroll in a Non-Statutory Plan), (ii) designate from time to time which Subsidiaries will participate in the Statutory Plan, which Subsidiaries and Affiliates will be Participating Companies, and which Participating Companies will participate in a particular Non-Statutory Plan, (iii) determine procedures for eligible employees to enroll in or withdraw from a sub-plan, setting or changing payroll deduction amounts, and obtaining necessary tax withholdings, (iv) allocate the available shares under the Plan to the sub-plans for particular offerings, and (v) adopt amendments to the Plan or any sub-plan including, without limitation, amendments to increase the shares available for issuance under the Plan pursuant to Section 20 (but not including increases in the available shares above the maximum permitted by Sections 6 and 20 which shall require Board and stockholder approval).
22.2    The Administrator shall be vested with full authority and discretion to construe the terms of the Plan and make factual determinations under the Plan, and to make, administer, and interpret such rules and regulations as it deems necessary to administer the Plan, and any determination, decision, or action of the Administrator in connection with the construction, interpretation, administration, or application of the Plan shall be final, conclusive, and binding upon all participants and any and all persons claiming under or through any participant. The Administrator may retain outside entities and professionals to assist in the administration of the Plan including, without limitation, a vendor or vendors to perform enrollment and brokerage services. The authority of the Administrator will specifically include, without limitation, the power to make any changes to the Plan with respect to the participation of employees of any Subsidiary or Affiliate that is organized under the laws of a country other than the United States of America when the Administrator deems such changes to be necessary or appropriate to achieve a desired tax treatment in such foreign jurisdiction or to comply with the laws applicable to such non-U.S. Subsidiaries or Affiliates. Those changes may include, without limitation, the exclusion of particular Subsidiaries or Affiliates from participation in the Plan; modifications to eligibility criteria, maximum number or value of shares that may be purchased in a given period, or other requirements set forth herein; and procedural or administrative modifications. Any modification relating to offerings to a particular Participating Company will apply only to that Participating Company, and will apply equally to all similarly situated employees of that Participating Company. The rights and privileges of all employees granted options under the Statutory Plan shall be the same. To the extent any changes approved by the Administrator would jeopardize the tax-qualified status of the Statutory Plan, the change shall cause the Participating Companies affected thereby to be considered Participating Companies under a Non-Statutory Plan or Non- Statutory Plans instead of the Statutory Plan.
22.3    Notwithstanding the provisions of Sections 22.1 and 22.2 above, in the event that Rule 16b-3 promulgated under the Exchange Act or any successor provision thereto (“Rule 16b-3”) provides specific requirements for the administrators of plans of this type, the Plan shall only be administered by such body and in such a manner as shall comply with the applicable requirements of Rule 16b-3. Unless permitted by Rule 16b-3, no discretion concerning decisions regarding the Plan shall be afforded to any person that is not “disinterested” as that term is used in Rule 16b-3.
23.    Notices. All notices or other communications by a participant to the Company or other entity designated for a particular purpose under or in connection with the Plan shall be deemed to have been duly given when received by the Company or other designated entity, or when received in the form specified by the Company at the location, or by the person, designated by the Company for the receipt thereof.
24.    Change of Control. In the event of a Change of Control, each outstanding option shall be assumed or an equivalent option substituted by the successor company or parent thereof (the “Successor Company”). In the event that the Successor Company refuses to assume or substitute for the option, any offering then in progress shall be shortened by setting a new Purchase Date. The new Purchase Date shall be a specified date before the date of the Change of Control. The Administrator shall notify each participant in writing, prior to the new Purchase Date, that the Purchase Date for the participant’s option has been changed to the new Purchase Date and that the participant’s option shall be exercised automatically on the new Purchase Date, unless prior to such date the participant has withdrawn from an offering then in progress or the Plan as provided in Section 9.
25.    Dissolution or Liquidation of the Company. In the event of the proposed dissolution or liquidation of the Company, the offering then in progress shall be shortened by setting a new Purchase Date and shall terminate immediately prior to the consummation of such proposed dissolution or liquidation, unless provided otherwise by the Board. The new Purchase Date shall be a specified date before the date of the Company’s proposed dissolution or liquidation. The Administrator shall notify each participant in writing, prior to the new Purchase Date, that the Purchase Date for the participant’s option has been changed to the new Purchase Date and that the participant’s option shall be exercised automatically on the new Purchase Date, unless prior to such date the participant has withdrawn from an offering then in progress or the Plan as provided in Section 9.
26.    Limitations on Sale of Stock Purchased Under the Plan. The Plan is intended to provide Common Stock for investment and not for resale. The Company does not, however, intend to restrict or influence any employee in the conduct of the employee’s own affairs. An employee, therefore, may sell Common Stock purchased under the Plan at any time the employee chooses, subject to compliance with any applicable Federal, state or foreign securities laws. THE EMPLOYEE ASSUMES THE RISK OF ANY MARKET FLUCTUATIONS IN THE PRICE OF THE COMPANY’S STOCK.

8



27.    Governmental Regulation/Compliance with Applicable Law/Separate Offering. The Company’s obligation to sell and deliver shares of the Company’s Common Stock under this Plan is subject to the approval of any governmental authority required in connection with the authorization, issuance, or sale of such shares. In addition, the terms of an offering under this Plan, or the rights of an employee under an offering, may be modified to the extent required by applicable law. For purposes of this Plan, the Administrator also may designate separate offerings under the Plan (the terms of which need not be identical) in which eligible employees of one or more Participating Companies will participate, even if the dates of the offerings are identical.
28.    No Employment/Service Rights. Nothing in the Plan shall confer upon any employee the right to continue in employment for any period of specific duration, nor interfere with or otherwise restrict in any way the rights of the Company (or any Subsidiary or Affiliate employing such person), or of any employee, which rights are hereby expressly reserved by each, to terminate such person’s employment at any time for any reason, with or without cause.
29.    Dates and Times. All references in the Plan to a date or time are intended to refer to dates and times determined pursuant to U.S. Eastern Standard Time. Business days for purposes of the Plan are U.S. business days.
30.    Masculine and Feminine, Singular and Plural. Whenever used in the Plan, a pronoun shall include the opposite gender and the singular shall include the plural, and the plural shall include the singular, whenever the context shall plainly so require.
31.    Governing Law. The Plan shall be governed by the laws of the State of Delaware without giving effect to principles of conflict of laws, and applicable federal law.
32.    No Liability of Committee Members. No member of the Committee shall be personally liable by reason of any contract or other instrument executed by such Committee member or on his or her behalf in his or her capacity as a member of the Committee nor for any mistake of judgment made in good faith, and the Company shall indemnify and hold harmless each member of the Committee and each other employee, officer or director of the Company to whom any duty or power relating to the administration or interpretation of the Plan may be allocated or delegated, against any cost or expense (including counsel fees) or liability (including any sum paid in settlement of a claim) arising out of any act or omission to act in connection with the Plan unless arising out of such person’s own fraud or willful bad faith; provided, however, that approval of the Board shall be required for the payment of any amount in settlement of a claim against any such person. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such persons may be entitled under the Company’s Articles of Incorporation or By-Laws, as a matter of law, or otherwise, or any power that the Company may have to indemnify them or hold them harmless.


9


Exhibit 31.1
 
Certification of Principal Executive Officer
Pursuant to Section 302 of Sarbanes-Oxley Act of 2002

I, Benjamin Gliklich, certify that:

1.
I have reviewed this Quarterly Report on Form 10-Q of Element Solutions Inc;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date:
August 2, 2019
 
 
 
 
/s/ Benjamin Gliklich
 
Benjamin Gliklich
Chief Executive Officer





Exhibit 31.2
 
Certification of Principal Financial Officer
Pursuant to Section 302 of Sarbanes-Oxley Act of 2002
 
I, Carey J. Dorman, certify that:

1.
I have reviewed this Quarterly Report on Form 10-Q of Element Solutions Inc;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
(a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date:
August 2, 2019
 
 
 
 
/s/ Carey J. Dorman
 
Carey J. Dorman
Chief Financial Officer





Exhibit 32.1
 
CERTIFICATION
OF
CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 

 
I, Benjamin Gliklich, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Element Solutions Inc on Form 10-Q for the fiscal quarter ended June 30, 2019 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Element Solutions Inc.
 

 
 
Date:
August 2, 2019
 
By:
/s/ Benjamin Gliklich
 
Name:
Benjamin Gliklich
 
Title:
Chief Executive Officer



I, Carey J. Dorman, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Element Solutions Inc on Form 10-Q for the fiscal quarter ended June 30, 2019 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Element Solutions Inc.



 
Date:
August 2, 2019
 
By:
/s/ Carey J. Dorman
 
Name:
Carey J. Dorman
 
Title:
Chief Financial Officer